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FiO2 – Fraction of inspired oxygen, usually quoted as a fraction or percentage (i.e. 0.21 or 
21 % is normal oxygen concentration in air), and is the parameter set in a hospital when a 
patient is receiving supplementary oxygen. 
Hypothermia – A fall in body temperature to below 35°C.  Babies have an increased risk 
of hypothermia they lose heat rapidly and cannot easily reverse a fall in temperature (Peters, 
2007). 
Hypovolaemia – An abnormally low volume of blood in the circulation, usually following 
blood loss due to injury, internal bleeding or surgery.  It may also be due to loss of fluid 
from diarrhoea and vomiting (Peters, 2007). 
Septicaemia – A potentially life threatening condition in which there is a rapid 
multiplication of bacteria and in which bacterial toxins are present in the blood (Peters, 
2007). 
Vasoconstriction – Narrowing of blood vessels, causing reduced blood flow to a part of 
the body.  Vasoconstriction under the skin occurs in response to the cold amd reduces heat 
loss from the body (Peters, 2007). 
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In children and newborn babies on intensive care, information regarding blood oxygen saturation 
(SpO2) is determined non-invasively by a device called a pulse oximeter.  Sensors are usually placed 
on a hand or foot where their operation relies on the presence of pulsatile arterial blood.  Light 
shines at two or more wavelengths (usually red and infrared) into the tissue where the pulsatile 
blood modulates, absorbs and scatters the different wavelengths of light in varying amounts and is 
detected by a photo-detector as a photoplethysmograph (PPG). The spectral information received 
is then processed electronically and digitally to determine the amount of haemoglobin present.   
In the sickest of children blood supply can become compromised to these sensor locations and the 
pulsatile component of the blood may diminish and pulse oximeter readings may become 
unreliable, especially at times when accurate blood oxygen information would be vital.  Currently 
the alternative is to take blood from an arterial line and run a relatively lengthy analysis (pulse 
oximeters are near-instantaneous in their operation) that may be unnecessary if the pulse oximeter 
could be relied upon at these critical moments.  In the smallest of babies invasive sampling of blood 
becomes even more of an issue as any blood loss could lead to hypovolaemia and introduce extra 
sites of infection plus it causes a lot of stress to the neonate.   
Since central blood flow may be preferentially preserved, the anterior fontanelle was investigated as 
an alternative monitoring site.  Custom reflectance fontanelle and reference PPG sensors have been 
designed and built to investigate the fontanelle in those children at risk of peripheral supply 
compromise.  Dedicated instrumentation and software has also been successfully developed for the 
control of the sensor electronics and the data-logging of PPG signals for retrospective analysis. 
Sixteen neonates were recruited for fontanelle monitoring; all were ASA 1 – 3 (ASA ranges from 1 
to 5 where 1 is the least sick and 5 is the most critically ill).  As part of the approved protocol the 
delivered oxygen to the patients was artificially altered to look for corresponding changes in PPG 
signal amplitudes.  Amplitude results reveal strong correlations (R > 0.5) between the reference 
sensor (placed on the foot) and the fontanelle sensor.  This suggests that the fontanelle sensor is 
sensitive to changes in amplitude when oxygen in the blood alters.  Correlation of the health of the 
child, using the ASA score, and the difference in amplitudes of PPGs between the sensors reveals 
that the fontanelle sensor does detect increasing fontanelle PPG amplitudes when compared to the 
PPGs from the reference sensor the sicker the child is, confirming that pulsatile flow is being 
preferentially preserved at the fontanelle in those children who are the most at risk from peripheral 
supply compromise.  SpO2 estimation at the fontanelle reveals a mean difference of 2.2 % to the 
SpO2 as read by the commercial device and a 1.7 % difference to the blood gas results.  These 
results confirm that the anterior fontanelle may be used as an alternative location for SpO2 
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Introduction 
aediatric and neonatal intensive care relies on constant monitoring of the vital signs 
of the child.  Pulse oximetry has been called the “Fifth Paediatric Vital Sign” (Mower 
et al., 1997) 
In neonates and paediatrics it has been shown that at times of periphery supply 
compromise, caused by the onset of hypovolaemia, hypothermia or septicaemia, the pulse 
oximeter can become inaccurate or fail (Kugelman et al., 2004).   
The cause of these inaccuracies and failures are due to the fundamental principle on which 
pulse oximeters work. Pulsatile blood at the area of measurement, typically a hand or foot, 
is detected by a dual-wavelength light source (red and infrared light emitting diodes) and 
photo detector (a photodiode or phototransistor).   The different wavelengths of light are 
absorbed differently by oxygenated haemoglobin (HbO2) and deoxygenated haemoglobin 
(Hb) and the detected intensities are modulated by the pulsatile arterial blood, this 
modulation is then used to determine what percentage of HbO2 is present within the 
arteries.  This method of measurement is known as photoplethysmography (PPG).  
Conditions such as hypovolaemia and hypothermia can cause vasoconstriction at the limbs, 
which can cause a compromise of blood flow to the periphery, and thus the PPG signal 
needed for SpO2 calculation diminishes, and the pulse oximeter may report an incorrect or 
no SpO2 value.  It is at these times that a constant SpO2 reading would be the most 
beneficial, as an estimation of oxygenated blood may be useful in the treatment and 
diagnosis without having to run a separate invasive blood-gas analysis test, as this takes 
time and may be obtrusive, especially if the patient has no arterial line present. 
1.1 Hypothesis 
It has been proposed that the anterior fontanelle (AF), the soft area of unformed skull on a 
newborn, be tested as an alternative site for saturation monitoring.  The hypothesis 
underlying this is that the blood supply is preferentially preserved at this location at times 
where the peripheral circulation is compromised, as the body tries to protect the most vital 
organs. 
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At the AF there is no obstruction offered by any bony material, therefore it is theorised 
that the AF can be used as an optical window where both red and infrared light can be 
used to make PPG measurements at a point below the scalp to directly monitor saturation.  
Other studies into SpO2 readings from the core of the neonate would also support this 
(Kugelman et al., 2004) and a singular study where the AF was included as a site for PPG 
monitoring for the assessment of intrapartum monitoring showed that it is possible to 
receive PPGs in this location (Dassel et al., 1997).  A second location, the infant 
oesophagus has also been given consideration for alternative SpO2 monitoring, based on 
previouis work (Kyriacou et al., 2008). 
To test these hypotheses a schedule of technical work and clinical experiments has been 
designed to investigate these two areas for PPG monitoring.  Below is an outline of this 
research and the work carried out. 
1.2 Thesis Outline 
Chapter two presents a basic description of the anatomy under investigation for alternative 
SpO2 monitoring.  An emphasis has been given to the localised blood supply of the head 
and the oesophagus and the basic structure of those organs so as to better understand the 
design choices made in chapter six for the construction of the PPG sensors.  The 
circulatory and respiratory systems have also been briefly described for their role in the 
transport of oxygen in the body. 
Chapter three introduces the concept of photoplethysmography to this research and the 
modalities in which it can operate.  A short history of photoplethysmography and its 
relation with pulse oximetry has also been included. 
Chapter four covers in greater detail the history of the design of the pulse oximeter and the 
scientific concepts that underpin its operation.  The technology of the pulse oximeter has 
been outlined with its applications of use and a brief description of some of its limitations. 
Chapter five describes in detail the use of the pulse oximeter in paediatric care.  Attention 
has been focused on what affects the reliability and accuracy of pulse oximetry, in particular 
on those areas of research that have looked at improving outcomes when the pulse 
oximeter fails due to poor periphery blood supply.  A hypothesis has been brought forward 
as to how to improve reliability in those neonatal and paediatric patients at risk of 
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periphery supply failure, by suggesting the anterior fontanelle and infant oesophagus as 
alternative locations of measurement for SpO2. 
Chapter six begins the technical aspect of this research by describing the design, 
construction and pre-trial evaluations of custom anterior fontanelle, reference and 
oesophageal sensors.  Instrumentation and software was developed simultaneously to allow 
the ongoing improvement of all three technical aspects (sensors, instrumentation and 
software) until a satisfactory PPG monitoring setup was established. 
Chapter seven describes the detailed electronic design, prototyping and testing 
documentation of the necessary hardware instrumentation needed to drive the custom 
PPG sensors and detect the returning optical signals received from the tissue. 
Chapter eight finalises the technical aspect of this research by describing the design of the 
LabVIEW virtual instrumentation software needed to interact with the developed hardware 
from chapter seven.  This software is responsible for data logging the recorded PPGs, and 
time-stamping important markers into the raw data files for synchronising with clinical 
events, critical to the retrospective analysis described in the following chapters. 
Chapter nine presents the methodology used in the assessment of PPG signals for SpO2 
estimation, specifically how the PPGs were processed and the equations needed to 
compute SpO2. 
Chapter ten presents the results of amplitude analysis from 16 neonatal intensive care 
patients who underwent anterior fontanelle PPG investigations during delivered oxygen 
change.  Correlations between the amplitudes of the PPG signals from the sensors and the 
monitoring periods have been made, as well as assessments of the amplitudes for each class 
of patient (ASA 1, 2 and 3). 
Chapter eleven are the results of the outcome of SpO2 calculation on the received PPGs 
described in chapter ten.  Comparisons with clinical devices and methods of measurement 
have been made and the accuracy of the new sensors has been assessed. 
Chapter twelve describes two in-vivo case studies utilising the oesophageal sensor 
described in chapter six.  Two ASA – 3 patients, considered at risk of periphery supply 
compromise were studied.  Similar amplitude and SpO2 analysis carried out in chapter ten 
and eleven was performed on the data gathered from these two children. 
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Chapter thirteen critically discusses the results obtained from all clinical trials and makes an 
overall evaluation on the performance of the technology developed.  Future work is 
suggested and final thoughts brought forward. 
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The Neonatal Head and the Infant Oesophagus 
he human body needs oxygen (O2) in order to metabolise food and release energy, 
and is therefore an essential statistic that needs constant monitoring in the paediatric 
intensive care environment. 
For continuous, non-invasive monitoring of blood O2 levels, a device called a pulse 
oximeter is utilized. This device will be discussed in detail in chapter four.  Various 
disadvantages of this technology, which are covered in the later chapters, mean that 
traditional monitoring locations, such as the periphery (toe, finger), are not always suitable 
for all patients in certain clinical situations, and most critically for this thesis, new-born 
babies and small children in intensive care.  In an effort to overcome the limitations of 
current commercial pulse oximeters when applied to these populations, this thesis proposes 
the development of new pulse oximeter sensors designed to be applied at new anatomical 
areas such as the soft spot (anterior fontanelle) of a new-born’s head, and the infant 
oesophagus.  The underlying hypothesis is that such locations might be better perfused in 
cases where the peripheral commercial probes fail to estimate blood oxygen saturation. An 
overview of the related anatomy needs to be described before this technology is further 
discussed.  This chapter provides a synopsis of the anatomy of the fontanelle and of the 
oesophagus and their relation with the surrounding vasculature.  
2.1 The Fontanelle of the Neonate 
The skull is made up of forty-four separate bones, in an adult these are fused together 
along rigid joints, known as sutures (Carlson, 2004).  At birth these bones are not fused 
rigidly, between them there is a connective fibrous tissue (un-ossified mesenchyme), this 
results in large soft gaps between the cranial bones, where sutures intersect; these are the 
fontanelle, more commonly referred to as “soft spots” and are illustrated in figure 2.1.  The 
term fontanelle comes from the Latin fontanelles meaning “little fountain”, as the pulsations 
from the brain, which can be visibly observed at these soft spots, are said to resemble the 
rising and falling of a fountain head (Gray, 2008). The flexibility of the skull, thanks to the 
presence of this connective tissue, aids in the birthing procedure by allowing the head to 
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distort and thus pass more comfortably along the birth canal.  They also aid in later 
development of the child by allowing rapid growth during infancy (Graaff et al., 2009). 
 
 
Figure 2.1. The Neonatal Skull, taken and adapted from (Gray 2008).  Left; Side profile view of skull. Right; 
Top oblique view of skull. 
There are six main fontanelle at birth, the largest of these is the anterior fontanelle (AF), 
located at the junction of the frontal and parietal plates, between the frontal, coronal and 
sagittal sutures.  The other five include one occipital fontanelle (OF), two mastoid 
(posterolateral) fontanelles and two sphenoidal (anterolateral) fontanelles.   
By about eight weeks the OF will close, however the large AF can persist for eighteen 
months, and usually by 24 months the fontanelle have ossified enough for the skull to be 
fully rigid, offering a protective covering for the brain (Scanlon and Sanders, 2007).  
Ossification is the process by which bone is formed, renewed and repaired, starting in the 
embryo and continuing throughout life (Peters, 2007). 
Clinically the AF can be examined to note possible dehydration (the AF appears “sunken”), 
or a possible rise in intracranial pressure (indicated by a tense or bulging appearance).  
Commonly in intensive care ultrasonography is used to image the neonatal brain through 
either the OF or AF to aid in the diagnosis of conditions such as intracranial bleeds.  The 
AF also serves as a landmark for withdrawal of blood for analysis from the superior sagittal 
sinus (Derrickson and Tortora, 2008). 
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2.2 Vasculature of the Head 
Blood supply to the head can be split into two areas, the one that serves the face and scalp, 
and that one that serves the internal organs such as the brain and sensory organs. 
The internal and external carotid arteries branch into five main pairs of arteries that supply 
the face and scalp; the ophthalmic branch from the internal carotid supplies blood to the 
supratrochlear and supraorbital arteries that in turn connect to the midline and lateral 
forehead sections of the scalp.  Figure 2.2 depicts the main superficial arteries and veins of 
the face and scalp.  The external carotid artery branches to the superficial temporal, 
posterior auricular and occipital arteries which supply oxygenated blood to the temporal, 
auricular and occipital region of the scalp respectively (Scanlon and Sanders, 2007).  
Venous drainage commences with respective paired veins that all drain into the internal 
jugular vein. 
 
Figure2.2: The Superficial Arteries of the Face and Scalp, Adapted from, © 2009; 
The brain receives oxygenated blood from the carotid arteries, which commences from the 
arch of the aorta, and returns deoxygenated blood via venous drainage into the jugular vein 
(Scanlon and Sanders, 2007).  The blood supply that communicates with the external 
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surfaces of the brain is the extracranial artery from the internal carotid artery.  This 
subdivides into the anterior, posterior and middle cerebral arteries, which supply the frontal 
and occipital lobes, the inferior temporal lobe and the frontoparietal somatosensory cortex 
(Scanlon and Sanders, 2007).  These three arteries subdivide even further to supply blood 
over the entire surface. 
Venous drainage commences via the internal cerebral veins into various sinuses via veins 
on the dura mater.  The largest of these sinuses is the sagittal sinus which runs from the 
anterior to the posterior between the two hemispheres within the longitudinal fissure of the 
brain (Scanlon and Sanders, 2007).  The longitudinal fissure runs directly beneath the join 
between the parietal and frontal bones of the skull, and thus runs directly beneath the AF.  
Figure 2.3 illustrates the position of the sagittal sinus in the head. 
 
Figure 2.3.  The Sagittal Sinus, taken and adapted from (Gray, 2008). Left; Superior cut-away view. Right; 
Mid-sagittal view. 
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2.3 The Oesophagus 
The oesophagus is the muscular tube that connects the pharynx to the stomach, its’ 
primary function is the transportation of food and liquid to the stomach, therefore it forms 
part of the digestive system.  At birth the oesophagus has been shown to be (Jackson, 
1950), approximately 10cm in length and increases by: 




The route of the oesophagus, as illustrated in figure 2.4, starts at the back of the oral cavity 
in the neck, at approximately C5-6 vertebrae, the pharyngoesophageal junction.  It 
descends anteriorly through the mediastinum and traverses the diaphragm, at 
approximately T10 of the vertebrae, at which point it then extends through the 
gastroesophageal junction and ends at the orifice of the stomach (Gray, 2008).  On its 
route through the thorax the oesophagus passes behind the trachea and the pericardium, 
the double-walled sack that protects and encloses the heart and the roots of the great 
vessels, the aorta and the vena cava, and in front of the spine (Faller, 2004). 
 
Figure 2.4.  The Route of the Oesophagus, downloaded from (training.seer.cancer.gov, 2010) June 2010. 
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2.4 Vasculature of the Oesophagus 
The blood supply of the oesophagus is directly supplied by the core blood supply, via 
vessels from the aorta and drains into the vena cava via various stem veins and the portal 
vein. 
There have been many studies detailing the major stem vessels supplying blood to the 
oesophagus, all using different techniques and with varying results (Shapiro and Robillard, 
1950, Swigart et al., 1950, Gloor, 1953, Tompsett, 1969, Lunderquist et al., 1983) took this 
previous work further and was able to visualize the microcirculation as well as the 
macroscopic display of the major arteries.  The study concluded that the cervical portion is 
supplied by the superior and inferior left and right thyroid arteries, the intrathoracic by 
stem arteries from the caudal aspect of the aorta and the intra-abdominal supply is 
delivered by vessels from the left gastric artery and the splenic artery, a general pattern of 
blood supply from the study was constructed and illustrated in figure 2.5. 
 
Figure 2.5.  Pattern of Blood Supply to the Oesophagus, reproduced from (Liebermann-Meffert et al., 
1987) 
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It was observed in an earlier study (Williams and Payne, 1982) that two cases in adults, long 
sections of oesophagus remained well perfused with blood even after being detached from 
their segmental blood supply.  This suggested that the oesophagus complements the supply 
of blood to itself by a rich intramural network of arteries and veins. 
Main drainage is facilitated by two major routes; the first into the superior vena cava via the 
azygous and hemiazygous veins for the upper portion, the second into the  portal vein via 
branches of the left gastric vein for the lower portion (Hansen and Lambert, 2005) 
2.5 The Circulatory and Respiratory System  
The vasculature just described are of course part of the circulatory system, a rich network 
of arteries and veins that supply all the tissues of the body with the blood needed in order 
to receive O2, energy and to exchange waste products such as carbon dioxide (CO2).  The 
circulatory system comprises of two blood circulations, the pulmonary circulation (through 
the lungs) and the systemic circulation (Peters, 2007). 
The pulmonary circulation carries deoxygenated blood from the systemic circulation to the 
lungs where it exchanges waste CO2 with O2 from the air at the blood-air interface (the thin 
barrier between individual alveoli sacks in the lung and the blood vessels which surround 
them) (Graaff et al., 2009).  Blood is then returned to the heart where it is then passed to 
the systemic circulation and distributed to the body via various branches from the aorta, 
the major blood vessel leading from the heart.  Oxygen is exchanged with the tissues in the 
body for waste CO2 and the blood returns to the heart via the veins where it re-joins the 
pulmonary circulation to begin the process once again (Graaff et al., 2009). 
2.6 The Respiratory System 
The function of the circulatory system is to deliver O2 and energy, and also remove waste 
(CO2).  This cannot be fully accomplished without the function of the respiratory system. 
The respiratory system comprises of the lungs, airways (nasal cavity, trachea and bronchi) 
and the respiratory muscles (the diaphragm and intercostal muscles of the rib cage). The 
action of the diaphragm and the intercostal muscles draws air into the lungs where the 
blood-air interface aids in the transferal of O2 from the air, and the exchange of waste CO2 
from the blood.  Relaxation of these muscles expels air, and therefore the waste CO2 from 
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the body (Derrickson and Tortora, 2008).  Figure 2.6 illustrates all the major components 
of the respiratory system. 
 
Figure 2.6.  The Respiratory System adapted from (www.student.loretto.org/anatomyphys/, 2013 
(downloaded)) 
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Photoplethysmography 
irst described in the 1930s (Rolfe, 1979), photoplethysmography is a photometric 
technique that is commonly used to monitor blood volume changes in a micro-
vascular bed of tissue (Allen, 2007).  This chapter describes the key concepts of 
photoplethysmography, the principles of operation of the technique and a brief history of 
its discovery and how it is used in healthcare.   
3.1. Key Concepts of Photoplethysmography 
Most of the studies conducted utilizing the technique of photoplethysmography have been 
concerned with monitoring on the peripheral parts of the body such as fingers, toes, ear 
lobes and other skin vascular surfaces, however there are reports that 
photoplethysmography has been used in the monitoring of more internal organs such as 
the oesophagus (Kyriacou, 2006) and other splanchnic organs (Hickey et al., 2011) 
Photoplethysmography – literally meaning “measurement of volume change through the 
use of light” is a widely accepted term when used to describe the measurement of blood 
pulsations in skin and organs, utilising an optical source and a photo-detector.  However, 
this is considered somewhat inaccurate, as alternative theories and practical experiments 
have revealed that the PPG waveform is far more complicated (Rolfe, 1979). 
Fundamental to the idea of photoplethysmography is the fact that light is observed to pass 
through tissue, this can be demonstrated simply by holding a light source such as a torch 
against a hand and being able to discern a faint red “glow” around the torch and on the 
other side of the hand(Rolfe, 1979).  A relatively broad-spectrum white light traverses the 
tissues of the hand and photons are absorbed, scattered and reflected, the faint red glow we 
see is a result of these processes having varyingly different amounts of effects on different 
wavelengths of light until only the red hues are permissible.  Utilising photo-detectors, a 
quantitative analysis of this light shows that the light being received varies with time and in 
synchronicity with the beating of the heart (Allen, 2007). 
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The observations made with the torch reveal that detecting photons from the light source 
can be done with two different methods of source-detector orientation.  Where light is 
seen to pass all the way through the hand the photo-detector can be placed opposite the 
source, this is called transmission-mode photoplethysmography. This is the common 
technique used in ambulatory or bedside monitoring where a pulse oximeter (a device used 
to measure blood oxygen saturation utilising the principles of photoplethysmography) uses 
a finger probe attached to the patient.  A diagrammatic representation of transmission-
mode photoplethysmography is shown in figure 3.1.   
 
Figure 3.1.  Transmission-mode photoplethysmography, source and detector are opposite. 
The second method involves orientating the source and detector on the same plane, the 
glowing around the torch would then be detected as light is back-scattered towards the 
sensor, this is called reflectance-mode photoplethysmography and is illustrated in figure 
3.2.  Monitoring sites used are typically the forehead or the temple, however monitoring 
from any site is possible (Rolfe, 1979).   Reflectance mode has found a use in the research 
of new ways of monitoring PPGs from various anatomical sites (Kyriacou, 2006, Phillips et 
al., 2009, Phillips et al., 2010, Hickey et al., 2011), where the usage of a transmission mode 
sensor is impractical. 
 
Figure 3.2. Reflection-mode photoplethysmography, source and detector are adjacent. 
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The properties of the PPG waveform, whether from transmission or reflectance mode, 
bare the same physical characteristics.  As the heart contracts (systole) blood is forced 
through the arterial system and a pressure wave is produced, which gives rise to an increase 
in blood volume at sites where these “pulses” can be physically observed.  During 
photoplethysmographic monitoring the increase in blood volume can be attributed 
(although it is debated that this is not the only contributory factor to the PPG waveform) 
by a reduction in the light intensity that is being received by the photo-detector.  This in-
turn represents itself as a decrease in current output from the photodetector, and therefore 
a decrease in electrical voltage, when observed using an oscilloscope (assuming no signal 
inversion).  At diastole, the heart relaxes and the pressure wave diminishes and therefore so 
does the blood volume at the pulse sites.  This manifests as a rise in electrical voltage on 
the oscilloscope as the amount of light penetrating through to the detector intensifies.  The 
PPG waveform is more commonly plotted with absorption rather than voltage; these are 
inversely proportional, so diastole is now represented by the trough of the waveform, and 
systole with the peaks.  The actual morphology of the signal produced has a large DC 
offset with a vaguely sinusoidal riding waveform.  The riding waveform is indicative of the 
process just described and has a distinct shape, with notches and a generally steeper 
increase at the systolic portions of the signal, the photoplethysmographic signal (figure 3.3) 
can be divided into two separate components; 
DC PPG – Manifests on the plot (figure 3.3) as a perceptibly consistent voltage offset.  
Since light is always passing through tissue, some of this light is always absorbed by the 
skin, bone, other various tissues and venous blood.  Signal extraction techniques can 
extract this component for further analysis, usually with simple low-pass filters with a 
typical bandwidth of 0 - 0.5 Hz  (Webster, 1997). 
AC PPG – The pulsatile component of the signal and its’ origin comes from the beating of 
the heart as has been previously described.  This rides on top of the DC PPG and only 
accounts for 1 – 2% of the entire signal.  Like the DC part this can also be extracted for 
individual analysis using a band-pass filter with a typical bandwidth of 0.5 – 20 Hz is typical 
(Webster, 1997). 
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Figure 3.3.  The AC-DC characteristic of the Photoplethysmographic (PPG) signal. 
3.2. History and Origin of the Photoplethysmographic Signal 
In 1936 Molitor & Knizazuk, and Hanzliki et al both described photoelectric apparatus 
used to measure blood volume changes in the rabbit ear where they were investigating the 
effects of occlusion and vasoactive drugs.  Molitor & Knizazuk also described an apparatus 
where the photocell and light source were adjacent and a report of recordings from human 
fingers was made(Rolfe, 1979). 
Early work in this time, which provided the greatest knowledge, was probably due to one 
individual and the work done by his affiliates, Alrick B. Hertzman, who conducted 30 years 
of experiments in this subject.  His first paper on photoplethysmography was published in 
1937 (Hertzman, 1937); Hertzman coined the term “photoelectric plethysmograph” and 
made measurements using his apparatus to show blood volume changes induced by 
exercise, cold, and the Valsalva manoeuvre (forceful exhalation with the mouth and nose 
shut) (Rolfe, 1979). 
The AC and DC PPG components previously described were considered by Hertzman 
early on (Hertzman and Dillon, 1940), and the apparatus was modified to amplify these 
components separately.  For the first time simultaneous measurements of both 
components were shown to provide more information on vasomotor changes (dilation or 
constriction properties of blood vessels) of the skin which was not possible previously. 
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The advancement of semiconductor technology reduced the size of early photo-detectors, 
whilst also making them more sensitive(Rolfe, 1979).  New studies were conducted that 
were able to look at the previous findings in more detail.  Senay et al (1960) and Hertzman 
and Flath (1963) (Senay et al., 1960, Hertzman and Flath, 1963), were able to detect the 
onset of cutaneous vasodilation in fingers and forearms.  In 1968 and 1969, Pollard, and 
Weinman et al  respectively (Pollard, 1968, Weinman et al., 1969) both confirmed findings 
from Hertzman of the Valsalva manoeuvre causing changes in blood flow in the skin. 
Section 3.1 described the general formation of the photoplethysmographic signal as 
observed with the arterial pulse, however as stated earlier there is debate amongst scientists 
as to the true origin of the signal which has produced experimental results that demonstrate 
the PPG as a far-more complicated signal.  Moyle (Moyle, 2002) describes several key 
factors that affect the amount of light received by the photo-detector, these include; 
changes in the amount of blood under the probe, erythrocyte orientation, erythrocyte 
concentration (hematocrit of the blood), rouleau formation, local blood velocity, separation 
of light source and detector, arterial inflow and venous outflow. 
Notably it is the effect of the erythrocytes (red blood cells) that have produced some 
interesting studies.  In 1967 D’Agrosa and Hertzman studied various small vessels, (frog 
mesentery, hamster cheek pouch and rat mesoappendix) using microscopic photoelectric 
photometry (D'Agrosa and Hertzman, 1967).  The study looked at the varying opacity of 
the vessels during different inhibited situations, such as the injection of adrenalin, and they 
compared their results to that of others and concluded that the “opacity pulse” of arterial 
vessels is not volumetric in origin.  A postulation was put forward that either the pulse is 
due to orientation of the erythrocytes, and/or a change in hematocrit (concentration of red 
blood cells) of the blood.  In 1981 Nijboer, Dorlas and Mahieu published results from a 
rigid tube experiment that make suggestions that for reflectance photoplethysmography the 
erythrocyte orientation did have an effect on detected light intensity (in vitro 
experimentation) (Nijboer et al., 1981).  During systole the erythrocytes would align 
themselves perpendicular with the flow of the blood, and in diastole the alignment would 
be parallel, figure 3.4.  However the in vivo results showed that the reflection of light from 
surrounding tissue dominates reflection from erythrocytes, thus, in vivo, the reflectance 
PPG is dominantly an absorption measurement, and it cannot be said for certain if this 
mechanism is a major contributory factor.   
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Figure 3.4.  Erythrocyte orientation with systolic and diastolic action. 
3.3. Photoplethysmography in Pulse Oximetry and Summary 
Early bedside oximeters (such as the 1970 HP47201A) used multiple wavelengths of light 
and complicated computer algorithms to distinguish the oxygenated blood from the 
deoxygenated.  Although a vast improvement and a breakthrough for early clinical non-
invasive oximetry, this device required that the tissue was heated, and this presented the 
risk of burning, especially to infants who have sensitive skin (Webster, 1997).   
The pulse oximeter challenged this method by assuming that the pulse detected via the 
photoplethysmogram was solely due to the arterial component of the blood supply, and 
therefore the oxygenated haemoglobin.  This lead to the invention of the pulse oximeter in 
1973 by Takuo Aoyagi (Japan), a detailed history and the functionality the pulse oximeter is 
described in the next chapter. 
Essentially a pulse oximeter shines light at two or more wavelengths through a tissue bed, 
e.g. the finger or earlobe, and measures the returning light signal.  Differences in detected 
light are computed to obtain a reading for arterial blood oxygen saturation, or SpO2.  The 
wavelengths chosen (usually one red and one infrared), are such that the light absorbance 
for oxygenated and deoxygenated haemoglobin is different enough to accommodate 
adequate sensitivity to each of the haemoglobin types (Webster, 1997). 
Many, if not all of today’s modern pulse oximeters include the ability to display a 
photoplethysmographic signal (figure 3.5), the use of which is used to determine whether 
the pulse oximeter is functioning correctly, as it is considered good practice to treat any 
pulse oximeter reading with caution when the photoplethysmograph signal is not displayed, 
or does not resemble an arterial pressure waveform, complete with a diacrotic notch 
(Moyle, 2002). 
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Figure 3.5.  A modern pulse-oximeter, complete with  with plethysmograph signal display (downloaded 
from www.masimo.com, 2010). 
The photoelectric plethysmograph, or photoplethysmography is a relatively simple concept 
to understand, however the implementations to which it can be applied to in medicine have 
far reaching benefits in health care.  The next chapter Pulse Oximetry describes in detail the 
operation of this device and how the concepts introduced in this chapter have been 
effectively applied to make measurements of blood oxygen saturation (SpO2). 
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Pulse Oximetry  
ver the period of sixty years (late 1920s to 1980), new technological advancements 
and scientific discoveries propelled the measurement of arterial blood oxygen 
saturation from an in vitro method (Glen A Millikan’s blood oxygen saturation meter) to a 
real time in vivo method (The first commercially available pulse oximeter, Minolta 
OXIMET, 1980).  This chapter covers a brief history of this development and looks at the 
key scientific discoveries that inspired the work done by the pioneers in this field.  The 
technology and methods used, applications and limitations are also described. 
4.1 A Short History of the Development of the Pulse Oximeter 
The pigment that gives rise to the reddish hue in blood, haemoglobin, had been crystallized 
from various animals as early as the 1840s, but it wasn’t until 1862 that this substance was 
first reported to change colour when mixed with oxygen by the biochemist Felix Hoppe-
Seyler (Hoppe-Seyler, 1864).  Hoppe-Seyler described the process of colour change as 
“beautiful” and noted two specific absorption bands, one at 560 nm and the other at 
535 nm (both in the visible green band of the electromagnetic spectrum.)  In 1864 a 
physicist, George Gabriel Stokes, was the first to report the effect of treating blood with a 
reducing agent, observing that the two distinct bands merge to a broader absorption band 
with a peak roughly half-way between the peaks for the untreated blood (Stokes, 1864).  
Crucially it was what Stokes did next in his experiment that demonstrated for the first time 
the dual-nature of the pigment, he reintroduced oxygen by shaking the blood with air, and 
the original bands reappeared.  This process could be repeated indefinitely, and Stokes 
concluded that the pigment could exist in two states of oxidation, distinguished by their 
visible difference in colour (red for the oxygenated state, and deep red/purple for the 
deoxygenated state).  Stokes called these two substances Scarlet Cruorine and Purple 
Cruorine, but it is Hoppe-Seyler’s oxyhaemoglobin and haemoglobin, respectively, that we 
use today (Edsall, 1972). 
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In the late 1920s Glenn Allan Millikan from the physiological laboratory in Cambridge built 
and tested, as part of his graduate thesis, a simple device for measuring the oxygenation of 
a haemoglobin solution.  His basic setup is shown in figure 4.1. 
 
Figure 4.1. Principle of photoelectric colour analyser applied to haemoglobin (Millikan, 1933). 
Light from a mercury-arc lamp passes through two filters (one purple and one yellow), so 
that when light goes from one end of the colour spectrum to the other there will be a 
significant change in the light being detected on one side of the differential photo-electric 
cell, the distribution of light reverses and thus so does the electric potential measured on 
the galvanometer.  The absorption spectra for oxyhaemoglobin and haemoglobin were 
obtained, and calibration curves were derived.  When samples of known saturation were 
then tested the overall accuracy of the device was approximately 4% for individual readings 
(Millikan, 1933, Severinghaus and Astrup, 1986). 
In 1931 and 1934, Ludwig Nicolai and his associate Kurt Kramer performed the first 
oximeter experiments in vivo (Nicolai, 1932, Kramer, 1934).  Nicolai’s apparatus used the 
same Hg-ARC lamp as Millikan, and his protocol for measurement produced results that 
showed that the light transmitted through tissue, that had been occluded, would change 
linearly with time, when the logarithm was plotted.  This was as expected as one would 
expect to see with oxygen consumption in a tissue.  Kramer’s experiment used the 
principles of the Beer and Lambert Law (see section 4.2) by fixing the optical path length 
(2 mm cuvette) of an exposed, unopened blood vessel in a groove (see figure 4.2).  He 
changed his light source from the blue-green emission of the Hg-ARC lamp used by 
Nicolai and Millikan, and used an incandescent source with a red filter.  Using a 
galvanometer, to make measurements, Kramer showed that saturation could be measured 
reproducibly and to an accuracy of ±1% (Severinghaus and Astrup, 1986).  
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Figure 4.2.  Kramer’s apparatus for optically recording oxygen saturation in unopened arteries of 
experimental animals (Severinghaus and Astrup, 1986). 
The first oximeter system to utilise two spectral regions, one not affected by the other, 
similar to what is seen in today’s modern pulse oximeters, was developed by Karl Matthes 
and Franz Gross in 1939.  The device was a red-infrared ear oxygen saturation meter, 
however it proved too large and inconvenient to use, and Matthes and Gross went back to 
reinvestigate the spectral properties of blood in order to improve the accuracy of their 
device (Severinghaus and Astrup, 1986). 
The second-world war stimulated the need for an oximeter device that could be used in 
military aircraft in the unpressurized cabins.  In 1940 Millikan had developed a working 
device, figure 4.3, which, according to a report by his wife, could be used to control a servo 
system that would control the supply of oxygen to the mask of the pilot wearing the device. 
 
Figure 4.3.  The Millikan Oximeter (Severinghaus and Astrup 1986). 
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Also in 1940, J R Squire from University College Hospital, London, added a new concept 
to the measurement procedure, by setting a zero point for the optical channels he used 
(one red, one infrared).  By compressing the tissue in the web of the hand, and squeezing 
out the blood, when the compression was released the change in absorption signal seen 
would only be due to the blood returning, thus the surrounding tissue could be eliminated 
in their estimation of oxygen saturation (Squire 1940).  Squire also introduced the idea of 
adjusting the red and infrared signal strengths, so that they would be equal with the inflow 
of blood, which should have made compensation perfect.  This method was used by Earl 
Wood from the Mayo Clinic in his experiments, and anticipated the idea of the pulse 
oximeter (Severinghaus and Astrup, 1986). 
In 1948 J E Geraci, under the guidance of Earl Wood at the Mayo Clinic, modified the 
Millikan ear oximeter to include an inflating balloon (Wood and Geraci, 1949).  This was 
inflated to occlude the tissue in the ear and set a device “initial zero setting,” similar to 
Squire’s instrument.  The balloon was deflated and the influx of blood to the tissue was 
used to determine the saturation reading.  By 1950 the Mayo group had reported use of the 
new oximeter in newborn infants, thoracic surgical operations, cardiac diagnostic 
procedures and exercise testing (Severinghaus and Astrup, 1986). 
In the Hewlett Packard Journal of October 1976 (Merrick and Hayes, 1976), a review of 
the methods of oximetry, and a new multi-wavelength device were discussed.  In this they 
highlighted the key limitations on the work done by Wood and those before him on ear 
oximetry.  With regard to the ear oximetry technique they noted these points; The 
bloodless ear is not truly bloodless; The optical characteristics of the compressed ear differ 
from those of the ear in the normal state; The optical path in the compressed state differs 
from that of the relaxed state; Any movement of the earpiece changes the measuring 
circumstances, requiring a re-measurement of the bloodless state; The forces required to 
secure the earpiece could interfere with the flow of blood. 
It was Robert Shaw, an M.D. from the Presbyterian Hospital in San Francisco that went to 
Hewlett Packard and showed that using a combination of measurements from several 
wavelengths it was possible to overcome these limitations.  Feasibility studies were 
conducted, a product was designed and finally the achievement was the Hewlett Packard 
Model 47201A Oximeter (Figure 4.4) (Merrick and Hayes, 1976).  In operation the device 
used a Tungsten-Iodine lamp with a rotating wheel of optical filters that cut the beam 
sequentially.  This light was carried by a fibre-optic bundle to the emitting window of the 
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earpiece.  A returning bundle of fibres carried the transmitted light back to the instrument 
where a silicon photo-detector and amplifier was used to measure the returning light.  The 
rotating filter was used to synchronise reference and ear measurements so that the 
difference in each measurement for each wavelength could be compared, measured and 
digitised by an on-board analogue to digital converter.  An on-board computer then made 
the calculation of oxygen saturation. 
 
Figure 4.4. Model 47201A Oximeter (left) and application of the ear probe (Merrick and Hayes, 1976). 
The pulse oximeter, as we know it today, was conceived in December 1972 by Takuo 
Aoyagi (Nihon Kohden Corporation, Japan).  In a review of his discovery (Aoyagi, 2003), 
Aoyagi makes it clear that the majority of his research was based on work done by the likes 
of Wood and Squire, even going as far as obtaining a Wood ear oximeter that they could 
study.  The principles of operation of the pulse oximeter are detailed below, however it was 
in 1974 that the invention of the pulse oximeter was disclosed to the Japanese Society of 
Medical Electronics, and the OLV-5100 (figure 4.5) went to market, however this was 
somewhat unsuccessful commercially.  In 1979 the patent for the Pulse Oximeter was 
granted with Aoyagi named as inventor.  Aoyagi left his research group for a period of 
eight years and it was in this time that the first commercially successful pulse oximeter hit 
the market, the Minolta OXIMET-1471 (1980), which used a conventional lamp + filters + 
optical fibres for the delivery of light to the tissue.  In 1983 Nellcor Developed the N-100, 
which had replaced the light source and detector with LED’s and photodiode that could be 
mounted directly in the probe where the measurement was taking place.  Aoyagi gives his 
thanks to Minolta and Nellcor for their development of the pulse oximeter, without them 
he says “the idea of pulse oximetry would have been buried” (Aoyagi, 2003). 
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Figure 4.5.  The Nihon Kohden OLV-5100, the first commercially available pulse oximeter, with ear-probe 
(Aoyagi, 2003). 
4.2 Pulse Oximetry Principles 
4.2.1 Beer and Lambert law 
The principles of the Beer-Lambert law underpin spectrophotometry, a scientific method 
used to measure concentrations of transparent substances in a solution.  The work done by 
Kramer, for example, attempted to use spectrophotometry on living animals by fixing the 
path length by mounting the artery in a clamp (figure 4.2).  Monochromatic light, I0, 
entering a medium will be partly absorbed, and the intensity, I, of this light will diminish 
exponentially with increasing distance: 
 𝐼 = 𝐼�𝑒��(�)��  (4.1) 
where the molar extinction coefficient, ε(λ) (L mmol-1cm-1), is specific for a given 
wavelength, c is the concentration of the absorbing substance (mmol L-1) and d is the 
optical path length.  To give this measurement a meaning in terms of “absorbance” 
transmittance, T, firsts needs to be calculated: 
 𝑇 = 𝐼
𝐼�
= 𝑒��(�)��  (4.2) 
then absorbance, A, is defined as: 
 𝐴 = − ln 𝑇 = 𝜀(𝜆)𝑐𝑑 (4.3) 
In reality any solution is itself an absorber, as well as the substance being measured, and 
there may also be other absorbers present, therefore the total absorbance, At, is the sum of 
all the independent absorbencies: 
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 𝐴� = �𝜀�(𝜆)𝑐�𝑑�
���
 (4.4) 
By measuring the absorbance through a medium at several wavelengths, and knowing the 
coefficients for the multiple absorbers, then by simultaneous equations the absorbance due 
to each component, and hence the concentration can be calculated.   
4.2.2 Optical properties of blood 
Blood is a substance of multiple absorbers, and although it appears opaque in fact 
transmits light over a broad range of wavelengths, and is especially reflective in the red to 
infrared region.  When talking about pulse oximetry the principle absorbers we are 
interested in are oxyhaemoglobin (HbO2) and haemoglobin (Hb).  When Stokes first 
observed the separate bands of absorption for Hb and HbO2, it was in the visible green 
part of the spectrum (535 – 560 nm) (Edsall 1972).  Visualising this on a modern 
absorption spectra (figure 4.6) we observe these bands fairly clearly.   
 
Figure 4.6.  Absorption spectra of oxyhaemoglobin and haemoglobin, 400 – 1000 nm plotted with data 
from (Prahl, 1998). 
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Modern pulse oximeters take advantage of the coefficients in the red-near infrared region 
(630 – 950 nm).  In his original experiments and developmental work of the pulse oximeter 
Aoyagi had selected 630 nm and 900 nm filters for his light sources.  Light absorption at 
630 nm was found to be most sensitive for oxygen saturation (Severinghaus, 2007), and 
900 nm was chosen, because at the time Aoyagi was utilising the injection of a dye to 
measure cardiac output, which did not absorb this wavelength.  In this region it is also 
observed that at approximately 805 nm the coefficients become equal, the isobestic point. 
4.2.3 Limitations of the Beer-Lambert law 
When calculating the concentration of a singular substance in a solution, in a cuvette of a 
fixed length, and assuming that light is either transmitted or absorbed only, then the Beer-
Lambert law is valid.  Unfortunately in the case of pulse oximeters, and early oximeters, the 
measuring “cuvette” is the tissue under investigation, whether it is the web of the hand or 
an ear lobe, etc.  This presents several problems:  Firstly the compressible nature of tissue 
means that the path length can never truly be fixed, and therefore when measuring the 
attenuation of light through such thin tissue the minute differences that may arise from the 
natural swelling, or pulsations (caused by expanding and contracting of the arteries and 
arterioles) in the tissue will have a significant impact.  Figure 3.1 in chapter 3 demonstrates 
this pulsation as seen in photoplethysmography.   Secondly the Beer-Lambert law does not 
take into account the effect of light scattering.  When a photon enters a medium it is either 
scattered by a surface (a cell wall for example), and scattered in a different direction, or it is 
absorbed by the tissue.  Transmission of any remaining photons in a medium with multiple 
absorbers will be a combination of these two phenomena, and the actual path length 
travelled will be longer than the distance between the entrance and exit points.  
4.2.4 Ratio of Ratios  
Takuo Aoyagi’s “Eureka!” moment was when he was observing his cardiac output 
experiments and noticing the pulsation of the photoplethysmographic trace from his 
detector.  Aoyagi realised that by computing the ratio of the pulsating, AC, and non-
pulsating, DC, portions at two wavelengths (Red and Infrared) he could achieve the same 
ratio that Wood used in his oximeter when he occluded blood from the ear to obtain a 
reference point.  In other words the pulsatile portion of the photoplethysmograph, which 
is attributable only by the arterial blood as it is pumped by the heart, could be separated 
electronically from the rest of the blood and the surrounding tissue (Webster, 1997).  This 
would also mean that the measurement site was not restricted to the ear, as the pulsations 
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observed could be obtained from anywhere, and for each pulse, so any momentary shift of 
the probe would cause a small artefact before the measurements returned to normal.  
Aoyagi termed this as the ratio of ratios (Aoyagi, 2003): 




A new method for obtaining a ratio with which to calculate oxygen saturation was now 
available, however this also did not account for light scattering, and calibration based on 
the Beer-Lambert law is unreliable for these reasons (Moyle, 2002).  Reliable methods of 
calibration were needed that could be used to derive equations and calibration curves so 
that saturation could be calculated. 
4.2.5 Calibration of Pulse Oximeters 
In Moyle’s “Pulse Oximetry” (Moyle, 2002), it is stated that it is important to know what 
the pulse oximeter is actually measuring, and thus what they are calibrated to measure.  
There are two major definitions, functional oxygen saturation and fractional oxygen 
saturation. 
Functional saturation is defined as the amount of oxygen carrying content of the blood, i.e. 
the total percentage of whole blood that is oxyhaemoglobin and not haemoglobin, and is 
defined as; 
 𝐹𝑢𝑛𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑆𝑎𝑂� = 𝐻𝑏𝑂�𝐻𝑏𝑂� + 𝐻𝑏 × 100% (4.6) 
Fractional saturation still measures the amount of oxygen carrying content, but takes into 
account the other two main species of haemoglobin, and is considered far more accurate.  
The other two species, carboxyhaemoglobin (HbCO) and methaemoglobin (MetHb) are 
now included in the total blood content; 
 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑆𝑎𝑂� = 𝐻𝑏𝑂�𝐻𝑏𝑂� + 𝐻𝑏 + 𝐻𝑏𝐶𝑂 + 𝑀𝑒𝑡𝐻𝑏 × 100% (4.7) 
Pulse oximeters that measure SaO2 will state what they measure, either functional or 
fractional, whereas those pulse oximeters which state neither and use the conventional two 
wavelengths will measure SpO2, which is defined as oxygen saturation measured by a pulse 
oximeter (Moyle, 2002). 
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The “gold standard” for calibration of pulse oximeters is the CO-oximeter.  The CO-
oximeter uses the standard spectrophotometric techniques, utilising wavelengths in the 
visible part of the spectrum.  Depending on the model of the CO-oximeter a sample of 
blood somewhere between 35 μl and 100 μl is introduced to the input port.  The blood is 
haemolysed with ultrasound and a tungsten-halogen lamp is used to illuminate the sample 
at a number of wavelengths (which is usually determined by the number of constituents the 
machine is capable of measuring).  Light is detected using a photodiode; the measurement 
is converted to a digital number for a microprocessor, which then calculates the 
measurements needed (Moyle, 2002). 
Pulse oximeters that have been calibrated in vivo, i.e. a healthy human volunteer has had 
blood samples taken at different oxygen saturations whilst having their saturation artificially 
lowered have only needed to be calibrated during the developmental stages, the values 
obtained are stored in a lookup table that the pulse oximeter then uses to correlate the ratio 
with the appropriate SaO2 level.  The only calibration needed after this stage is a two-point 
check of the wavelength of the LEDs, slight deviations from the appropriate wavelength of 
either LED are compensated for by the calibration data for that specific wavelength.  It has 
to be understood, however that the ethical implications of artificially lowering a person’s 
oxygen saturation is considered dangerous, and guidelines state that the saturation level 
being investigated should not drop below 85%, otherwise the risk of hypoxic brain damage 
is too high, therefore values below this have to be extrapolated, and may not be accurate 
(Webster, 1997; Moyle, 2002). 
4.2.6 Technology of pulse oximeters 
Light sources 
The Nihon OLV-5100 and the Minolta OXIMET-1471 both used conventional lamps with 
filters and fibre-optic bundles to transmit the monochromatic light required for 
measurements, however this had always proved bulky and expensive.  The Nellcor N-100 
demonstrated that there was a new method for delivering the light needed the light 
emitting diode (LED). 
The LED has the ideal characteristics to be used as the near-ideal light source for pulse 
oximeters. They are small in size and can be mounted directly in the probe at the sight of 
measurement. They have excellent drive characteristics with a large output in a very narrow 
bandwidth. Also, they have become so cheap that the LEDs used in multi-use probes can 
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be the same as the ones used in the one-time probes, i.e. ones used in neonatal care that are 
incorporated into sticky plasters, thus no disadvantage in terms of light output can be 
determined between the different types of probe. 
The choice of LED wavelength is an important consideration.  Typically 660 nm and 
940 nm are chosen for the red and infrared LEDs respectively.  At 660 nm it is observed 
(figure 4.6) that there is a large difference in coefficients for Hb and HbO2.  At 940 nm the 
spectras of the coefficients have overlapped and there is a small difference in their values 
(Mendelson and Ochs, 1988). 
Photo detectors 
All modern pulse oximeters use photodiodes as their choice of photo detector.  The 
historical reasons that lead to virtually all modern pulse oximeters using this form of 
detector are largely unimportant, but their main characteristics that certainly contributed to 
their use are; Relatively low cost; Linear output current response to incident light, no need 
for complicated linearization circuitry; Response speed can be increased by applying a 
reverse bias voltage (although largely unused for pulse oximeter applications); Low dark 
current, as the ambient temperature increases so does the dark current, having low dark 
current ensures that the transimpedance amplifier stage after the photodiode has less 
chance of over-amplifying the signal that may lead to the circuit becoming saturated and 
the signals become useless; Good sensitivity, important to achieve good signal to noise 
ratio for the signal, as less amplification is needed; Spectral response can be broad over the 
desired wavelengths, typically 80 – 100% relative response from 660 – 940 nm.  Specially 
treated photodiodes can even respond with a relatively good response to lower or higher 
wavelengths, facilitating the use of more than one wavelength of light, i.e. green or even 
blue; Available in a wide variety of packaging which makes their use widely adaptable. 
Instrumentation 
The instrumentation involved in driving the LEDs and detecting the output current from 
the photodiode is relatively simple, an outline of the main typical components are 
illustrated in figure 4.7; Low-cost microcontrollers used to control a constant current 
source for the LEDs; Current source drives the LEDs with the desired current; A 
transimpedance amplifier amplifies and converts the small current signal from the 
photodiode to a large voltage signal; Demultiplexing circuitry separates the signal for the 
individual wavelengths; Analogue filters split the signal into AC and DC components; 
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Optional amplification of the AC components may be utilised with another gain-stage; The 
signals are sent to an analogue to digital converter (ADC) where they can then be sent to 
the microcontroller for SpO2 calculation, or externally to a computer for off-line storage 
for further analysis. 
 
Figure 4.7. The main components of a pulse oximeter. 
4.2.7 Pulse oximeter probes 
The placement of the emitting components, the LEDs, relative to the photo-detector, the 
photodiode, can be set up in one of two ways, and although the finger is a common site, 
the methods of component orientation about to be described can be applied to various 
measurement sites. 
Transmission-type pulse oximeter probes (figure 4.8) have the LEDs and photodiode 
mounted opposite each other.  In this configuration the light is made to transverse the 
entire length of the tissue before reaching the detector.  This is most common in areas such 
as the finger or earlobe where the distance travelled by the light is minimal and where a 
mechanical clip can be securely fastened to the patient without causing much discomfort. 
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Figure 4.8. Transmission-type pulse oximeter probe. 
Reflective-type pulse oximeter probes (figure 4.9) have the source and detector mounted 
next to each other.  In this configuration the light must reach the detector by back-
scattering from the underlying blood vessels and surrounding tissue.  This offers the 
advantage that it may be used anywhere on the skin surface (Mendelson and Ochs, 1988), 
but offers lower signal to noise ratio (Webster, 1997). 
 
Figure 4.9.  Reflective-type pulse oximeter probe. 
4.3 Pulse oximetry applications 
Its’ common presence in hospitals, on ambulances and in other health care settings 
demonstrate that the pulse oximeter is a versatile and robust instrument.  The use for 
which it has found a place include; 
1. As an indicator of arterial oxygen saturation, alerting medical professionals to 
rapidly-occurring hypoxic events. 
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2. All modern pulse oximeters will display the pulse of the patient, an indicator of 
heart rate. 
3. Perfusion index indicators may detect a change in the circulation in the skin, often 
an indication that circulation is deteriorating, which can be a symptom of an 
infection or that the patient is beginning to “shut down” (patients with mild to 
severe systemic disturbance). 
4. The latest pulse oximeters from makers such as Masimo are able to display the 
values for the other haemoglobin species, HbCO and MetHb, useful when 
assessing accident and emergency patients who have suffered smoke inhalation 
from fires or gas poisoning.  
4.4 Summary of Pulse Oximetry Limitations 
A summary of the main reported limitations of pulse oximetry is presented below: 
1. In vivo calibration, as previously stated, is limited by ethical concerns about 
artificially inducing a hypoxic event in the human being.  Severinghaus and Koh 
have shown that there is indeed an inaccuracy at low readings, especially in cases of 
anaemia (Severinghaus and Koh, 1990). 
2. Over or under-estimation of saturation levels has also been reported where there 
are high levels of skin pigmentation (Adler et al., 1998, Feiner et al., 2007). 
3. Dyshaemoglobinaemias, non-functional haemoglobins such as HbCO and MetHb, 
have been known to cause false readings where patients have suffered excessive 
inhalation of smoke or poisonous gas (James, 1999), however recent advancements 
in pulse oximeter technology mean that these non-functional haemoglobins may be 
measured as well, or simply taken into account when SpO2 is measured (Masimo, 
2007, Masimo, 2008), this issue is described some more in Chapter 5. 
4. Problems arising from a low peripheral perfusion when a patient becomes cold due 
to illness or surgery can bring the accuracy of the pulse oximeter into question, and 
has been shown to occur in neonates and infants, as well as adults undergoing 
certain forms of surgery (Iyer et al., 1996), this issue is described some more in 
Chapter 5. 
Page | 54 
Pulse Oximetry in Paediatric Care 
f we consider the modern pulse oximeter as the device which utilises light emitting 
diodes (LEDs) as the light source, rather than conventional filament lamps, as in the 
Nihon Kohden pulse oximeter of 1974, then the first reviews we started seeing of the 
reliability and accuracy of pulse oximeters appear in the early 1980’s.  Such devices had 
started making their way into hospitals, thanks largely to the reduction in cost attributed to 
the switch from expensive filament bulb and fibre optic bundle combinations to the low 
cost LEDs and photodiodes we are familiar with today.  This chapter concentrates on the 
review of pulse oximeter technology, specifically in neonatal and paediatric care. 
5.1 Reliability and Accuracy of Pulse Oximeters in Paediatric Care 
In the 1980s pulse oximetry was largely seen as an “alternative” measurement technique, 
rather than the de facto (Deckardt and Steward, 1984, Fanconi et al., 1985, Jennis and 
Peabody, 1987).  In 1986 there was a case from Birmingham Maternity Hospital, UK, that 
reported the use of the Ohmeda BIOX 3700 pulse oximeter on a 620g 25 week-old baby 
who had moist friable skin (Morgan and Durbin, 1986).  The use of ECG electrodes 
caused trauma to the superficial layers of skin and the risk of sepsis and fluid loss was 
deemed too high for continued use of the ECG monitor, and also of a transcutaneous 
oxygen (O2) sensor.  The decision was taken to monitor the heart rate and O2 saturation 
entirely with the pulse oximeter, and was done successfully for two weeks without any 
complications whilst simultaneously reducing the need to handle the infant.  It was noted, 
however, that in order to detect hypoxaemia the use of an indwelling arterial line was 
needed for partial pressure monitoring.  This was an early demonstration of the advantages 
of pulse oximetry over other well established procedures. 
Dedicated researchers persisted in their investigations of the devices at the time, one review 
detailing the reliability of one device was made by Hay and associates in 1989 (Hay et al., 
1989).  The device in question, an Ohmeda BIOX 3700, was determined to have sufficient 
accuracy of SpO2 (89% - 95% range) that it could be used reliably to predict PaO2, however 
it was noted that at low and high SpO2 readings (SpO2< 89% and SpO2> 95%) the device 
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could not be relied upon as an accurate indicator of PaO2.  The causes of these inaccuracies 
needed to be investigated. 
A number of sources of error, both from the point of view of the ability of the pulse 
oximeter and clinical situations had been identified.  These include; 
• The use of intravenous dyes  
• Motion artefact  
• Ambient light  
• Dyshaemoglobins  
• Hypothermia  
• Non Pulsatile Flow, hypo-perfusion, vasoconstriction and hypotension 
5.1.1 Intravenous Dyes 
Methylene blue, indocyanine green and indigo carmine have all been shown to lower SpO2 
readings (Sinex, 1999).  In these cases other methods should be used to determine the 
oxygen saturation.  The MasimoSET line of pulse oximeters warn in their guides that the 
presence of dyes may cause erroneous SpO2 readings (Masimo, 2006). 
5.1.2 Motion Artefact 
Pulse oximetry relies on a good signal to noise ratio, and being able to extract the signal 
due to the absorption of light by pulsatile arterial blood in order to make calculations for 
SpO2.  When there is heavy movement by the patient this portion of the signal can become 
lost and the result is erroneous readings, loss of readings and false alarms (Trivedi et al., 
1997).  While this may have been a major contention for pulse oximeters in the past there 
now exists various technologies that are designed to read through the motion and reduce 
false alarms and improve reliability (Petterson et al., 2007). 
5.1.3 Ambient Light 
The specific wavelengths of light, commonly 660 nm (Red) and 940 nm (Infrared), used in 
pulse oximetry are, unfortunately, common bands that exist in the environment in typical 
clinical setups.  Interference has been shown to come from fluorescent lights, infrared 
heaters, other medical devices, and daylight (Poets and Southall, 1994).  Where this may 
have once been quite a common occurrence, it was realised early on that using optical 
shields around the probes and positioning them properly eliminated many of the errors 
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once seen (Poets and Southall, 1994).  A controlled study (Fluck et al., 2003), set out to 
study the effect of different light sources in a darkened environment, utilising the Nellcor 
N200 transmission finger pulse oximeter.  The study concluded that light sources common 
in the clinical setting had no clinically important effect on the ability of the pulse oximeter. 
5.1.4 Dyshaemoglobins 
As described in chapter 4, there are two ways that pulse oximeters present SpO2 readings.  
The values given are either functional oxygen saturation values (only takes into account 
oxyhaemoglobin and deoxyhaemoglobin) or fractional oxygen saturation (accounts for the 
four main haemoglobin species, oxyhaemoglobin, deoxyhaemoglobin, carboxyhaemoglobin 
and methaemoglobin).  In monitors that measure functional saturation errors can occur in 
cases where there are unusually high concentrations of the other two haemoglobin types 
(carboxyhaemoglobin and methaemoglobin).  This happens because the different species 
interact and absorb light at specific wavelengths at different rates, and pulse oximeters 
usually only rely on two wavelengths to make their measurements, so when there is a 
contamination of another absorber that absorbs in the same region as the species of 
interest then readings can become falsely high or low.  Emergency patients who have 
suffered some sort of gas poisoning often present this problem (Eisenkraft, 1988, Ralston 
et al., 1991, Reynolds et al., 1993).   
A new generation of pulse oximeter (The MasimoSET with Masimo RAD-57 sensors) 
which utilises up to eight wavelengths of light, has been shown independently to 
successfully measure carboxyhaemoglobin within ±2% in a range of 0 – 15% and 
methaemoglobin with a confidence limit of 0.5% in the range of 0 – 12% (Barker, 2006, 
Barker and Badal, 2008). 
5.1.5 Hypothermia 
Neonates and infants who have undergone hypothermic cardiothoracic surgery will have a 
period of time where they recover from hypothermic shock.  This presents a unique 
opportunity to study the effect of skin temperature on pulse oximetry readings in the 
neonate or infant that would otherwise be unethical to induce.  A study (Iyer et al., 1996) 
examining pulse oximetry in a set of twenty-five infants who had undergone hypothermic 
cardiopulmonary bypass surgery demonstrated that for 95% of the cases a peripheral 
temperature greater than 29°C yielded saturation values that were in good agreement with 
hemoximeter oxygen saturation (SaO2) (within 3%), below a peripheral temperature of 
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27°C caution was recommended as it was found that less than half (45%) agreed within the 
same limits. 
5.1.6 Non Pulsatile Flow, Hypo-perfusion, Vasoconstriction and 
Hypotension 
It has been shown that various conditions of the tissue where a pulse oximeter is placed 
can have an effect on the ability of a pulse oximeter to function (Lawson et al., 1987, 
Morris et al., 1989, Severinghaus and Spellman, 1990, Trivedi et al., 1997).  In these reviews 
the ability of the devices under investigation to detect an arterial pulse varied, and even 
went as far as to point out that some oximeters were in fact very good at detecting pulses 
of small amplitude (Lawson et al., 1987) when the arm was occluded up to 93% of systolic 
pressure.  Most, if not all, of the studies were performed on adults receiving hospital care 
or on volunteers.   
There is a serious lack of knowledge from the paediatric or neonatal populations.  
Villanueva (Villanueva et al., 1999) from the department of Anaethstesiology Yale Medical 
School, USA, set out to assess a selection of pulse oximetry failure criteria in 19 children of 
10 years of age or less including blood flow and pulse pressure.  The main results 
concluded that low blood flow, induced artificially by increasing cuff pressure has little 
effect on the ability of the pulse oximeter to perform its functions, however it was noted 
that artificial inducement would not necessarily induce systemic vasoconstriction and 
therefore arterial pulsations at the periphery were still detectable.  The end of Villanueva’s 
study noted that it took at least two factors to affect the pulse oximeter significantly, 
particularly the combination of low skin temperature and low haemoglobin concentration, 
thus giving support that systemic vasoconstriction, induced by cold periods or 
hypovolaemia does significantly affect pulse oximeter function.  It would be unethical to 
induce vasoconstriction on the human infant or neonate in order to see what affect this 
has.  Therefore more efforts need to be made to look for opportunities to study infants in 
critical care who are already at risk of peripheral shutdown.  
There remains the question of what effect sensor placement has on the reliability and 
accuracy of pulse oximetry, as the architecture of the tissue at any one location can differ 
greatly.  The location chosen has a bearing on what type of sensor technology to use, 
transmission or reflectance mode, and because this is more of a technical 
limitation/problem it cannot easily fall into the same category as measurements made 
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during specific clinical situations.  It is the focus of the following section to look at the 
effect of the differences in these two modalities. 
5.2 Effect of Location of Sensors in Pulse Oximetry 
Chapter four described the two different modes of pulse oximetry, transmission mode and 
reflectance mode.  The vast majority of sensors are configured for transmission, placed on 
the finger, ear or foot where source and detector can easily be arranged either side a sample 
of tissue (finger ear lobe or toe).  This has the major disadvantage that when a patient has 
poor or no periphery blood flow then the pulse oximeter has been known to fail. 
A number of researchers and manufacturers have described their efforts to overcome these 
problems by designing various reflectance mode sensors for use in locations where it has 
been theorised that perfusion is preserved at times when the periphery has failed, including 
in the paediatric and neonatal populations.  These include oesophageal sensors (Kyriacou, 
2006, Kyriacou et al., 2008), and head/scalp/trunk sensors (Faisst et al., 1995, Dassel et al., 
1997, Faisst et al., 1997, Berkenbosch and Tobias, 2006).   
A pilot study on ten adult volunteers (Mendelson et al., 2006) demonstrated that it was 
possible to acquire SpO2 readings from the forehead using a reflectance sensor.  The sensor 
was setup against a conventional finger sensor with only a small difference in mean and 
standard deviation of the values between sites. 
Research into pulse oximetry from the head, whether from paediatrics or adults, was prone 
to giving falsely high or low readings when compared against readings from a peripheral 
location.  Six adults and seven neonates were selected for a study in 1995 (Nijland et al., 
1995) to compare the effect of pulsating arteries on reflectance pulse oximetry.  To make 
the comparison the sensor was placed either on the forehead or the temple (temporal area 
of head), where the effect of the superficial temporal artery on pulse oximetry could be 
studied closely and without any invasive intervention.  The orientation of the sensor on the 
temple was varied between having either the LEDs or the photodiode directly over the 
blood vessel.  When the photodiode was placed over the artery SpO2s were shown to be 
lower in both populations (7.5% and 5.8% for neonates and adults respectively) than the 
reading from the forehead.  When re-orientated, so that the LEDs were over the artery, 
there was an insignificant change in SpO2, however the plethysmograph signals were larger 
than at the forehead.   
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Another investigation into erroneous SpO2 readings at the forehead was made with twenty-
five general anaesthetic patients, ASA category I and II scheduled for gynaecological and 
urological procedures (Shelley et al., 2005).  The patients were assessed with pulse 
oximeters placed on the finger, ear and forehead.  The study set out to investigate reports 
of erroneously low SpO2s and signal instability from commercial forehead pulse oximeter 
sensors.  The findings from the investigation suggest that the problems previously reported 
were due to complex waveforms at the forehead.  The complex waveforms showed 
morphology that was consistent with a central venous trace, and therefore that the 
presence of venous signals was the source of the problems experienced previously.  
These two studies suggest that the superficial vessels in the head/scalp may have a bearing 
on SpO2 and photoplethysmography results, and all efforts should be made to include their 
effect when analysing results from any new studies. 
It is either the forehead or temple that seems to be the main focus for reflectance pulse 
oximetry at the head; this is probably suggestive of the fact that these two locations are 
generally easy to locate a sensor since there is no obstruction that may be caused by hair.  
In neonates, who are often born with little or no hair there exists the opportunity to locate 
the sensor in other scalp locations where SpO2 monitoring may be unaffected by the 
phenomena previously described.  Two studies of reflectance pulse oximetry in neonates 
describe at least one other location selected for sensor placement (Faisst et al., 1995, Dassel 
et al., 1997). 
Faisst (Faisst et al, 1995) recruited thirty-one neonates from an ICU who had a reflectance 
sensor placed on the forehead, cheek, occiput (back of the head) and back, in turn, to 
determine optimal positioning of the sensor.  Dassel (Dassel, Graaff et al, 1997) solely 
concentrated on placing the sensor only on the scalp (eight separate locations) of seven 
healthy infants.  Faisst reported close agreements for the reflectance sensor versus a 
transmission sensor placed simultaneously on the hand for SpO2 and heart rate.  It was 
noted that the reflectance sensor placed on the back was unreliable and susceptible to 
breathing artefacts, but this is unimportant to this review as it is the head locations which 
are of interest.   
Dassel’s efforts seem to be unique in these studies as the methods used include the use of a 
dedicated photoplethysmography system capable of analysing the individual red and 
infrared PPG waveforms, as well as the usual SpO2 and heart rate values.  From the 
plethysmograph signals recorded it was observed that there was a clear difference in the 
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effect of location, with up to a 13% difference in SpO2s.  Dassel states that the differences 
observed can be explained by the optical differences of different tissues at each of the 
locations.  Interestingly it is when there is a space in the skull (over the anterior fontanelle) 
where the largest red/infrared values are observed, which again can be attributed by 
specific optical properties of the underlying tissues, and in this case the specific lack of any 
solid material, i.e. skull.  Dassel reports that underlying pulsations from the sagittal sinus at 
the fontanelle may have been the cause for inaccurate readings.  Although a source of error 
for global saturation, these pulsations may help in determining local saturation values 
at/under the fontanelle, a hypothesis yet to be investigated. 
The latest advancements in reflectance pulse oximetry have led to sensors such as the Max-
Fast forehead sensor from Nellcor, independently assessed for use in patients with poor 
perfusion (Bebout et al., 2001, MacLeod et al., 2005).  Berkenbosch (Berkenbosch and 
Tobias, 2006) reported the use of the Max-Fast sensor in twenty-eight paediatric patients, 
comparing against a conventional transmission digit sensor.  Results from all three studies 
suggest a faster response time to changing oxygen levels.  Berkenbosch did comment on 
the lack of data in the paediatric population regarding that perfusion is preferentially 
preserved at the forehead than in the periphery at times of poor perfusion.  There was 
some indication, however, that the paediatric patients receiving vasoactive medicine did 
exhibit better precision from the forehead sensor.  The suggestion here being that forehead 
perfusion may well be better preserved than the periphery, but without a case of peripheral 
shut-down this is difficult to substantiate. 
Because of the adaptability of reflectance mode pulse oximetry there were also efforts to 
develop reflectance pulse oximeters for  the oesophagus (Kyriacou, 2006).  In the topical 
review by Kyriacou 2006, he first presented the work by a number of groups who recorded 
SpO2s from the upper oesophagus, but quickly noted that there were no efforts made to 
study the signal morphology directly.  Following development of a custom PPG system 
with customized oesophageal sensors (Kyriacou et al., 1999), a batch of clinical 
investigations were carried out to assess oesophageal pulse oximetry from anaesthetised 
patients (Kyriacou et al., 1999, Kyriacou et al., 2001, Kyriacou et al., 2002b, Kyriacou et al., 
2002a, Pal et al., 2005).  Reflectance pulse oximetry from the oesophagus in the adult 
population presents as a reliable and accurate method for SpO2 monitoring at times when 
periphery pulse oximetry may fail.  In the paediatric population there is less supportive 
evidence, however a pilot study carried out at Great Ormond Street Hospital for Children, 
UK (Kyriacou et al., 2008) has demonstrated successfully that the neonatal oesophagus is 
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viable for PPG and saturation monitoring.  This study was unable to gather simultaneous 
readings from a finger or foot (either from a commercial or customised sensor) so it is 
unclear whether the oesophagus in neonates and paediatrics exhibits similar behaviour to 
the adult at times of peripheral compromise. 
There may also other reasons to pursue alternative locations for SpO2 monitoring. It has 
been demonstrated (Sedaghat-Yazdi et al., 2008) that some transmission-based sensors are 
less accurate when placed on the sole or palm, as opposed to the finger or toe when SpO2 
< 90%.  In neonatal a paediatric critical care the smaller dimensions of the infant toe or 
finger make them inadequate for proper attachment of the sensors, and so accuracy and 
precision may be affected when the sensor is alternatively placed. 
5.3 Paediatric Pulse Oximetry Summary and Proposed Research 
Over the course of its thirty year life, pulse oximetry has undergone significant 
developments and improvements and is, by some “...more than the fifth vital sign” (Hay, 
2005).  In nearly every clinical setting, including monitoring new-borns, it is the principle 
measurement used for early detection of oxygen saturation problems and general heart rate 
monitoring.   
Since its conception, and by its nature, the pulse oximeter is a true multi-parameter 
monitoring technology (SpO2, heart rate and perfusion index are at least the minimal 
parameters expected to be found on the majority of bedside devices today), an ability 
afforded to virtually no other medical device, costing relatively little. At the time of writing 
this thesis portable pulse oximeters for use in the home can be bought for as little as £20. 
Monitoring oxygen saturation is dependent on being able to detect the human pulse, from 
which an accurate measure of heart rate can be obtained. 
Advancements in device manufacture have seen the pulse oximeter sensor migrate from 
the finger to the neonatal oesophagus and utilise new microprocessor technology to 
become ever more accurate and reliable.  The efforts by individual companies have meant 
that pulse oximetry has gone beyond O2 saturation measurements, and can function in 
scenarios where it was once impossible to use such devices. 
Reflectance pulse oximetry, along with continued research, may offer us new methods of 
monitoring the critically ill, especially at times when the periphery is unavailable, especially 
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in the most vulnerable of patients, the neonate and the infant, and this will be the focus of 
this research. 
In summary it is proposed that two monitoring sites are explored for the purpose of PPG 
and SpO2 investigations, the neonatal anterior fontanelle and the infant oesophagus.  
Custom sensors will be constructed along with instrumentation and software that will be 
able to simultaneously monitor two anatomical locations together; the fontanelle or 
oesophagus and a reference location that is prone to periphery supply failure (either a hand 
or foot).  In this manner a true comparative study can be performed, where PPGs and 
SpO2s can be directly compared and tested for accuracy with commercial devices and “gold 
standard” blood-gas analysis. 
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Design and Development of Multi-Wavelength 
Photoplethysmographic Sensors 
hapter four and chapter five introduced the concept and history of arterial oxygen 
saturation (SpO2) monitoring from the head and the oesophagus.  A hypothesis has 
been proposed that aims to study the photoplethysmograph (PPG) signal from the head 
and the oesophagus in an effort to estimate SpO2 at times of periphery supply 
compromise.  This chapter describes the design and development of custom fontanelle, 
oesophageal and foot reflectance PPG sensors specifically for this purpose. 
6.1 Sensor Design and Construction 
Acquisition of either fontanelle or oesophageal PPGs needs to be simultaneously compared 
with PPGs from a traditional sensor location so that a true comparative study can be made 
on the raw signals being acquired.  For this reason a sensor has been designed and 
constructed that can be placed on either the hand or foot.  This sensor will have the same 
electrical and optical specifications as the separate fontanelle and oesophageal sensors. 
General construction for all three sensors will be based around the concept of reusability; 
this eliminates any sensor construction flaws that may influence the data between individual 
studies.  In order to be reusable all outer materials (any part of the sensor that may come in 
contact with a patient) will be medical-grade, non-conducting (electrically) and able to be 
sanitized with standard sanitization fluids/wipes available in the hospital.  
6.1.1 The Fontanelle Photoplethysmograph/SpO2 Sensor 
LED Selection 
Webster (Webster 1997) describes the two wavelengths traditionally used for SpO2 
monitoring, red (660 nm) and infrared (940 nm).  A third wavelength in the green part of 
the visible spectrum (525 nm) will also be incorporated into the sensor.  This would allow 
the possibility of additional PPG investigations that may go beyond standard SpO2 
measurement.  There have been a number of studies investigating the use of green light 
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PPGs (Stack et al., 1998, Futran et al., 2000, Sandberg et al., 2005, Näslund et al., 2006, 
Maeda et al., 2008, Maeda et al., 2010).  The range of wavelengths documented in these 
were all in the range of 510 – 565 nm, and were primarily used to look at the flow of blood 
or perfusion of specific tissues in an attempt to assess the health of that tissue following a 
surgical procedure.  Work done, by Maeda et al (Maeda et al., 2008, Maeda et al., 2010)  
used green light PPG in an attempt to measure heart rate more precisely, for 
example.   The three LEDs chosen for the sensor are summarised in table 6.1 and shown 
in figure 6.1. 
Table 6.1: LED specifications. 
Parameter LED 1 LED 2 LED 3 Units 
Manufacturer Kingbright Kingbright Kingbright - 
Part Number KP-2012SRC KP-2012F3C KPTK-2012VGC - 
Colour Red Infrared Green - 
Peak Wavelength 660 940 525 nm 
Dimensions 
(HxWxL) 1.1 x 1.25 x 2.0 1.1 x 1.25 x 2.0 0.75 x 1.25 x 2.0 mm 
Vf @ 20 mA If 1.85 1.2 3.2 V 
Max Peak If 
150 @ 0.1 ms 
pulse width 
1200 @ 10 μs 
pulse width 
100 @ 0.1 ms 
pulse width mA 
 
Figure 6.1: Left KP-2012 series LED (660 nm and 940 nm). Right KPTK-2012VGC 525 nm LED 
Photo-detector Selection 
The LEDs have to be switched on and off simultaneously at a rate of approximately 
100 Hz.  The LEDs cover a spectral bandwidth in the range 525 – 940 nm.   A high-speed 
(rise and fall time = 100 ns), wide-bandwidth (410 – 1100 nm), large photo-sensitive area 
(7.5 mm2) photodiode (TEMD5010X01, Vishay Intertechnology Inc, USA) was selected as 
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the photo-detector (see figure 6.2).  Other specifications of the photo-diode are; has a peak 
sensitivity at 940 nm, matching the peak output from the infrared LED, and a reverse dark 
current (Iro) of 2 – 30 nA.  Reverse light current (Ira) is 45 – 55 µA. 
 
Figure 6.2: Vishay TEMD5010X01 broad-spectrum high speed photodiode. 
Geometry 
Previous studies (Davies et al., 1975) revealed the mean size of the AF to be 220 mm2, 
treating the AF as an irregular quadrilateral diamond with four points of reference (see 
figure 6.3).  These mean dimensions served as a primary reference for the optical 
component layout in figure 6.4.   
 
Figure 6.3: Area of the neonatal fontanelle 
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Line BX intersects line AC at point bx and by treating an area within triangle BC(bx) as a 
placement for the photodiode it was determined that the LEDs can be placed around the 
photo-detector, which will be optically isolated, at a distance of 5 mm from the centre of 
the photodiode.  To account for any curvature or irregularity of the shape of the head, and 
the AF, the sensor will be made to be semi-flexible, allowing slight distortion so that the 
active components of the sensor lay flat against the head during monitoring. 
 
Figure 6.4: Fontanelle PCB Layout Concept 
Sensor construction 
With sensor geometry and component selection specified, a PCB layout was drawn in 
Altium (Sydney, Australia), a three-dimensional PCB layout is shown in figure 6.5.  This 
design has space for the planned LEDs, including an arrangement of pads that would allow 
the LEDs to be arranged opposite, as in figure 6.4, or next to each other as is found in 
commercial sensors.  The design was chemically etched onto a flexible copper substrate 
(Pyralux, DuPont, USA).  Components were manually soldered onto the circuit with a six-
strand ribbon cable.  An ECG electrode (Ambu® Blue, Ambu A/S, Denmark) was de-
constructed which then had the PPG sensor circuit encased into it and sealed with medical-
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grade epoxy resin (Dymax Corporation, USA).  This would help ensure electrical insulation 
and a safe cleaning surface when cleaned between studies during the planned clinical 
trials.  Figure 6.6 is the final construction of the fontanelle sensor. 
 
Figure 6.5: Three-dimensional concept of flexi-pcb layout for fontanelle sensor. 
 
Figure 6.6: Final reflectance fontanelle PPG/SpO2 sensor. 
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6.1.2 The Oesophageal Photoplethysmograph/SpO2 Sensor 
An effective design for a neonatal/paediatric oesophageal PPG sensor was demonstrated 
by Kyriacou et al (Kyriacou et al., 2008) based on designs done for the adult (Kyriacou et 
al., 1999). The size restrictions encountered meant that the original photodiode had to be 
replaced so that the sensor could be threaded into an oesophageal feeding tube. 
LED selection 
The red and infrared LEDs chosen for the oesophageal sensor were the same as in section 
6.1.1.  Due to size constrictions of placing the sensor in a feeding tube with an inner 
diameter ≈ 1.5 mm there was no configuration of LED and photodiode that meant that all 
components were evenly spaced, for this reason the green LED was omitted and PPGs 
from green light within the oesophagus will not be explored. 
Photodiode  
The photodiode selected (TEMD7000X01, Vishay Intertechnology Inc, USA) has an active 
area of 0.23 mm2 and almost identical dimensions to the red and infrared LEDs (2 x 1.25 x 
0.85 mm), see figure 6.7.  The standard specifications of the photodiode are; spectral 
bandwidth = 430 – 1100 nm; peak sensitivity = 900 nm; reverse dark current = 1 – 3 nA; 
reverse light current = 2.4 – 3.6 µA; rise and fall time = 100 ns. 
 
Figure 6.7: Vishay TEMD7000X01 broad-spectrum high speed photodiode. 
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Connecting wire 
The developed neonatal oesophageal probe was connected to custom multi-core cable 
which was constructed in the laboratory utilising ultra-thin insulated (enamel-coated) single 
core wires (0.15 mm).  Five cores were needed for the sensor and were wrapped in a PVC 
heat shrink to provide strength and additional insulation. 
Construction 
A design was drawn (figure 6.8) that emphasised on reducing sensor head width, to allow 
for the insertion into feeding/nasogastric tubes with an inner diameter of 1.5 mm.  LEDs 
were soldered into place with their centre’s 5 mm from the centre of the photodiode on to 
a thin fibreglass-backed copper board.  The ends of the cores from the custom cable were 
attached and the end of the sensor head incorporated into the end of the heat shrink 
surrounding the cable.  A thin layer of medical-grade epoxy resin was then applied to the 
head to add strength, rigidity and a final layer of electrical insulation.  Figure 6.9 is the final 
oesophageal sensor construction. 
 
Figure 6.8:  Oesophageal sensor construction drawing 
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Figure 6.9: Final reflectance oesophageal PPG/SpO2 sensor. 
6.1.3 The Reference Photoplethysmograph/SpO2 Sensor 
The reference sensor was designed to be optically identical to the fontanelle sensor.  A 
slightly modified PCB layout (figure 6.10) was employed in this design as it closely 
resembles the way commercial sensors have their components arranged.  Photodiode to 
LED distance was identical to the fontanelle sensor.  Figure 6.11 is the final foot sensor 
construction. 
 
Figure 6.10: Three-dimensional concept of flexi-pcb layout for the reference sensor 
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Figure 6.11: Final reference sensor 
6.2 Sensor Evaluation 
Development of instrumentation and software of the described sensors is covered in the 
chapters Dual Photoplethysmograph Instrumentation Development (Chapter 7), and Virtual 
Instrumentation Development (Chapter 8).  The following evaluations were conducted with the 
instrumentation and software in those chapters.  
6.2.1 Photoplethysmographs from the Sensors 
Utilising the instrumentation and software, discussed in the following chapters, the sensors 
were tested to assess their operability.  The sensors were tested by placing the fontanelle 
sensor on the temple of a healthy adult volunteer, the oesophageal was place in the mouth 
(held against the buccal mucosa) of a healthy adult volunteer and the reference sensor was 
placed on the finger of an adult healthy volunteer. Figure 6.12a-c shows PPG signals from 
all three developed sensors at all available wavelengths.  
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Figure 6.12a:Five second PPG capture using the fontanelle sensor on the temple of a female volunteer.  
Average heart rate = 84 bpm 
 
Figure 6.12b:Five second PPG capture using the reference sensor on the left index finger of a female 
volunteer.  Average heart rate = 61 bpm 
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Figure 6.12c: Five second PPG capture using the oesophageal sensor on buccal mucosa of a female 
volunteer.  Average heart rate = 61 bpm 
 
6.2.2 Thermal Safety Testing 
As an active sensor technology PPG and SpO2 sensors interact with their environment by 
illuminating the tissue with non-ionising radiation.  It is important to consider this thermal 
radiation as heating effects to the tissue could cause thermal damage. 
Thermal Safety Test Method 
Thermal safety testing was carried out only on the fontanelle sensor as the active 
components (the LEDs) were electrically identical to the foot sensor.  The oesophageal 
sensor has one less LED, however as already described has identical LED specifications 
also.  The fontanelle sensor was connected to the PPG sensor test circuit described in 
section 7.3 (Chapter 7) which could drive each LED simultaneously.  Each LED was 
driven with a 0 – 5 V square wave at 100 Hz with a duty cycle of 1/6.  The epoxy layer 
thickness is similar across all sensors and should act as an effective thermal insulator. 
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Four LED currents were selected for testing (20, 40, 60 and 80 mA).  The current was 
varied by changing the resistor R1 in the LED current driver circuit figure 7.6, section 
7.1.3, (Chapter 7). 
An in vivo experiment was carried out on the forearm of a male volunteer.  The sensor was 
placed face down onto the skin, with an LM35 temperature sensor (National 
Semiconductor, USA) directly adjacent on the tissue next to the LEDs.  This was 
connected to one analogue input of a data acquisition card (USB 6009, National 
Instruments, USA).  The output of the sensor was 10 mV/°C in the range of -55°C - 
150°C, and had a resolution of 0.1°C, accurate to 0.5°C.  Data was recorded at a rate of 
100 Hz by the use of a virtual instrument implemented in LabVIEW (National 
Instruments, USA).  Data was processed offline in Matlab (The Mathworks, USA). 
For each LED current setting a baseline of two minutes of temperature recording was 
taken before the LED current was switched on.  All three LEDs were driven 
simultaneously.  At commencement of the LEDs being switched on temperature recording 
continued for ten additional minutes before the LEDs were then switched off and 
temperature recording continued for a further ten minutes to allow the skin on the forearm 
to cool.  The experiment was repeated twice more to confirm and average out results. 
Results 
Successful temperature rise and fall data was gathered and is displayed in figures 6.13a – 
6.13d, where steps in temperature can clearly be seen in the 60 and 80 mA settings.  By 
taking the mean temperature in each on and off period for each LED current setting the 
average tissue temperature rise could be determined.  It was found that at 20 and 40 mA 
the temperature rise seen was below the precision of the temperature sensor, suggesting 
that temperature rise was not significant.  At 60 and 80 mA the temperature rise was 0.5 °C.  
This temperature step is clearly visible in the graphs in figure 6.13b – 6.13c and can 
therefore certainly be attributable to the operation of the LEDs.  All temperatures recorded 
were below average human core body temperature (37 °C) and would unlikely cause any 
thermal damage.  A summary of the temperature rises is shown in table 6.2. 
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Figure: 6.13a:  Temperature change at the tissue surface when LED driving current = 20 mA 
 
Figure: 6.13b:  Temperature change at the tissue surface when LED driving current = 40 mA 
 
Figure: 6.13c:  Temperature change at the tissue surface when LED driving current = 60 mA 
 
Figure: 6.13d:  Temperature change at the tissue surface when LED driving current = 80 mA 
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Table 6.2: Temperature change with changing LED supply current, all LEDs driven simultaneously. 
LED status 































6.2.3 Electrical insulation 
A simple continuity test done on each PPG sensor between the termination connector and 
the sensor face revealed no flow of any current or any potential difference (measured in 
Ohms).  When the sensor was connected to the test circuit used for the thermal evaluation 
and switched on, a volt-meter could not read any potential across the components or on 
any part of the sensor where insulation was applied (either epoxy resin or PVC heat 
shrink). 
6.3 Sensor Construction Summary 
Design and construction of the three PPG/SpO2 sensors has been successfully and fully 
realised, meeting the specifications set out in the introduction and conforming to the layout 
and design considerations.  A thermal and electrical test of the sensors has determined that 
the use of such sensors is unlikely to cause thermal or electrical injury during the in vivo 
investigations. 
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Dual Photoplethysmograph Instrumentation 
Development 
hapter six described the design and manufacture of three photoplethysmograph 
(PPG) sensors for the monitoring of pulsatile blood in different locations of the 
neonate or infant.  A custom made hardware PPG processing system was also developed to 
drive the optical probes, multiplex the three wavelengths of the sensors, de-multiplex the 
photodiode current and convert it into a voltage signal, condition (filtering and 
amplification) of all acquired physiological signals and prepare them for digitisation and 
retrospective analysis.  Software to handle data acquisition, online signal processing and 
offline analysis is covered in chapter eight. 
7.1 System Design 
Design and testing of the instrumentation was split into several separate electronic design 
stages, as shown in the block diagram in figure 7.1. 
 
































Chapter Seven   
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7.1.1 Power Supply  
The instrument runs off two 12 V lead acid batteries (SONNENSCHEIN - A512/2.0S, 
EXIDE Technologies, Büdingen, Germany) with a 2 Ah capacity.  These have been set in a 
parallel configuration to give a 4 Ah capacity charge and were used to supply a ±12 V DC-
DC converter (THD101222, Traco Power, Zurich, Switzerland) (Figure 7.2 for DCDC Pin 
Out).  The ±12 V from the DC-DC powered the analogue circuitry (current supplies, 
transimpedance amplifiers, filters and post amplifiers and the 5 V regulator).  The 5 V 
regulator (LM7805CT, Fairchild Semiconductor Corp, CA, USA) supplied the power for 
the microcontroller. It required two capacitors for stability, 0.33 µF on the input, and 
0.1 µF on the output.  Figure 7.3 is a schematic of the 5 V regulator setup. 
 
Figure 7.2: DCDC Pin-out. 
 
Figure 7.3: 5 V regulator setup. 
7.1.2 Microcontroller / Multiplexer 
The multiplexer is responsible for the fast and accurate switching of current sources that 
activate the specific LEDs on the sensors.  This switching was achieved with multiple TTL-
level (+5 V) square waves operating at approximately 100 Hz. The multiple square waves 
were sequenced as such to produce a cycle where only one LED is activated at any one 
moment, and there was an off period between the activation of each LED to allow time for 
the LEDs to settle between their on and off states.  The duty cycle (d) was determined by: 
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 𝑑 = 1 2𝑛�  (7.1) 
where n is the number of current sources to be multiplexed.  For a rate of 100 Hz each 
duty cycle’s time duration (t) was determined by: 
 𝑡 (𝑠) = 1 𝑓�  × 𝑑 (7.2) 
where f is the desired frequency.  When n = 6, d = 0.166 (16.6 %) and t = 1.66 ms.  The 
system then multiplexed three current sources in the manner shown in figure 7.4. This is 
based on a similar routine described in Webster (Webster, 1997). 
 
Figure 7.4:  Current source multiplexing routine.  Three clocks (C1, C2, C3), one for each current source, 
are switched “ON” sequentially with an “OFF” period between to allow for the settling time of the LEDs. 
The hardware component chosen for this task was a 20 MHz Atmel AVR micro-control-
unit (MCU) (ATTiny2313-20PU, Atmel Corp, CA, USA).  Its low cost, relative ease to 
program and robust specifications, without the need to use an external oscillator mean that 
it is less reliant on other components and less likely to fail due to other circuit problems.  
The MCU will be flash-programmed from a C-source code file created in Win-AVR studio 
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(Atmel Corp, CA, USA) (Appendix A).  The MCU drew current and power from the +5 V 
regulator.  Figure 7.5 is a pin-out representation of the chosen MCU.  Port B, channels 0 – 
2 (pins 12 – 14), was programmed with the three output clocks. 
 
Figure 7.5:  Pin-out diagram of the Atmel AVR MCU. 
7.1.3 Current Supply 
Most LEDs operate in a given range of 20 – 100 mA.  From Ohm’s law we know the 
relationship of current and voltage is determined thus; 
 𝑉 = 𝐼𝑅 (7.3) 
By combining a single operational amplifier with a bipolar transistor and wiring in a 
negative feedback we can cause the voltage at the emitter (Ve) to be equal to the voltage at 
the input to the operational amplifier (Vin) (See figure 7.6).  Thus, by selecting an 
appropriate resistance value at the emitter we can set any desired current value, simply by; 
 𝐼� = 𝑉� 𝑅��  (7.4) 
For this design it was assumed that the collector current (Ic) is equal to the emitter current 
(Ie) and the current at the base (Ib) is negligible, and so did not affect the final current 
output.  In reality Ic = Ie + Ib, but Ib is often a great deal smaller than Ie and for simple 
current supply implementations, this value can be ignored. 
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Figure 7.6: Preliminary LED current supply schematic 
The input to the operational amplifier non-inverting pin was a 5 V square wave, with the 
same routine as calculated in 7.1.2.  By equation 7.4 we can see that an appropriate range 
for R1 is 250 Ω (20 mA) - 50 Ω (100 mA).  During circuit prototyping this was 
accomplished by the use of swap sockets for the resistors, and eventually became a variable 
resistor. 
7.1.4 Transimpedance Amplifier with Variable Gain 
To convert the current of the photodiode into a voltage ready for digitisation at the last 
stage of the circuit required the use of a transimpedance amplifier.  The design chosen for 
this application was in the form of a dual transimpedance configuration as the photodiode 
is a current source and can therefore drive two inputs simultaneously at opposing polarities.  
The two outputs then became the inputs to a differential amplifier with an adjustable gain, 
see figure 7.7 for the preliminary design. 
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Figure 7.7: Preliminary dual transimpedance differential amplifier schematic. 
The transimpedance stage consists of a feedback resistor (Rf) and feedback capacitor (Cf).  
Rf is responsible for the voltage gain (Vout) of the transimpedance by: 
 −𝑉��� = 𝐼��𝑅�  (7.5) 
Vout is identical for V1 and V2 in figure 7.7.  The value of Cf can be determined by: 
 
𝐶� = 14𝜋𝑅�𝐺𝐵𝑊 �1 + ��1 + 8𝜋𝑅�𝐶�𝐺𝐵𝑊�� (7.6) 
where GBW was the bandwidth gain product of the specific operational amplifier, and Cd 
was the capacitance of the photodiode (see chapter 6).  Cf was responsible for stabilising 
the transimpedance stage, by helping reduce overshooting artefacts arising from the 
capacitance across the photodiode in the sensor. 
Variable gain (Av) on the amplifier was controlled by Rg on the differential input stage, and 
was determined by: 
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 𝐴� = 𝑉�(𝑉� − 𝑉�) = 2𝑅�𝑅� �1 + 𝑅�𝑅�� (7.7) 
where V1 and V2 are the Vout of the two transimpedance amplifiers from equation 7.5, and 
Vd is the output voltage of the differential amplifier.  The photodiodes described in chapter 
6 have different specifications regarding their typical reverse light current (expected current 
flow at a given amount of light).  The variable resistor, Rg, in this amplifier will allow for 
adjustment of the gain of the circuit to suit the diodes in each sensor; however the fixed 
components still needed to be calculated.  Selecting the extremes of these specifications 
from the photodiode data sheets allowed an informed design choice.  Photodiode 
TEMD7000X01 had the smallest reverse light current (2.4 μA), whilst photodiode 
TEMD5080X01 had the largest reverse light current (60 μA).  Selecting a desired output of 
10 V peak-to-peak amplitude meant that Av from equation 7.7 had a maximum value of 
approximately 4.2 million. 
7.1.5 Demultiplexing 
The output of the transimpedance amplifier (Vd) was a mixed (multiplexed) signal, since 
light from all three LEDs is sensed by one photodiode.  To recover the amplitude 
information belonging to the individual wavelengths it was necessary to split Vd into three 
parts that were then passed to the filters and the AC post-amplifier. In 7.1.2 it was 
illustrated that the LEDs are switched on and off sequentially with periods where all LEDs 
are off between each LED switching on (Figure 7.4).  Using the same timing clocks (C1 – 
C3) it was possible to “sample” Vd at specific intervals so that the signal being passed to 
the filters for each light source only received the amplitude level for individual wavelengths.  
Whilst the LEDs are off it was necessary to “hold” the sampled voltage until the next clock 
pulse triggers a new acquisition.  Figure 7.8 demonstrates this “sample and hold” routine. 
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Figure 7.8:  Sample and hold demonstration.  The three voltage amplitudes (A, B, C) represent the 
different light sources, each is sampled (S1, S2, S3) respectively and then held at that level (H1, H2, H3) 
until the next sample is taken. 
Electronically this was implemented with the use of a purpose-built sample and hold 
(S&H) IC (LF398AN, Texas Instruments, TX, USA).  The chip required a power source 
(±12 V), a sampling clock (either C1, C2 or C3 depending on what channel to sample), the 
input signal to be sampled (Vd) and an external capacitor to stabilise the hold routine 
operation of the chip.  Figure 7.9 is a pin-out diagram of the Sample and Hold (S&H) chip. 
 
Figure 7.9:  Sample and hold IC pin out diagram. 
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7.1.6 Filtering 
The raw signals obtained after the demultiplexing stage were passed through filters to 
remove unwanted high frequencies and any “step” (aliasing) artefacts caused by the sample 
and hold circuits.  This anti-aliasing filter is a low-pass filter with a cut off of approximately 
20 Hz, sufficient bandwidth to pass all PPG information, whilst staying well below the 
100 Hz of the demultiplexing cycle that causes the aliasing.  This signal is then passed 
simultaneously to the data acquisition card for immediate digitisation of the raw signals, 
containing both the DC and AC portion of the signal, and to a high-pass filter.  The high-
pass filter is implemented to remove the DC portion and therefore extract the AC portion 
of the signal before it was passed to a post-amplification  and  digitisation stages.  This 
cascade of filters is in effect a band-pass filter. 
The topology chosen to implement the band-pass filter is of two separate Sallen-Key 2nd – 
order filters.    The preliminary schematic of the filter is shown in figure 7.10.   
 
Figure 7.10: Band-pass filter comprising of two Sallen-Key unity gain filters. 
Vlp on the schematic is where the two filters couple, and where the raw signal (AC+DC) 
will be digitised.  The low-pass stage of the amplifier can be described by: 
 2𝜋𝑓�� = 1
�𝑅��𝑅��𝐶��𝐶��
 (7.8) 
where fcl is the desired cut-off frequency of the low-pass filter.  Rearranging and equating 
R1a = R1b (R1) and C1a = C1b (C1) yields: 
 
𝑓�� = 12𝜋𝑅�𝐶� (7.9) 
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The high pass stage can be dealt with in the same manner giving: 
 
𝑓�� = 12𝜋𝑅�𝐶� (7.10) 
where fch is the desired cut-off of the high-pass filter. 
7.1.7 Post Amplification 
SpO2 calculation relies on the ability to measure the AC and DC component of the red and 
infrared PPGs.  To make maximum use of the digitisation process in the final stage of the 
instrument it was desirable to amplify the AC component separately.  An inverting 
amplifier (figure 7.11) was implemented to amplify this signal until the output is within 
±10 V, the range of the data acquisition device.   
 
Figure 7.11:  Preliminary post amplifier schematic 
 The amplification was selectable with two resistors, Rf and Ri: 
 
𝑉𝑎𝑐 =  −𝑅�
𝑅𝑖
𝑉�� (7.11) 
where Vac is the amplified AC signal and Vin is the AC signal from the band-pass filter.  
The AC signal of the PPG is typically as much as 2 % or less of the total PPG signal, 
therefore if a maximum peak at the TIA stage of 10 V is observed then only 0.1 – 0.2 V 
(Pk – Pk) will be the AC portion.  In this range a simple gain of 100 would mean that by 
eqn. 7.11 Vac = 10 – 20 V (Pk – Pk).  Issues may arise at the data-acquisition stage with Pk 
– Pk values of 20 V, as this will be maximum range of the card (typically ±10 V), and some 
clipping may occur and some data may be lost.  For this reason lowering the gain to 85 
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would give Pk – Pk values of 8.5 – 17 V, good large amplitudes that still make use of most 
of the range of the card.  From standard resistor values and by eqn. 7.11, Rf = 330 kΩ, Ri 
= 3.9 kΩ.  Gain = 84.6. 
7.1.8 Data Acquisition and Digitisation 
All mixed PPG signals (AC/DC) and separately amplified AC PPG signals were passed 
onto a 16-bit data acquisition card (USB6212, National Instruments, TX, USA).  This card 
has selectable voltage resolutions ranging from ± 250 mV to ± 10 V.  It is a bus-powered 
device, drawing its operational current directly from the attached laptop computer via USB 
cable.  Software controlling the operation of the card is covered in chapter 8. 
7.2 Electrical Circuit Simulation  
To assess all stages of the circuit before prototyping and final construction it was necessary 
to model the circuits on a personal computer to identify any potential problems that may 
occur. All simulations were performed in Multisim (National Instruments, TX, USA). 
The operational amplifier used in the simulations was the OPA4137PA (Burr Brown, 
Texas Instruments, TX, USA), chosen for its’ high performance characteristics (slew rate = 
3.5 V/μs and wide bandwidth = 1 MHz) and suitability for various applications that 
include photodetector amplifier, precision integrator, active filters and battery-powered 
instruments.  The NPN transistor was a 2N3904 (Fairchild Semiconductor Corp, CA, 
USA).  Resistors were simulated from a generic model with component tolerances taken 
into account.  Capacitors were similarly modelled with tolerances and lead polarisation if 
appropriate.  
7.2.1 Current Supply 
From section 7.1.3 suitable limiting resistors, R1, were calculated to be in the range of 50 – 
250 Ω.  A simulation was constructed, and a transient analysis performed for a range of R1.  
The data was then saved and analysed in MATLAB.  The multiplexing signal was a 
simulated square wave with matching characteristics to the output of the MCU, (100 Hz 
square wave with a 17 % duty cycle).    Table 7.1 shows the simulation setup parameters 
with the results of the simulation.  Note that the expected duty cycle is 17 % as opposed to 
16.6 %, as calculated by eqn. 7.1; this was due to a limitation of Multisim where the input 
parameter “duty cycle” would only accept whole integers. 
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Table 7.1:  Current source simulation results. 
 Current (mA) Duty Cycle (%) 
R1 (Ω) Expected Simulated Expected Simulated 
50 100 100.60 (+ 0.6 %) 17 
17.3 
(+ 1.76 %) 
100 50 49.66 (- 0.68 %) 17 
17.3 
(+ 1.76 %) 
150 33 33.98 (+ 2.96 %) 17 
17.4 
(+ 2.35 %) 
200 25 25.83 (+ 3.32 %) 17 
17.4 
(+ 2.35 %) 
250 20 19.98 (-0.1 %) 17 
17.2 
(+ 1.18 %) 
Through simulation it was observed that both the desired LED driving current and the 
duty cycle was maintained to within 3 % or better of the desired values between the 
maximum and minimum R1. 
7.2.2 Transimpedance Amplifier with Differential Variable Gain 
The photodiodes TEMD7000X01 and TEMD5080X01 have a Cd of 4 pF and 90 pf 
respectively.  Due to the variable nature of the gain on this circuit it is not necessary to 
choose such a high Rf value at the transimpedance stages.  A resistor of value 680 kΩ (a 
common value), would mean that the gain of the differential stage need only vary between 
1 and 3.09 for the desired gain calculated in 7.1.4. 
By eqn. 7.6; when Cd = 4 pF, Rf = 680 kΩ and GBW = 1,000,000 the feedback capacitor, 
Cf, needed on the transimpedance stages = 1.09 pF.  When Cd = 90 pF and all other values 
remain the same, Cf = 4.7 pF. 
A simulation was constructed using the above values for Rf and Cf, and the photodiode was 
modelled as a current source with a parallel capacitance equal to Cd, see figure 7.12.  The 
photodiode receives light from all 3 LEDs sequentially, meaning that the resulting 
photodiode output will have 3 distinct on and off periods, each representing one LED 
wavelength.  With a multiplexing rate of approximately 100 Hz per LED with a duty cycle 
of approximately 17 %, the combined photodiode output will produce a square wave of 
300 Hz with a duty cycle of 50 %.  This will be the routine used in the photodiode model 
during simulation.  The current level for the routine will be set at 1 μA for both simulated 
photodiodes.  Data from the simulation was saved and analysed in MATLAB.  Table 7.2 is 
the simulation setup parameters with simulation results. 
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Figure 7.12: Equivalent photodiode model used for simulation, where Ti1 and Ti2 represent the cathode 
and anode respectively. 
Table 7.2: Transimpedance amplifier simulation results, with theoretical Cf values. 
Capacitance 
Voltage (mV) 






(± % diff) Expect 
Sim 
(± % diff) V2  V1 V2 V1 
4 1.09 680 673 (-1.04 %) -680 
-672 
(+1.19 %) +533 +119 -137 -356 
90 4.7 680 677 (-0.44 %) -680 
-677 
(+0.44 %) +271 +203 -209 -273 
Both photodiodes showed considerable overshoot, with their calculated Cf values, see 
figure 7.13.  The final circuit will use a single value of Cf regardless of the photodiode 
present on the sensor, therefore it was only necessary to find an appropriate value that 
would eliminate these overshoots for both photodiodes.  The Cf value was changed to 
10 pF and the simulation re-run, see Table 7.3 and Figure 7.14. 
Table 7.3:  Transimpedance amplifier simulation results, with adjusted Cf values. 
Capacitance 
Voltage (mV) 






(± % diff) Expect 
Sim 
(± % diff) V2 V1 V2 V1 
4 10 680 649 (-4.78 %) -680 
-646 
(-5.26 %) +33 +8 -12 -29 
90 10 680 664 (-2.41 %) -680 
-667 
(-1.95 %) +20 +17 -47 -20 
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Figure 7.13: Simulated output of transimpedance amplifier, V1 (top) and V2 (bottom), Cd = 4 pF, Cf = 
1.09 pF. 
Clearly visible in figure 7.13 (highlighted) are the positive and negative overshoots that may 
cause distortion in the signal when it is sampled by the demultiplexing stage.  This 
phenomenon was observed when Cd = 90 pF and Cf = 4.7 pF also. 
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Figure 7.14: Simulated output of transimpedance amplifier stages, V1 (top) and V2 (bottom) Cd = 4 pF, Cf = 
10 pF. 
Figure 7.14 effectively demonstrates the almost complete elimination of the positive and 
negative overshoots illustrated in figure 7.13, again the same effect was observed when Cd 
= 90 pF and Cf = 10 pF. 
Design of the differential amplifier stage began by building the balanced differential bridge 
(R4a – d figure 7.7).  A value of 560 Ω (±1%) was selected.  The input resistors (R3a+b figure 
7.7) were set at 1.2 kΩ (±1%), which are responsible for maintaining a high input 
impedance to the operational amplifier and helping to set the overall gain (eqn. 7.7).  The 
variable gain resistor (Rg figure 7.7) was calculated by solving 7.7 when 1 ≤ Av ≤ 3.09.  
When Av = 1, Rg = 7839 Ω, and when Av = 3.09 Rg = 243 Ω.  A simulation of the 
differential stage was run where the inputs, V1 and V2, were driven by the expected outputs 
of the dual transimpedance amplifiers, as already demonstrated.  Table 7.4 is the simulation 
results for the differential stage. 
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Table 7.4:  Effect of varying Rg on Vout for the desired Av range. 
Rg (Ω) 
Voltage (V) 
V1 Peak (V) V2 Peak (V) Vout Expect 
Vout Sim 
(± % diff) 
243 -0.680 0.680 4.195 4.225 (+0.715 %) 
7839 -0.680 0.680 1.360 1.396 (+2.647 %) 
7.2.3 Filtering 
Setting fcl = 20 Hz, fch = 0.3 Hz, C1 = 22 nF and C2 = 100 nF then solving equations 7.9 and 
7.10 R1 = 361715 Ω and R2 = 5305165 Ω.  The closest standard resistors are 390 kΩ and 
4.7 MΩ for R1 and R2 respectively.  Recalculating fcl and fch gives theoretical values of 
0.33 Hz and 18.5 Hz respectively for the pass band of the filter.   
A frequency response for the low-pass filter stage in figure 7.10 was first simulated in 
Multisim with the derived values for R1 and C1 and is shown in figure 7.15.  As can be seen 
the -3 dB cut off, the point at which the input power is reduced by half, the cut-off is 
found to be approximately 12.1 Hz, 5.9 Hz below the calculated and 7.9 Hz below the 
desired. 
 
Figure 7.15:  Low-pass filter stage simulated frequency response.  -3 dB cut-off at approximately 12 Hz. 
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This simulation was repeated with the addition of the high-pass pass filter, with R2 = 
4.7 MΩ, C2 = 100 nF, to simulate the band-pass filter.  Figure 7.16 is the simulated 
frequency response of the filter.  The cut-off frequencies were found to be approximately 
0.5 and 12.1 Hz. 
 
Figure 7.16:  Band-pass filter stage simulated frequency response.  -3 dB cut-off at approximately 0.5 and 
12.1 Hz. 
The low pass and band-pass cut-off frequencies were below the expected and desired cut 
off frequencies, and may be explained by component tolerances used in the simulation.  
However the bandwidth remained sufficient wide enough to accommodate the frequencies 
associated with normal and abnormal heart rates.  The 0.5 Hz cut-off introduced by the 
high pass stage into the band-pass filter will allow the post amplification stage before 
analogue to digital conversion to digitise only the AC portion of the signal. 
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7.2.4 Post Amplification 
A simulation of the post amplifier described in 7.1.7 with Rf = 330 kΩ, Ri = 3.9 kΩ, and a 
5 Hz 0.2 V (Pk – Pk) sine wave generates the plot in figure 7.17. 
 
Figure 7.17: Post Amplifier simulation.  Vin = 0.2 mV (Pk – Pk), Vout = 16.83 V. Gain = 84.29 
Simulated response for the post-amplifier shows a gain of 84.29 (-0.4 % from theoretical).  
The simulation also shows the inversion of the test signal due to the inverting 
configuration of the circuit. 
7.3 Electrical Prototyping 
Full electronic testing was achieved by implementing the circuits from section 7.1 onto a 
prototyping strip board (Figure 7.18), utilising all the component values calculated in 
section 7.2. Electrical testing was done with the use of a bench-top DC power supply 
(GPS-4303, GW INSTEK ,Taiwan), digital waveform generator (TGA1241, AimTTi, 
Cambridgeshire, UK), multi-meter (FLUKE187, Fluke Corp, WA, USA) and two digital 
oscilloscopes (TDS3012B, and TDS3014B, Tektronix, OR, USA).  Figure 7.19 is a 
diagrammatic layout of the strip board.  This is a single PPG sensor set-up; a full dual 
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sensor design has been implemented as the final circuit construction (Section 7.4).  All 
operational amplifiers used were the Burr Brown OPAX137PA (Texas Instruments, TX, 
USA) (Dual OPA2137PA or Quad OPA4137PA). 
 
Figure 7.18:  Single PPG sensor test circuit strip board. 
 
Figure 7.19:  Diagrammatic layout of the strip board. 
Chapter Seven | DUAL PPG INSTRUMENTATION DEVELOPMENT 
 
Page | 96 
7.3.1 Microcontroller / Multiplexer 
The microcontroller (MCU) was flashed with the c-code in Appendix A using an AVR 
STK 500 programming board (Atmel Corp, CA, USA).  The MCU was then placed into 
the circuit (Figure 7.19), and using a bench-top power source, switched on.  Pins 12 – 14 
were the output pins for the Clocks (C1 - C3) and were monitored on the digital 
oscilloscope.  The duty cycle (measured using the DO vertical cursors), frequency and 
amplitude were all recorded via the screen capture function on the DO (Figure 7.20) 
 
Figure 7.20:  The three TTL-level clocks (1, 2, 3) from the MCU.  Duty cycle = 1.68 ms ≈ d = 0.166 
(16.6 %), f = 99.92 Hz, Amplitude = 4.8 V.  
7.3.2 Current Supply 
The R1 values tested in the simulation in 7.2.1 were tested in the prototype circuit by 
systematically swapping out the resistors at each current source utilising pin sockets.  Once 
again the screen capture and various measuring utilities on the digital oscilloscope were 
utilised (Figure 7.21a – 7.21e).  Table 7.5 compares the expected, simulated and actual 
outputs of the current driver circuit. 
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Figure 7.21a:  Current output when R1 = 50 Ω. Iout = 99 mA 
 
Figure 7.21b: Current output when R1 = 100 Ω. Iout = 50.6 mA 
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Figure 7.21c: Current output when R1 = 150 Ω. Iout = 32.8 mA 
 
Figure 7.21d:  Current output when R1 = 200 Ω.  Iout = 24.8 mA 
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Figure 7.21e: Current output when R1 = 250 Ω.  Iout = 20.3 mA 
Table 7.5:  Actual driving currents and simulated currents correlate well, suggesting that the circuit 
performs as expected and can handle the current range expected. 
R1 (Ω) 
Current (mA) 
Expect Sim (± % diff) Actual (± % diff) 
50 100 100.60 (+ 0.6 %) 
99.0 
(- 1.00 %) 
100 50 49.66 (- 0.68 %) 
50.6 
(+ 1.2 %) 
150 33 33.98 (+ 2.96 %) 
32.8 
(- 0.6 %) 
200 25 25.83 (+ 3.32 %) 
24.8 
(- 0.8 %) 
250 20 19.98 (-0.1 %) 
20.3 
(+ 1.5 %) 
7.3.3 Transimpedance Amplifier 
A prototype reflectance PPG sensor, placed on the left index finger, was used to test the 
transimpedance amplifier circuit.  The component values from 7.2.2 were kept, and the 
LED currents set to 40 mA.  Figure 7.22 is the output of the amplifier before the 
demultiplexing stage.  Overshoots and undershoots are kept to a minimum, and the 
maximum voltage does not clip the voltage supply rails, ensuring full signal integrity.  The 
three different level flat peaks are clearly identifiable arise from the PD’s ability to capture 
the different intensities of the different wavelengths of light as they are absorbed differently 
by the tissues of the in the area being monitored. 
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Figure 7.22: Digital oscilloscope capture of the voltage output from the transimpedance amplifier. 
7.3.4 Demultiplexing 
To test the demultiplexing stage of the circuit, the TIA was driven with a 0.15 µV (achieved 
with a voltage divider circuit after the output of the function generator), 5 Hz sinusoid.  
TIA overall gain was set to 4.2 M (Rg = 243 Ω).  This produced Vd ≈ 630 mV (Pk – Pk).  
Figure 7.23 is a DO screen shot of one LF398AN IC performing the sample and hold 
function on the test signal.   
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Figure 7.23: Digital oscillopscope capture of the output (Ch2) of one LF398 S&H chip. Input = 5 Hz 
sinusoid (Ch1). 
The stepping artefact (aliasing) seen in Ch2 is caused by the chip “holding” the voltage 
level at the previous sample before a new one is made.  This will be smoothed out by the 
low-pass filter (anti-aliasing filter) in the next stage of the circuit. 
7.3.5 Filtering 
An experimental frequency response was carried out separately on the low-pass and band-
pass points of the filter (Vlp and Vout respectively).  The tabulated data can be found in 
Appendix B.  Figure 7.24 and 7.25 are the experimental frequency response graphs for the 
low-pass and band-pass filter stage respectively.  
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Figure 7.24: Low-pass frequency response.  The -3 dB cutoff is 11.49 Hz (0.5 Hz difference to the 
simulation,7 Hz difference to calculated). 
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Figure 7.25: Band-pass frequency response.  The -3 dB cut-offs are 0.6 Hz (+0.1 Hz difference to the 
simulated value, +0.3 Hz difference to calculated value) and 11.08 Hz (-1 Hz difference to the simulated 
value, -7.4 Hz difference to the calculated value) 
7.3.6 Post Amplification 
Set-up parameters from the simulation (7.2.4) were repeated for the PA on the prototyping 
circuit.  A 5 Hz sine wave with approximate 0.2 V (Pk – Pk) amplitude was applied to Vin 
and the output observed on the DO.  Figure 7.26 is a screen capture and direct 
measurement of the input an out signals. 
 
Figure 7.26: Digital oscilloscope capture of AC PPG post amplifier.  Vin(Ch1) = 191 mV (Pk – Pk), 
Vout(Ch2) = 15.4 V (Pk – Pk), Gain ≈ 81. 
The gain achieved with the prototype circuit (≈81), was -4 % below the theoretical gain and 
-3.9 % below the simulated gain.  As with the simulation the effect of the inverting nature 
of the PA is observed clearly. 
7.3.7 Prototyping Summary 
All stages of the electronic prototyping correlated well with calculated values and with the 
simulations.  The current supply for the final circuit will use components that allow for the 
ability to dynamically adjust the currents between 100 mA and 20 mA.  Stable control 
clocks were observed, and all amplification stages (transimpedance amplifier + post 
amplifier) performed within acceptable limits.  The transimpedance amplifier stage will 
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incorporate a variable Rg to allow the use of different photodiodes on different sensors, or 
simply to adjust the gain of the signal during clinical trials on a patient-by-patient basis. 
Filtering has a narrower bandwidth than calculated in 7.1.6.  However, the bandwidth 
achieved is sufficient enough to pass the signals of interest and will not be altered for the 
final circuit construction. 
7.4 System Construction 
A schematic of the final circuit incorporating repeated circuitry to allow the operation of 
two PPG/SpO2 sensors simultaneously was finalised (Appendix C.1).  From this a printed 
circuit board layout was generated (Appendix C.2), and using in-house manufacturing 
facilities a final circuit board was manufactured and populated and installed into a shielded 
steel instrument case (SA series instrument case, RS Components, Northants, UK), figure 
7.27.  Included into the box also was the data acquisition card and lead acid batteries (not 
shown). 
 
Figure 7.27: Final circuit installed into instrument case. 
The circuitry can be switched on and off with a panel mount power switch and an LED 
indicator notifies the user of circuit operation.  Two keyed panel-mound sockets for the 
PPG/SpO2 sensors (Lemo Redel, Ecublens, Switzerland), have also been incorporated 
onto the front panel for the sensors described in chapter 6 (See figure 7.28). 
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Figure 7.28:  Completed dual PPG instrument front panel. 
Access to the data-acquisition card USB terminal has been facilitated by a USB-B 
connector on the rear panel.  Control of the LED currents for the exploratory sensor (the 
fontanelle or oesophageal sensor) as well as control for the transimpedance amplifier gain 
for the same sensor have been facilitated by panel mount potentiometers (P16 series, 
Vishay, PA, USA).    LED currents and transimpedance gain for the reference sensor (the 
foot sensor) can also be set by potentiometers, but these are located internally and will be 
set to standard values for the majority of the clinical trials.  An MCU reset switch 
(connected to the reset pin of the MCU), has also been included should the need arise to 
restart the circuit quickly and safely.  Figure 7.29 shows the rear panel of the completed 
instrument. 
 
Figure 7.29:  Completed dual PPG instrument rear panel. 
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7.5 Acquisition of PPGs and Summary 
A short test using a reflectance PPG/SpO2 sensor placed on the left index finger was 
observed on the DO at the output of the post amplifier on all channels.  Little to no noise 
or aliasing was observed on the PPGs, and they demonstrated large amplification with no 
clipping or distortion.  Figure 7.30 is a short (4 seconds) DO capture of PPGs from two 
channels on one sensor. 
 
Figure 7.30:  Dual channel PPG from one sensor. Visible are the red PPG signal (Ch1) and the infrared 
PPG signal (Ch2). 
PPGs with definable features (peak and dicrotic notch) are clearly observable as a raw 
waveform direct from the circuit.  This tiered design process (circuit design, circuit 
simulation, circuit testing and final construction) has produced a high quality instrument 
adequate for the acquisition of raw PPGs.  The final stage, digitisation and offline storage 
of PPGs, is covered in the next chapter. 
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Photoplethysmograph Data-Logging Virtual 
Instrumentation Development 
n chapter seven instrumentation was developed to acquire the raw 
photoplethysmographic signals (PPGs) from the sensors described in chapter six.  The 
analogue signals that were digitised by the data acquisition device in the instrumentation 
now have to be stored offline for retrospective analysis.  This chapter describes the 
development of a virtual instrument (VI) created in LabVIEW (National Instruments, TX, 
USA), for displaying all acquired physiological signals in real time plus archiving all raw 
data for further offline analysis. Also, algorithms have been developed to enable the real 
time calculation of heart rate and blood oxygen saturation (SpO2) from the individual 
sensors.  A time-stamping function has also been implemented that allows the researcher to 
synchronise hand written notes regarding clinical events/observations directly into the raw 
signal data file, i.e. readings from commercial monitors regarding vital signs. 
8.1 Virtual Instrument Design 
A data flow diagram describing the path of the PPG signals was constructed to help with 
the VI program development.  Figure 8.1 shows the flow diagram. 
Chapter Eight   
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Figure 8.1: Virtual instrumentation data-flow block diagram. 
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8.1.1 LabVIEW 
The programming environment chosen for the VI development was LabVIEW (LV) 
(National Instruments, USA), short for Laboratory Virtual Instrumentation Engineering 
Workbench.  This is an environment with a graphical programming language known as “G”.  
When designing programs using the data-flow method as illustrated in figure 8.1, LV is 
uniquely suited, as the concept of data-flow is the heart of operation, with the flow of data 
provided by an end user, or external component, driving the various steps in the VI’s core 
algorithms.  Various data types can be handled by LV, and are represented by coloured 
icons and connecting wires that illustrate the flow of data and various operations.  Table 
8.1 illustrates the key data-types and their associated colour coding.  Figure 8.2 is a sample 
LV “block diagram” describing the process of a simple addition “calculator”. 
Table 8.1: LabVIEW data types. 




Any number represented as a single-precision 
floating-point to complex extended-precision, 
floating-point imaginary or real. 
 
Blue 
Integer Any whole number represented as byte (8-bit) signed integer to quad (64-bit) unsigned integer. 
 
Pink 
String ASCII characters that can represent data or function calls that can be manipulated by LV. 
 
Green 
Boolean True or False (0 or 1). 
 
Figure 8.2: Simple LabVIEW block diagram describing the algorithm needed to add two numbers together. 
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LV also has the ability of user interface (UI) design, or “Front Panel”, where end users may 
interact and observe the operations as they are happening in real-time.  Various UI 
elements such as numerical controls and graph displays have a corresponding icon in the 
block diagram so that inputs and outputs from the main code can be easily connected to an 
appropriate feature on the UI.  Figure 8.3 is the UI associated with the G code shown in 
figure 8.2. 
 
Figure 8.3:  Sample UI for the addition “calculator”. 
Traditional programming structures such as for-loops, while-loops case structures and 
sequences can all be programmed in a similar way, and are also represented by their own 
unique iconographic symbols.  Figure 8.4 shows the types of program structures available 
in LV. 
  
A: While loop B: For loop 
  
C.: Case structure D: Sequence (flat) 
Figure 8.4:  Basic programming structures of LabVIEW 
Chapter Eight | PPG DATA-LOGGING VIRTUAL INSTRUMENTATION DEVELOPMENT 
Page | 111 
The while-loop (Figure 8.4 A) will continuously execute all code within it until its’ 
conditional terminal (small red circle in green box) receives a Boolean “true” command.  At 
this point the while-loop will finish executing all code within it.  It also has an iteration 
terminal (blue “i” in a blue square) that can be used to call the number of iterations the 
while loop has made. The for-loop ((Figure 8.4 B) executes the code within it N times.  
This is determined by wiring a control or constant to the loop’s blue “N” terminal.  It also 
has an iteration terminal used for calling loop iterations. A case structure (Figure 8.4 C) can 
execute either of many codes within its’ frames, determined by a condition (usually true or 
false) that is wired to its selector terminal.  It ONLY executes one code, not all. A sequence 
structure (Figure 8.4 D) (flat or stacked) will execute the code within its’ frames sequentially 
so that operations can be forced or made to wait until a preceding piece of code has been 
executed.  It executes all code within ALL its’ frames, not one, unlike the case structure. 
8.1.2 Data Acquisition Card Setup and Acquisition Initialisation 
The data acquisition card (DAQ) described in the previous chapter (USB-6212, National 
Instruments, TX, USA), communicates with a PC or laptop via a set of drivers called NI-
DAQmx.  In LV all the function calls, commands and analogue to digital converter (ADC) 
output can be directly accessed via block diagram elements.  Figure 8.5 is the basic DAQ 
card commands needed to set sampling rate, buffer size, starting the ADC conversion, 
reading the samples taken and stopping the DAQ card before clearing the parameters 
before the card is used again. 
 
Figure 8.5: DAQ card setup block diagram. 
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The commands in figure 8.5 can be summarised as follows: 
1. The DAQ card is called and given the commands to set up the analogue in (AI 
Voltage) parameters.  This includes what channels should be sampled, the 
maximum and minimum input range of the signal, and the terminal configuration. 
2. The sample clock speed (rate) is set in Hertz, and what type of sampling should 
take place (i.e. continuous or finite sampling).  The input buffer is determined by 
the samples per channel terminal. 
3. The DAQ card is told to run (stat acquiring samples). 
4. Within a while-loop the AI voltages that have been sampled by the DAQ card are 
read to the size of the buffer set in the step 2.  To continuously read the input 
voltage at the AI terminals the loop will re-execute once all the code in the loop has 
been run once.  As long as the execution time of one loop does not exceed the time 
it takes to fill the buffer on the DAQ card all the “other processes” will execute in 
time to show their outputs to the researcher. The “other processes” illustrated in 
the figure will include writing to file, and calculations on the input signals for heart 
rate and SpO2.  When the while-loop receives a “true” condition at its conditional 
terminal it will finish executing all the code before step 5. 
5. The DAQ card is commanded to stop its current operation 
6. The DAQ card is cleared of its previous setup parameters ready for a new set of 
instructions. 
A number of input terminals in the block diagram at stages 1 and 2 require user-defined 
parameters.  These are set via the corresponding UI elements shown in figure 8.6. 
 
Figure 8.6: DAQ card setup UI elements. 
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The parameters required by the NI-DAQmx elements are: 
• maximum value (V) – The maximum voltage input to the DAQ card. 
• minimum value (V) – The minimum voltage input to the DAQ card. 
• rate (Hz) – The sampling rate per channel on the card. 
• samples per channel – The buffer size per channel when the DAQ card sampling 
mode is set to ‘continuous samples’. 
• physical channels – A string data-type command that can be read by LV to determine 
what card to select and what channels must be used. 
• input terminal configuration – This is the form in which samples are measured.  There 
are several choices: 
o RSE – reference single ended, voltages are read with respect to the ground 
terminal of the DAQ card. 
o NRSE – non-reference single ended, voltages are read with respect to a 
dedicated terminal on the DAQ card. 
o Differential – two channels are read simultaneously with respect to each 
other. 
• sample mode – how the card acquires samples from the AI terminals, again there a 
number of choices: 
o continuous samples – samples are acquired continuously until the card is told 
to stop. 
o finite samples – a set number of samples are taken, set by the “samples per 
channel” parameter. 
o hardware timed single point – one sample is taken per channel when the card 
receives a command from an external source. 
The parameters chosen as the default settings for the final PPG VI will be: 
• ±10 V max and min input range to closely match the output from the 
instrumentation (approximately ±5-9 V) 
• 200 Hz sampling rate, to ensure that all fundamental frequencies of the PPG and 
their residual harmonics are sampled adequately according to the Nyquist criteria. 
• 1 sample per channel buffer size, chosen because the sampling rate chosen is 
relatively low compared to the maximum rate the card can run 12 channels 
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simultaneously (33.33 kHz per channel), and data manipulation will be made simple 
when performing heart rate and SpO2 calculations. 
• RSE terminal configuration, the instrumentation ground line will be directly 
connected to the DAQ card AI GND input. 
• 12 channels input physical channel setup (2 sensors x (3(AC) + 3 (mixed)). 
• Continuous sampling as the length of any clinical trial is unknown. 
8.1.3 Setup PPG Data File and Continuously Save Raw Signals 
Saving the digitised raw PPG signals continuously to a tab-delimited spreadsheet is easily 
realised using the “File I/O” blocks.  Figure 8.7 is the setup utilised to allow the user to be 
prompted for appropriate save location, setting some header information into the file and 
then continuously saving to the file in a spreadsheet format. 
 
Figure 8.7: Data file setup block diagram 
The stages involved in setting the appropriate parameters for the raw PPG data file can be 
summarised into three separate stages: 
1. Setting a custom file type (.ppg) and using “Patient ID” as the file name to be used 
as the file to be saved to.  The user is prompted via a system dialogue to confirm 
save location, and if a file already exists with the same name will be given the 
opportunity to change it.  Header information regarding time, date patient 
information will also be added at the beginning of the file so that each data-file is 
easily identifiable and unique.  A singular UI element “Patient ID” is used to name 
the output file. 
2. Data is written then appended to the file continuously in an ASCII formatted 
spreadsheet, directly to the hard disk, where “other processes” is the output from 
the DAQ card and time stamping function.  Data is written in the “tab de-limited” 
method with an accuracy of 6 decimal places.  This while-loop is the same one 
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from the DAQ card setup, therefore it can be said that data acquisition and file 
writing is occurring simultaneously.  Writing to the file is continuous until the 
while-loop receives a true input to its’ conditional terminal. 
3. At the commencement of the while-loop ending its’ last iteration the file is closed 
in system memory. 
The file setup routine only contains one unique UI element and one shared element that is 
global to the whole VI program.  These are illustrated in figure 8.8. 
 
Figure 8.8: Data file setup UI elements 
The UI elements for this routine are primarily the Patient ID input string, which is used as 
the file output name, and the stop button.  Although the stop button is global to the entire 
functioning of the VI it is described here because it is important that when used that all 
data read from the DAQ card and any time stamps logged by the user are successfully 
recorded into the data file.  Therefore, the final VI will incorporate coding into “other 
processes” that checks that this condition is met. 
8.1.4 Signal Display, Heart Rate and SpO2 Real-time Estimation 
To ensure that the instrumentation is functioning and that the signals being received are of 
use for retrospective analysis, an algorithm was developed that calculates heart rate, SpO2 
and displays the raw signals in real time.  Figure 8.9 is the developed algorithm for one 
sensor; the second sensor algorithm is a direct copy of this code. 
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Figure 8.9: PPG signal display and heart rate + SpO2 real time estimation block diagram 
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To calculate heart rate and SpO2 it was necessary to process the incoming raw PPG signals 
and extract certain parameters so that appropriate equations could be applied. 
The steps (1 – 6) figure 8.9 summarise this process: 
1. A calculation period (determined via a UI element) is set.  This value is the amount 
of time between successive calculations of the heart rate and SpO2.  This is 
multiplied with the sampling frequency (Fs) from the DAQ card setup.  This forms 
the “N” input to the for-loop inside the main program while-loop.  In this manner 
if the period is 2 seconds and Fs = 200 Hz, then N = 400.  This instructs the for-
loop to run this many times for every one iteration of the while loop. 
2. In the DAQ card setup the sampling size was set to 1, within the for-loop every 
loop iteration produces 1 sample per PPG channel which are then passed on to 
steps 3 and 4.  An array function (index array) splits the output from the DAQ card 
into the separate samples from the individual channels. 
3. The block diagram element “Butterworth filter point by point” , is used 
simultaneously on each channel to eliminate noise and aliasing that may affect the 
final calculation.  Three band-pass filters for the AC component and three low-pass 
filters for the DC component of the signal are utilised. 
4. Before all the filtered values are sent to the indexing function at the output of the 
loop they are simultaneously displayed on the chart display UI element (AC signals) 
and on numerical displays (DC signals). 
5. When the for-loop has run N times all N data points are sent to various array 
functions to extract the amplitude of the AC signals (REDac + IRac) and the mean 
of the DC signals (REDdc + IRdc).  One AC signal is also processed by the tone 
extractor block element , to look for the dominant frequency (f) within the 
sampled data this will be used to calculate the instantaneous heart rate at that 
period.  All outputs from the array functions and tone extractor (REDac, IRac, 
REDdc, IRdc and f) are then sent into a formula node where the equations (8.1 -
8.3) are implemented: 






 𝑆𝑝𝑂� = 110 − 25𝑅 (8.2)  
Chapter Eight | PPG DATA-LOGGING VIRTUAL INSTRUMENTATION DEVELOPMENT 
Page | 118 
 𝐻𝑅 = 60𝑓 (8.3)  
6. The outputs of the formula node are displayed on UI numerical displays and the 
while-loop reiterates, sending the next N samples into the for-loop which are 
processed identically.  This process continues indefinitely until the while-loop 
receives a true value at its’ conditional terminal sent from the UI stop button 
described in the file set-up routine. 
At this stage a number of UI elements are present on the front panel, used to display the 
outputs being calculated and setting various parameters needed to ensure successful 
calculations.  The UI elements are shown in figure 8.10. 
 
Figure 8.10:  Signal display, heart rate, SpO2 and user controls UI elements. 
The UI elements shown in figure 8.10 can be described in two categories; 
1. Numerical controls 
• Calculation Period – The time period over which to calculate each successive 
value of heart rate and SpO2. 
• order – The order of the Butterworth filters. 
• high cutoff freq:fh1 – the upper bandwidth limit of the band-pass filter for the 
AC signals. 
• low cutoff freq:fl1 – the lower bandwidth limit of the band-pass filter for the 
AC signals. 
• high cutoff freq:fh2 – the upper limit of the low-pass filter for the DC signals. 
2. Numerical Displays 
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• Ratio of Ratios, SpO2, Heart Rate, RED DC, IR DC and GREEN DC – 
corresponding outputs from the block diagram. 
• Waveform Chart – A graphical representation of the output from RED AC, 
IR AC and GREEN AC to display the PPG signals. 
8.1.5 Time-stamping Function 
The use of a time stamping function within the main VI will allow notes made during 
clinical trials to be synchronised easily with the raw data file.  Figure 8.11 describes the 
algorithm needed to mark the raw data file with the time information every time a UI 
control is activated. 
 
Figure 8.11: Time stamping algorithm block diagram. 
To time stamp the main data file at random intervals involves three main steps: 
1. Create a temporary file where information can be written before it is committed to 
the main data file. 
2. When the user interacts with the UI element “TIME STAMP” a case structure 
executes some code that writes the current elapsed time and event number into the 
temporary file.  At all other times the temporary file remains unwritten to. Each 
successive time stamp interaction appends the created string to the file.  The string 
is displayed in “STAMP string” for the benefit of UI interaction. 
3. When the main program while-loop is terminated the temporary file is merged into 
the main PPG data file from “other processes”.  The temporary file is then deleted 
from the hard disk and the raw PPG data file is updated and closed. 
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For the time stamping algorithm three new UI elements are introduced, and are shown in 
figure 8.12, the stop button of the main program loop is also shown as this is a critical 
element that allows the functioning of the code. 
 
Figure 8.12: Time stamping UI elements. 
The main time stamp UI elements are: 
• Elapsed Time (s)  - Shows the current elapsed time that the VI has been running 
• TIME STAMP – this is the action used to insert the current elapsed time into the 
data file. 
• STAMP String – Shows the last event # and the time that it was recorded. 
8.2 Final Virtual Instrument 
The code from sections 8.1.2 – 5 was combined to form the final code in figure 8.13 
The design of the user interface uses all the same UI elements previously described, but 
using the various design tools available in LV the final UI developed is that seen in figure 
8.14a and figure 8.14b. 
A number of visual differences to that which was described during development have been 
made. The underlying code remains identical.  The setup parameters have been moved to a 
separate tab (figure 8.14b) to the signal displays.  On the signal display tab the numerical 
indicators used for DC value display have been changed to bar indicators, this gives a quick 
and easy visual interpretation of the DC levels in the PPG signals.  The “STAMP String” 
has been renamed as “Event Index and Time” and now displays as a list of events rather 
than just the last recorded time.  The PPG signal display has been made to accommodate 
as much of the screen as possible and the heart rate and SpO2 indicators are also in a large 
font to be easily read. 
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Figure 8.13: Final LabVIEW block diagram code for the dual photoplethysmographic and SpO2 virtual instrument.
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Figure 8.14a:  Virtual instrument UI front panel main signal display tab. 
 
Figure 8.14b Virtual instrument UI front panel setup tab. 
The VI setup tab accommodates all the parameters used to set up the DAQ card, filters 
and to adjust some display properties on the main PPG signal display.  The numerical 
indicators previously described for DC values have also been retained and placed here for 
reference.  A sample of the output files (somename.ppg) created by this VI is shown in 
Appendix D. 
8.3 Virtual Instrumentation Development Summary 
A virtual instrument has been successfully implemented using LV.  During tests the VI was 
not observed to slow down or crash unexpectedly and the output PPG files, when viewed 
offline in  MATLAB (The Mathworks Inc, USA) show all the time stamps recorded, as well 
as all the raw PPG signals. 
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Photoplethysmograph and SpO2 Data Analysis 
Methodology 
aw photoplethysmograph (PPG) waveforms captured from clinical trials with the 
sensors and instrumentation described in chapter six and seven respectively were 
saved to hard-disk via the software described in chapter eight.  Retrospective analysis was 
needed to quantify and interpret this data to help reveal meaningful information that was 
used to assess the ability of the new sensors to estimate blood oxygen saturation (SpO2).  
This chapter presents the methods used to convert the raw unfiltered PPG waveforms into 
SpO2 values and introduces the statistical processes that helped assess whether these new 
sensors are viable alternatives to the traditional sensors already used. 
9.1 Signal Filtering 
To eliminate unwanted noise and condition the raw signals ready for SpO2 calculation the 
PPGs have been put through various stages of filtering.  The first filter used was a re-
sampling finite impulse response (FIR) anti-aliasing filter set to half the original sampling 
rate (Fs) from 200 Hz to 100 Hz.  This was implemented using the ‘resample’ function in 
MATLAB (The MathWorks, USA).  The form of the function used was y = 
resample(x,p,q,n), where x was the original signal, p and q were the numerator and 
denominator of the resample multiplication factor (p/q) and n was the length of the FIR 
filter.  Figure 9.1 is an example of the re-sampling filter.  The re-sampling was performed 
on all signals before additional filtering routines. 
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Figure 9.1: AC PPG signal re-sampling.  The effect of the resample filter is to half the length of the signal 
vector and eliminate the high-frequency noise associated with Fs = 200 Hz (HF noise = Fs/2).  The re-
sampled signal (bottom plot) is notably smoother, the effect of anti-aliasing 
Re-sampling to half the original sampling rate was performed on all signals from all clinical 
trials.  The next stage of filtering was to separate the AC and DC components using a 
band-pass and low-pass filter respectively.  The filter for DC separation was identical for all 
sets of data; it was designed using the filter design and analysis toolbox in MATLAB (The 
MathWorks, USA).  The parameters used were a low-pass equiripple FIR filter with a pass-
band of 0 – 0.15 Hz and a stop-band point of 0.1 Hz.  Attenuation beyond the pass-band 
was set to 40 dB.  This resulted in a 2835th order low-pass digital filter.  The filter 
coefficients were exported into the MATLAB workspace and used with the ‘filtfilt’ 
function to separate the DC signal from the re-sampled PPG.  The ‘filtfilt’ function is a 
zero-phase digital filter that preserves signal features in the filtered time waveform exactly 
where the original feature appeared in the unfiltered waveform, i.e. there is zero-phase 
distortion.  The filter used to separate the AC component was designed in the same 
manner, except the filter chosen was a band-pass filter, and the pass-band and stop-band 
parameters were determined individually for each set of signals by inspection of an 
amplitude spectrum:  To make the AC filter efficient at eliminating unwanted movement 
artefact and respiration/ventilator modulation all signals were subject to a fast-Fourier 
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transform (FFT) algorithm. This helped visualise the main frequency components of the 
PPG signals and hence determine the appropriate parameters for the filter design.  With 
attenuation set to 40 dB for every AC filter, and the pass and stop-band parameters set 
with a resolution of 0.05 Hz the resulting band-pass filter had an order of 2835 also.  The 
filter coefficients were similarly exported and used with the ‘filtfilt’ function.  Figure 9.2 is 
an FFT amplitude spectrum from one patient in the clinical trials, and figure 9.3 is the 
result of filtering the AC and DC components from the original PPG signal. 
 
Figure 9.2: FFT magnitude Spectrum of a PPG signal (Y) from 0 – 7 Hz.  Calculating SpO2 relies on the 
amplitude information from the heart rate component frequencies, designing a digital filter with an 
appropriate pass-band for each patient will effectively eliminate all unwanted frequency components 
(Respiratory Rate + LF Noise) for that patient, thus optimizing SpO2 calculation. 
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Figure 9.3:  AC and DC PPG separation and filtering example over 30 seconds of signal.  The unfiltered 
mixed signal (top) has been effectively filtered and the AC component attributed to the heart rate and DC 
component attributed to non-pulsatile blood flow separated successfully (middle and bottom respectively). 
9.2 Signal Normalisation 
In order to compare different wavelengths of light for the calculation of SpO2 all the PPG 
signals were divided by their respective DC component.  A PPG signal is formed of two 
constituent parts, the AC portion (attributed to the pulsatile arterial blood) and the DC 
portion (attributed to the tissue and non-pulsatile blood flow from veins).  This process is 
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necessary as the measured light intensities at the different wavelengths will be different for 
the different LEDs.  The absorbing characteristics of the DC components and the 
sensitivity of the photodetector also differ for different wavelengths and the tissue 
absorption and path length will vary widely from patient to patient (Webster, 1997).  
Normalisation (N) is done by dividing the PPG signal (AC + DC) at each wavelength with 
its individual DC component given by equation 9.1 
 Nλ=PPGλ/DCλ (9.1) 
where λ is the wavelength of light of the signal being normalised and PPGλ = ACλ + DCλ.  
Figure 9.4a and 9.4b are an illustration of this process for two wavelengths (red and 
infrared). 
 
Figure 9.4a: PPG signals before normalisation with their respective DC level (dotted lines). The DC 
magnitudes are different. 
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Figure 9.4b:  PPG signals after normalisation, each signal now has the same DC magnitude 
(1000 mV). 
9.3 Amplitude Measurements 
Calculation of SpO2 required the information from the measurement of the amplitude of 
the PPG signals at different wavelengths in order to determine the amount each source of 
light is absorbed by the blood and tissue.  Since it is the AC component of the signal, 
attributed to the pulsatile arterial blood, which is said to be representative of blood oxygen 
concentration when measured at more than one wavelength it is necessary to measure this 
amplitude (Aac).  The algorithm used, written in MATLAB (The MathWorks, USA), 
implements equation 9.2 on the normalised PPG signals; it takes each set of PPG signals 
and divides the length of the signal (L) into two-second portions (s).  For every two 
seconds the amplitude is simply calculated by subtracting the lowest detected amplitude 
value (AL) (usually the trough of a PPG waveform) away from the highest detected 
amplitude value (AH) (usually the peak of the PPG waveform); 
 A n ac = s 
n
AH - sAL n  (9.2) 
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where n is a number from 1 to (L/2) and represents the portion of PPG signal where Aac is 
being calculated.  Figure 9.5 illustrates this method. 
 
Figure 9.5:  AC PPG amplitude calculation for a single 2-second portion of signal. 
9.4 SpO2 Measurements 
For comparison of SpO2 values from the new sensors with the commercial pulse oximetry 
devices the amplitude measurements made by the method in section 9.4 were converted 
into meaningful values that were compared directly with SpO2.  The first stage of 
conversion was to derive an arbitrary value from the separate PPGs (red and infrared).  
Traditionally this value is known as ‘R’ and several methods of calculating it exist.  The 
method chosen for this thesis is described in Design of Pulse Oximeters (Webster, 1997), and 
is known as the derivative method, and is calculated using the separated AC and DC 
components that we have already computed.  By equation 9.3 the amplitudes from the AC 
and DC components for each wavelength (red and infrared) is used to compute R; 
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 R = ACRED DCRED�ACIR
DCIR�
 (9.3) 
When using the normalised signals, calculated in section 9.3, DCRED = DCIR; therefore eqn. 
9.3 becomes; 
 R = NRED NIR�  (9.4) 
This ‘R’ value, or ratio of ratios as it is commonly referred to, was then used with a 
calibration equation to estimate SpO2.  Again there are several equations in existence and 
many are described in both Design of Pulse Oximeters (Webster, 1997) and in Pulse Oximetry 
(Moyle, 2002).  However since a degree of calibration would be required to calibrate these 
new sensors with actual blood-gas analysis values for accurate operation, and since the 
protocol for the clinical experiments (described in Chapter 10) is looking for changes in 
SpO2 rather than accurate SpO2 scores, the SpO2 approximation chosen is equation 9.5, 
and is described briefly in Design of Pulse Oximeters (Webster, 1997); 
 SpO2 = 110 - 25R (9.5) 
This is a linear equation and can be represented graphically as shown in figure 9.6. 
Chapter Nine | PHOTOPLETHYSMOGRAPH AND SPO2 DATA ANALYSIS METHODOLOGY 
 
Page | 131 
 
Figure 9.6: SpO2 approximation linear equation 9.5 with R value. 
9.5 Statistics 
Following computation of amplitudes and SpO2 values, various statistical analyses and tests 
were performed on the sets of data to make the appropriate comparisons between the 
computed values and the actual observations made in the hospital.  Prior to the statistical 
analysis the amplitudes and SpO2 values obtained were inspected to eliminate those values 
which were calculated during any heavy movement artefact or clinical procedure which 
caused portions of the signals to become unreliable.  A signal portion was specified by this 
researcher to be unreliable when either the characteristic AC pulsatile signal ceased, or if a 
time stamp indicated a clinical procedure which caused unwanted movement in the patient.  
Figure 9.7a , 9.7b and 9.7c are an example of one PPG signal with unreliable signal 
portions and the elimination process on the corresponding amplitudes and SpO2 values. 
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Figure 9.7a: A sample of PPG signal with unreliable signal portions marked via time-stamps 
during the trial (red) and retrospectively via manual inspection (green – operator driven). 
 
Figure 9.7b: Eliminated PPG amplitudes through the use of time stamps (red) and manual 
inspection (green – operator driven). 
 
Figure 9.7c: Eliminated SpO2 values through the use of time stamps (red) and manual 
inspection (green – operator driven). 
With the amplitude and SpO2 data now conditioned to remove unwanted erroneous 
readings, a series of statistical tests were performed.  These included mean and standard 
deviation, correlation, “Bland and Altman” agreement analysis (Bland and Altman, 1986) 
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and paired distributiuon t-tests.  The pre-normalised data (AC and DC) was also tested 
using the t-test to look for changes in the signals before normalisation.  The details of how 
each of these tests was performed on the sets of data are covered in the following chapters.  
Results from the commercial sensors and blood gas tests were pooled into tables and 
analysed with the same statistical algorithms and compared accordingly.  All statistical 
computations were performed in MATLAB (The MathWorks, USA). 
9.6 Summary 
The methods outlined here have been used to derive the results in the following chapters, 
Chapter 10 – Anterior Fontanelle and Foot Photoplethysmography Analysis During Delivered Oxygen 
Concentration Change In-vivo , Chapter 11 – Anterior Fontanelle and Foot SpO2 Analysis, and 
Chapter 12 - Oesophageal Photoplethysmographs and SpO2 Analysis, a Proof of Concept Demonstration 
In-vivo.  Appropriate referencing to this chapter is cited. 
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Anterior Fontanelle and Foot 
Photoplethysmograph Analysis during Delivered 
Oxygen Concentration Change In-vivo 
hapter five summarised that at times of peripheral blood supply compromise in 
neonates and infants a core location such as the anterior fontanelle (AF) or the 
oesophagus may be better suited as an oxygen saturation monitoring (SpO2) location.  A 
clinical protocol was written and approved by a local ethics committee (Appendix E) to 
investigate whether  these locations could yield the necessary raw photoplethysmographic 
waveforms (PPGs) needed for SpO2 calculation.  All instrumentation was tested and passed 
for electrical safety by the participating hospital’s biomedical engineering department as 
part of the local ethic committee’s requirements.  This chapter presents the details of the 
clinical trials (from the fontanelle) including all the analysis on multi-wavelength PPGs 
from the AF and the foot of 16 neonates (9 male, 7 female) on an intensive care unit at 
Great Ormond Street Hospital for Children.   
10.1 Anterior Fontanelle Clinical Procedure 
Candidates for AF PPG monitoring were selected on ward rounds by the lead clinician 
against the list of inclusion/exclusion criteria specified in the protocol.  All patients were 
categorized as either ASA 1, 2 or 3 (American Society of Anaesthesiologists physical status 
classification system), where 1 is the least critical and the patient wasn’t on respiratory 
support and 3 was more severe and the patient was on an oscillator, a high frequency 
(typically 4 times greater than normal respiratory rate) mechanical ventilator that utilises 
small tidal volumes to effectively ventilate a patient with reduced risk of ventilator-
associated lung injury.  Category 2 patients were on regular ventilator support. 
In these pilot studies utilisation of the fontanelle sensor was carried out on 16 intensive 
care neonates (9 male, 7 female) with a mean age of 36.5 days (SD = 46.8 days) and a mean 
weight of 3.07 kg (SD = 0.93 kg).  All patients were assessed by the lead clinician as 
suitable for study (ASA score 1 – 3) where those with an ASA of 3 were considered to be 
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most at risk of periphery supply shutdown.  All patients were sedated and receiving 
delivered oxygen.  ASA 1 patients were not on mechanical respiratory support (5 cases), 
ASA 2 patients were on ventilator respiratory support (8 cases) and ASA 3 patients were on 
oscillatory respiratory support (3 cases).  One ASA 1 patient (Patient 3, Appendix G) failed 
to yield adequate PPGs for study from the AF, and the data was eliminated from further 
overall analysis.  For this patient it was commented by the clinician that the AF felt smaller 
than usual, suggesting that observations of PPGs through the AF were hindered by the 
presence of underlying tissue. 
Following informed consent from parents the procedure to look for PPG signal changes at 
the AF commenced; A routine blood gas test was scheduled and both sensors (foot and 
AF) were cleaned with alcohol wipes and placed into clear adhesive sterile pockets 
(Tegadern™, 3M, MN, USA).  The reference PPGs were established by placing and 
securing the foot sensor on the sole of the foot with standard medical tape.  The lead 
clinician then manoeuvred the AF sensor over the fontanelle until PPGs with good 
amplitude and signal to noise ratio were observed on the laptop monitor.  The AF sensor 
was then secured in position with a bandage that was wrapped around the back of the head 
or jaw-line.  Figure 10.1 shows the AF sensor in situ on a male patient, photographic 
consent was obtained from the parent for the use of this image in publications related to 
this work.  At this time the routine blood sample was taken for blood-gas analysis, and 
marked as a time stamp in the data file with the time-stamp function of the virtual 
instrument (VI).  Recording of PPGs was continued for a maximum length of 30 minutes 
before the baseline of delivered oxygen concentration (FiO2) was increased by 50 %, .e.g. 
30 % to 45 %.  The time of FiO2 changes were marked as time stamps.  Continued 
monitoring was maintained for a maximum time of one hour before the FiO2 was 
decreased back to the initial baseline value and PPGs were further monitored for 30 
minutes before the trial ended. 
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Figure 10.1:  AF sensor in-situ, in sterile pocket and secured with a head bandage. 
10.2 Anterior Fontanelle and Foot Photoplethysmographs 
The raw data was inspected before post processing was applied. Figure 10.2 is an example 
of the raw PPG recording at al three wavelengths from the AF and foot sensors over the 
entire duration of a trial, with FiO2 change time stamps depicted.  The pre-normalised 
amplitudes (AC and DC) were calculated and are tabulated in Appendix F. 
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Figure 10.2:  Full recording of AC PPG waveforms from the AF (Top) and Foot (Bottom) with Time stamp 
markings for FiO2 Change (dotted horizontal lines). 
Figures 10.3a – 10.3f illustrate typical AC PPGs from the AF fontanelle and reference 
sensor placed on the foot at all wavelengths during all three periods of monitoring. 
 
Figure 10.3a: Five second sample of green AF AC PPGs at the different monitoring periods 
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Figure 10.3b: Five second sample of infrared AF AC PPGs at the different monitoring periods  
 
Figure 10.3c: Five second sample of red AF AC PPGs at the different monitoring periods 
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Figure 10.3d: Five second sample of green reference foot AC PPGs at the different monitoring periods 
 
Figure 10.3e: Five second sample of infrared reference foot AC PPGs at the different monitoring periods 
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Figure 10.3f: Five second sample of red reference foot AC PPGs at the different monitoring periods 
SigmaPlot (SYSTAT Software Inc, USA) was used to test the PPG amplitudes for 
normality (Kolmogorov-Smirnov Test) prior to any further statistical tests. The results 
from the normality test are tabulated in table 10.1.   
Table 10.1  Kolmogorov-Smirnov normality test results (SigmaPlot, SYSTAT Software Inc) 
Wavelength Period Sensor 
AC Amplitudes DC Amplitudes 
p-score Result p-score Result 
660 nm RED 
Pre FiO2 
Foot P  = 0.064 Passed P  = 0.107 Passed 
AF P  > 0.200 Passed P  = 0.199 Passed 
During 
FiO2 
Foot P  = 0.057 Passed P  = 0.100 Passed 
AF P  = 0.167 Passed P  = 0.098 Passed 
Post FiO2 
Foot P  > 0.200 Passed P  = 0.157 Passed 




Foot P  = 0.020 Failed P  > 0.200 Passed 
AF P  = 0.124 Passed P  > 0.200 Passed 
During 
FiO2 
Foot P  = 0.009 Failed P  > 0.200 Passed 
AF P  > 0.200 Passed P  > 0.200 Passed 
Post FiO2 
Foot P  = 0.023 Failed P  = 0.149 Passed 




Foot P  = 0.006 Failed P  = 0.107 Passed 
AF P  > 0.200 Passed P  > 0.200 Passed 
During 
FiO2 
Foot P  = 0.163 Passed P  = 0.126 Passed 
AF P  > 0.200 Passed P  = 0.093 Passed 
Post FiO2 
Foot P  > 0.200 Passed P  > 0.200 Passed 
AF P  > 0.200 Passed P  > 0.200 Passed 
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A two-tailed paired t-test was then performed to test whether or not the change in FiO2 
caused a significant change in the resulting AC or DC amplitudes between monitoring 
periods for each sensor (P < 0.05 was used as the limit at which FiO2 was considered to 
have an effect on the PPG amplitudes).  These results are shown in tables 10.2a – 10.2l, 
with highlighted significant results. 
Table 10.2a: Paired t-test between periods on RED AC amplitudes from the AF sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.643 0.677 
During FiO2 increase 0.643 - 0.355 
Post FiO2 increase 0.677 0.355 - 
 
Table 10.2b: Paired t-test between periods on RED DC amplitudes from the AF sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.014 0.977 
During FiO2 increase 0.014 - 0.425 
Post FiO2 increase 0.977 0.425 - 
 
Table 10.2c: Paired t-test between periods on IR AC amplitudes from the AF sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.225 0.761 
During FiO2 increase 0.225 - 0.305 
Post FiO2 increase 0.761 0.305 - 
 
Table 10.2d: Paired t-test between periods on IR DC amplitudes from the AF sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.031 0.139 
During FiO2 increase 0.031 - 0.884 
Post FiO2 increase 0.139 0.884 - 
 
Table 10.2e: Paired t-test between periods on GREEN AC amplitudes from the AF sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.191 0.352 
During FiO2 increase 0.191 - 0.136 
Post FiO2 increase 0.352 0.136 - 
 
Table 10.2f: Paired t-test between periods on GREEN DC amplitudes from the AF sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.871 0.407 
During FiO2 increase 0.871 - 0.484 
Post FiO2 increase 0.407 0.484 - 
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Table 10.2g: Paired t-test between periods on RED AC amplitudes from the FOOT sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.355 0.694 
During FiO2 increase 0.355 - 0.442 
Post FiO2 increase 0.694 0.442 - 
 
Table 10.2h: Paired t-test between periods on RED DC amplitudes from the FOOT sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.003 0.033 
During FiO2 increase 0.003 - 0.576 
Post FiO2 increase 0.033 0.576 - 
 
Table 10.2i: Paired t-test between periods on IR AC amplitudes from the FOOT sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.661 0.921 
During FiO2 increase 0.661 - 0.912 
Post FiO2 increase 0.921 0.912 - 
 
Table 10.2j: Paired t-test between periods on IR DC amplitudes from the FOOT sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.256 0.244 
During FiO2 increase 0.256 - 0.309 
Post FiO2 increase 0.244 0.309 - 
 
Table 10.2k: Paired t-test between periods on GREEN AC amplitudes from the FOOT sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.802 0.482 
During FiO2 increase 0.802 - 0.355 
Post FiO2 increase 0.482 0.355 - 
 
Table 10.2l: Paired t-test between periods on GREEN DC amplitudes from the FOOT sensor 
Paired T-test Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Pre FiO2 increase - 0.943 0.643 
During FiO2 increase 0.943 - 0.124 
Post FiO2 increase 0.643 0.124 - 
10.3 Fontanelle and Foot PPG Normalised Amplitude Analysis 
The methods of filtering and normalisation described chapter 9 section 9.1 – 9.2 were 
applied to the raw signals.  Amplitudes were calculated by the method described in section 
9.3 (Chapter 9), and erroneous readings identified and removed from further calculations 
by the method given in section 9.5 (Chapter 9).  Figures 10.4a 10.4c are examples of 
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normalised amplitude traces across the three monitoring periods for the three wavelengths 
from the AF sensor. 
 
Figure 10.4a:  Normalised amplitude measurements fro the AF sensor for the Green PPGs. 
 
Figure 10.4b:  Normalised amplitude measurements fro the AF sensor for the Infrared PPGs. 
 
Figure 10.4c:  Normalised amplitude measurements fro the AF sensor for the RED PPGs. 
From the sixteen clinical trials 1 case (Patient #3) failed to yield adequate PPGs from the 
AF for any length of time, and has been completely omitted from the following results.  
The clinician’s observation about the AF noted that it was “smaller than usual” and may 
have been the contributing factor to the failure, and it was noted by the researcher that 
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although infrared signals from the AF were seen, because the red signals failed the trial was 
aborted as the primary goal of the experiment is to assess PPGs for the estimation of SpO2;  
Two cases (Patient #4 and #16) were receiving an FiO2 of 100 %), and hence there was no 
FiO2 increase or decrease, a further 2 cases posed technical difficulties where the trial 
procedure was interrupted and only partially completed (Patients #12 and #15). 
Four patients (#5, #7, #10 and #13) exhibited green PPGs from the AF, and only three of 
those (#5, #7 and #13) had green PPG traces across all three monitoring periods.  This 
will be discussed in the final chapter Discussions, Conclusions and Future Work. 
Amplitude analysis was conducted for each wavelength separately and individually for each 
sensor and during the three monitoring periods specified in the protocol, (Pre-FiO2 
increase, During-FiO2 increase and Post-FiO2 increase).  Figure 10.4a – 10.4c are 
normalised PPG traces from the AF from one individual at the three wavelengths at the 
different monitoring periods.  The normalised amplitude results for all patients are shown 
in tables 10.3a – 10.3c, and displayed as a bar-graph in figures 10.5 and 10.6. 
A statistical test to explore the correlation (R) of age and weight (Appendix G) against the 
mean amplitudes for each patient was performed and is shown in table 10.4. 
Table 10.3a: Mean red (660 nm) normalised AC (heart rate frequency) amplitudes. 
Patient 
# 
RED Normalised Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot AF Foot AF Foot AF 
1 122.7 66.8 115.8 74.3 110.8 87.0 
2 48.9 33.8 35.1 29.5 38.9 22.2 
4 25.9 30.6     
5 142.6 36.2 122.6 35.9 125.1 30.4 
6 143.5 29.7 90.2 36.9 92.3 31.8 
7 38.8 33.6 25.5 33.8 23.7 25.8 
8 17.5 27.0 16.5 36.5 26.5 33.7 
9 53.5 29.4 22.6 29.4 39.5 22.6 
10 137.4 34.4 119.6 29.0 83.9 31.2 
11 156.8 50.3 131.3 52.5 122.0 51.6 
12 16.5 19.8 18.1 27.8   
13 14.9 24.7 17.1 16.7 13.7 16.5 
14 156.5 40.8 196.6 28.1 259.2 38.2 
15 217.0 17.5     
16 65.5 10.0     
Mean 90.5 32.3 75.9 35.9 85.0 35.6 
SD 65.8 13.6 61.0 14.7 71.0 19.4 
Measurements 
(n) 15 15 12 12 11 11 
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Table 10.3b: Mean infrared (940 nm) normalised AC (heart rate frequency) amplitudes. 
Patient 
# 
IR Normalised Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot AF Foot AF Foot AF 
1 49.9 96.2 47.5 140.2 45.7 166.9 
2 87.7 100.0 82.3 77.2 73.0 77.2 
4 25.3 43.1     
5 271.7 152.4 252.1 135.8 241.3 117.4 
6 224.8 24.3 180.6 25.4 149.0 22.0 
7 37.4 26.3 29.4 29.0 25.6 22.6 
8 21.1 36.5 25.4 50.1 31.6 51.5 
9 58.9 56.0 56.1 35.2 60.1 34.0 
10 316.4 91.8 325.2 58.2 188.1 64.6 
11 174.7 99.6 175.7 122.1 155.2 101.3 
12 23.8 39.8 27.1 38.0   
13 35.4 50.7 38.3 43.0 31.9 38.7 
14 211.0 46.1 257.1 49.8 305.2 77.1 
15 190.3 37.4     
16 127.8 17.1     
Mean 123.7 61.1 124.7 67.0 118.8 70.3 
SD 100.1 38.1 107.9 42.1 95.7 44.6 
Measurements 
(n) 15 15 12 12 11 11 
Table 10.3c: Mean green (525 nm) normalised AC (heart rate frequency) amplitude 
Patient 
# 
GREEN Normalised Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot Font Foot Font Foot Font 
1 369.7  345.3  333.2  
2 54.1  52.9  45.9  
4 49.9      
5 563.0 104.4 552.9 97.8 570.7 90.9 
6 603.9  569.9  581.5  
7 161.9 51.9 144.8 51.2 126.5 38.5 
8 37.1  48.0  58.2  
9 70.1  51.6  61.1  
10 495.4 125.4 393.1  239.0  
11 390.3  390.9  350.2  
12 154.9  180.2    
13 39.7 98.5 51.3 65.3 38.5 74.7 
14 627.8  809.8  889.7  
15 627.4      
16 50.3      
Mean 286.4 95.0 299.2 71.5 299.5 68.0 
SD 244.9 31.0 252.7 23.9 280.4 26.8 
Measurements 
(n) 15 4 12 3 11 3 
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Figure 10.5:  Bar-graph of mean fontanelle AC PPG amplitudes across all three monitoring periods. 
 
Figure 10.6: Bar-graph of mean foot AC PPG amplitudes across all three monitoring periods. 
Table 10.4: Correlation results of normalised amplitudes with age and weight 
 Mean Normalised Amplitude 
Correlation 
(R) RED Foot RED AF IR Foot IR AF GR Foot GR AF 
Age 0.02 0.16 0.14 0.25 -0.13 0.81 
Weight 0.24 0.25 0.15 0.44 0.18 0.97 
32.3 35.9 35.6 
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The mean values for the individual wavelengths of both sensors were correlated against 
one another to look at the overall relationship of amplitudes between the foot and the AF, 
the results are displayed in table 10.5. 
Table 10.5: Correlation results for FiO2 change between the foot and AF sensors.   
Period 
Mean Normalised Amplitudes (mV) 
RED (660 nm) IR (940 nm) GR (525 nm) 
Foot AF Foot AF Foot AF 
Pre FiO2 90.5 32.3 123.7 61.1 286.4 95.0 
During FiO2 75.9 35.9 124.7 67.0 299.2 71.5 
Post FiO2 85.0 35.6 118.8 70.3 299.5 68.0 
Correlation 
(R) -0.833 -0.669 -0.995 
Finally an analysis was performed to search for a trend in PPG amplitudes against the 
relative health of the patient, assessed by the patient’s individual ASA score (Appendix G).  
This was done by computing the difference between foot and AF PPGs at each wavelength 
and at each monitoring period, then plotting the results against the relative ASA score  
(1 – 3).  The tabulated results are displayed in table 10.6 and illustrated in figures 10.7 – 
10.9. 
Table 10.6: Amplitude differences vs ASA scores 
# ASA 
Amplitude Difference (AF - Foot) (mV) 
Pre FiO2 increase 
During FiO2 
increase Post FiO2 increase 
RED IR GR RED IR GR RED IR GR 
1 2 -55.9 46.3  -41.5 92.7  -23.8 121.2  
2 3 -15.1 12.3  -5.6 -5.1  -16.7 4.2  
4 3 4.7 17.8        
5 1 -106.4 -119.3 -458.6 -86.7 -116.3 -455.1 -94.7 -123.9 -479.8 
6 2 -113.8 -200.5  -53.3 -155.2  -60.5 -127.0  
7 2 -5.2 -11.1 -110.0 8.3 -0.4 -93.6 2.1 -3.0 -88.0 
8 3 9.5 15.4  20 24.7  7.2 19.9  
9 2 -24.1 -2.9  6.8 -20.9  -16.9 -26.1  
10 1 -103 -224.6 -370.0 -90.6 -267  -52.7 -123.5  
11 1 -106.5 -75.1  -78.8 -53.6  -70.4 -53.9  
12 2 3.3 16.0  9.7 10.9     
13 2 9.8 15.3 58.8 -0.4 4.7 14.0 2.8 6.8 36.2 
14 1 -115.7 -164.9  -168.5 -207.3  -221 -228.1  
15 2 -199.5 -152.9        
16 2 -55.5 -110.7        
n 15 15 4 12 12 3 11 11 4 
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Figure 10.7: Mean RED normalised PPG amplitude vs ASA score. 
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Figure 10.9: Mean GREEN normalised PPG amplitudes vs ASA score. 
Correlation between the ASA score and the difference in amplitudes was calculated and is 
tabulated in table 10.7. 
Table 10.7: Correlation (R) of amplitude differences and ASA scores. 
Correlation (R) 
Pre FiO2 increase During FiO2 increase Post FiO2 increse 
RED IR GREEN RED IR GREEN RED IR GREEN 
0.599 0.627 0.945 0.792 0.653 0.976 0.668 0.635 0.973 
n =15 n = 15 n = 4 n = 12 n = 12 n = 3 n = 11 n = 11 n = 3 
 
10.4 Amplitude Analysis Summary 
Initial results indicate a strong correlation between sensors at times of known oxygen 
concentration change; suggesting that PPG monitoring from the AF may be a viable option 
to calculate SpO2.  What effect the negativity of the correlation has on the calculated SpO2 
values is the subject of the next chapter, although since SpO2 calculation is essentially a 
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would also be expected to be a negative correlation between the foot and AF, to what 
degree this affects the accuracy of SpO2 calculation when compared to the commercial 
devices and gold standard values from blood gas analysis is also covered in the next 
chapter. 
Tests for normality in section 10.2 reveal that the amplitude analysis data fits normal 
distributions for most samples, where the tests fail the deviation from the normal was very 
small, for this reason a parametric test method, paired t-test, was used to look for 
significant differences between monitoring periods, as opposed to a non-parametric 
method.  However it is observed that although a visible change in the amplitudes of PPGs 
can be directly observed (as in figures 10.3a – 10.3c), the paired t-test does not always 
reveal a significant change (P<0.05).  The significant changes (according to the paired t-
test) are observed from the DC portion of the signal, and only at the red and infrared 
wavelengths. 
Correlation of PPG amplitudes with the age and size (weight) of the patient reveals 
relatively little correlation with only weak to medium positive correlation at best.  Other 
factors affecting the observed PPGs may be a contributor and will be discussed in Chapter 
13 - Discussions, Conclusions and Future Work. 
The final analysis of differences in amplitudes versus the ASA score for each patient was 
designed in an attempt to reveal that the sickest of patients (i.e. those more at risk of 
peripheral supply compromise) would have smaller normalised peripheral PPG amplitudes 
than those who are assessed to be in a healthier condition.  In other words as the relative 
health of the patient diminishes (ASA score increases) then the AF sensor detects 
increasing normalised PPG amplitudes when compared to the peripheral sensor amplitude.  
At the point of peripheral supply compromise the AF sensor therefore should still be able 
to detect the AC PPG.  The results obtained do indeed show an increase in amplitude 
difference with increasing ASA score for all wavelengths, and the correlation results are 
positively strong to very strong (R > 0.5), supporting this assumption. 
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Anterior Fontanelle and Foot SpO2 Analysis 
hapter ten presented the analysis of raw PPG waveforms from the anterior 
fontanelle (AF) and a reference sensor placed on the foot of the neonate.  Analysis 
revealed that changes in blood oxygen saturation (SpO2), artificially brought about by 
changing delivered oxygen concentration (FiO2), correlated strongly with changes in the 
amplitude of the raw PPG waveforms.  This suggests that the PPG waveforms at the AF 
may well be suitable for SpO2 monitoring.  To test this hypothesis the normalised 
amplitudes from the AF and the foot, calculated in the previous chapter, have been utilised 
in the estimation of SpO2 and compared against the actual SpO2 values from a commercial 
monitor (Com) (Philips Intelliview with HP Merlin Sensors and Modules, Netherlands).  
Comparison with blood gas analysis arterial oxygen saturation (SaO2) (Abbott POC i-STAT 
Handheld, NJ, USA) has also been made. 
11.1 Estimation of SpO2 during FiO2 increase and decrease. 
SpO2 has been calculated using the method described in section 9.4 (Chapter 9). To make a 
comparison with actual SpO2 readings, as recorded by the clinical monitors, time stamps 
were marked into the raw data files using the time stamping function of the virtual 
instrument (VI) across all trials, coinciding with specific clinical events and/or observations 
(e.g. feeding, drug administration and readings from clinical monitors).  These values were 
then compared against the computed SpO2 values.  Figure 11.1 shows an example from 
one patient of the SpO2 values from the commercial monitor against those computed from 
the custom sensors. 
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Figure 11.1: Custom SpO2 sensor readings against commercial sensor readings from one patient with 
trend-lines during FiO2 change.  Commercial SpO2 time stamps (n) = 78. 
The method described in section 9.5 (chapter 9) was utilised to eliminate unwanted SpO2 
values from 759 recorded time stamps.  Mean and standard deviation was computed for 
each period for each sensor and is tabulated in table 11.1.  Figure 11.2 is a bar-graph of this 
data. 
Table 11.1:  Mean SpO2 Values in each period for each patient 
# 
SpO2 (%) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot AF Com Foot AF Com Foot AF Com 
1 98.5 92.6 100.0 99.1 96.8 100.0 99.4 97.0 99.3 
2 96.1 101.6 95.0 99.3 100.5 98.5 96.7 102.8 93.5 
4 84.4 92.3 77.6 - - 95.8 - - - 
5 96.9 104.1 93.2 97.8 103.4 98.7 97.0 103.5 95.6 
6 94.0 79.5 96.7 97.5 73.7 99.8 94.5 73.9 96.3 
7 84.0 78.1 97.9 88.4 80.9 99.1 86.9 81.4 98.5 
8 89.3 91.5 96.5 93.8 91.8 98.1 89.1 93.6 97.6 
9 87.3 96.9 99.1 99.9 89.1 99.8 93.5 93.4 99.3 
10 99.1 100.6 99.6 100.8 97.5 96.5 98.9 97.9 99.9 
11 87.6 97.4 91.6 91.3 99.2 98.5 90.4 97.3 93.0 
12 92.7 97.6 98.2 93.3 91.7 100.0 - - - 
13 99.4 97.8 100.0 98.8 100.3 100.0 99.3 99.4 99.9 
14 91.4 87.8 100.0 90.9 95.9 95.8 88.8 97.6 98.6 
15 81.5 98.3 98.0 - - - - - - 
16 97.2 95.5 93.7 - - - - - - 
Mean 92.0 94.1 95.8 95.9 93.4 98.7 94.0 94.3 97.4 
SD 12.5 7.5 5.7 14.0 8.7 1.4 14.0 9.0 2.5 
n 15 15 15 12 12 12 11 11 11 
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Figure 11.2: Mean bar-graph of SpO2 change across the three monitoring periods for the three different 
sensors. 
These values were then correlated with each other to look for similar trends (table 11.2). 
Table 11.2: Correlation of SpO2 values of the three sensors, computed with SpO2 values from the mean 
values at each period (pre, during and post FiO2 increase). 
Correlation (R) AF Foot Commercial 
AF - -0.731 -0.696 
Foot -0.731 - 0.999 
Commercial -0.696 0.999 - 
11.2 Fontanelle SpO2 compared to Blood Gas SaO2 Readings. 
From the examination of the 759 time stamps taken, a total of 26 arterial blood tests were 
conducted as part of routine clinical procedure, including the 15 tests used to time the start 
of the trial.  The time the blood was drawn from the arterial cannula it was marked into the 
raw data file via the time stamping function of the data-acquisition VI.  These time stamps 
were then matched against the corresponding commercial SpO2 reading and the SpO2 
reading calculated from the foot and AF at those times. 
A linear regression scatter plot has been constructed from the blood gas analysis versus the 
various SpO2 sensor data and is shown in figure 11.3. 
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Figure 11.3: Linear regression scatter plot of blood gas analysis (x-axis) versus the various SpO2 sensors 
(y-axis), n = 26. 
The Linear regression analysis is a good indicator of how well one method agrees with 
another method, where the ideal agreement lies along the line of identity, i.e. where 
measurement x = measurement y.  The Bland and Altman test for accuracy between two 
different measurement techniques (Bland and Altman, 1986), or “differences-between-
methods” has been utilised to help identify the relative accuracy of these three 
measurements.  Commercial SpO2, reference foot SpO2 and AF SpO2 have all been 
individually compared with the 26 blood gas samples taken.  Figures 11.4 – 11.6 are the 
three sensors comparison with the blood gas test results.  
The “gold standard” blood gas test values have been plotted in figure 11.7 as a distribution 
on a histogram against a normal distribution curve and a measurement of the skewness.  
This was done to investigate the normality of the SaO2 values, and to compare later on the 
distribution of SpO2 values computed using the custom sensors.  
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Figure 11.4: Blood Gas SaO2 verses Commercial SpO2 readings. 
 
Figure 11.5: Blood Gas SaO2 verses AF SpO2 readings. 
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Figure 11.6: Blood Gas SaO2 verses Foot SpO2 readings. 
 
Figure 11.7: Histogram of blood gas SaO2 readings with superimposed normal distribution function 
(mean = 92.5 %) with skewness measurement. 
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11.3 Anterior Fontanelle SpO2 compared to Reference Foot and 
Commercial SpO2 Sensors. 
After the elimination process described in section 9.5 (Chapter 9) the 759 time stamps 
revealed 621 time stamps suitable for SpO2 comparison.  A second difference-between-
methods analysis has been carried out to compare the three SpO2 sensors used in the trial 
(figure 11.8 – 11.10). 
The last three figures (figure 11.11 – 11.13) are histogram distributions of the measured 
SpO2 values (621 values) from the three monitors with their measurement of skewness 
included as an indicator of how far from a normal distribution each set of measurements 
deviates. 
 
Figure 11.8: AF and foot SpO2/PPG sensor accuracy relative to each other. 
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Figure 11.9: AF and commercial sensor accuracy relative to each other. 
 
Figure 11.10:  Reference foot and commercial sensor accuracy relative to each other. 
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Figure 11.11: Histogram of commercial SpO2 readings with superimposed normal distribution function 
(mean = 97.1 %) and skewness measurement (-3.91). 
 
Figure 11.12: Histogram of fontanelle SpO2 readings with superimposed normal distribution function 
(mean = 94.9 %) and skewness measurement (-1.17). 
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Figure 11.13: Histogram of foot SpO2 readings with superimposed normal distribution function 
(mean = 93.3 %) and skewness measurement (-0.32). 
11.4 Fontanelle SpO2 Analysis Summary 
Comparisons of SpO2s from both custom sensors have been made with gold standard 
measurements (blood gas analysis) and the bedside SpO2 monitor.  These analysis reveal a 
strong correlation (R > 0.5 | R < -0.5) between conventional transmission commercial 
sensors and both custom reflective sensors (-0.696 for the AF sensor and 0.999 for the 
reference foot sensor) when the amount of delivered oxygen is altered.  Correlation 
between the custom sensors (R = -0.731) also demonstrates strong correlation between 
periods.  This suggests that the AF sensor may be used as an alternative to sensors placed 
on the foot or other peripheral locations. 
The histogram plot of the “gold standard” SaO2s (figure 11.7) from the commercial blood 
gas analyser reveals that the expected distribution of blood oxygen values for the group of 
neonates studied is negatively skewed, a result repeated when looking at the histograms of 
SpO2 values from the commercial pulse oximeter and the SpO2 values computed using 
both custom sensors (figures 11.11 – 11.13).  This would indicate that the AF sensor is in 
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relatively broad agreement with the commercial sensor and the results from blood gas 
analysis. 
The linear regression plot in figure 11.3 suggests that no method of calculating blood 
oxygenation (commercial, custom foot sensor or AF sensor) is accurate for SaO2s below 
about 90 %.  Interestingly it is observed that a direct comparison of the commercial SpO2 
values with the blood gas tests reveal a large mean difference (figure 11.4) of nearly 5 %, 
whilst the SpO2 values computed from the custom sensors show better agreement with the 
blood gas tests (less than 2% for both sensors).  However the limits of agreement for the 
custom sensors are observed to be larger than the commercial sensor. 
Possible reasons and explanations for the discrepancies observed are discussed in Chapter 
13 – Discussions, Conclusions and Future Work. 
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Oesophageal Photoplethysmographs and SpO2 
Analysis, Proof of Concept Demonstrations In-
vivo 
t has been previously discussed (Chapter 5) that the oesophagus (OES) may be an 
alternative monitoring location for SpO2 at times of peripheral compromise in the 
paediatric population.  This chapter presents the findings from two ASA-3 Patients who 
were enrolled for a study of the comparison of PPGs simultaneously from a peripheral 
location and the oesophagus, SpO2s from a commercial device (COM) (Philips Intelliview 
with HP Merlin Sensors and Modules, Netherlands) and the custom sensors; and blood gas 
results (SaO2) (Abbott POC i-STAT Handheld, NJ, USA). 
12.1 Clinical Methods 
Candidates for OES PPG/SpO2 monitoring were selected on ward rounds by the lead 
clinician against the list of inclusion/exclusion criteria specified in the protocol (Appendix 
E).  Two patients were successfully recruited for the procedure; both patients were classed 
as ASA-3, on an oscillator for respiratory support and under adequate sedation.  Patient 1 
was a 7 year-old, 23 kg female admitted to the paediatric ICU with breathing complications 
related to other medical conditions.  Patient 2 was a 9 month-old female burns patient 
admitted with 1st degree burns to 40 % of her body.  
Following informed consent from parents the procedure to compare PPG signals for the 
estimation of SpO2 commenced; A routine blood gas test was scheduled and both sensors 
(peripheral and OES) were cleaned with alcohol wipes.  The peripheral sensor (REF) was 
placed into a clear adhesive sterile pocket constructed from clear dressing sheets 
(Tegadern™, 3M, MN, USA).  The reference PPGs were established by placing and 
securing the peripheral sensor with standard medical tape.  Patient 1 had the peripheral 
sensor placed on the palm of the hand, and Patient 2 (due to the extent of dressings used 
for the treatment of the burns) had the sensor placed on the right temple.  The OES sensor 
was placed into a disposable size 12 nasogastric tube sealed with a fast-acting sterile skin 
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adhesive (Dermabond, Johnson & Johnson, NJ, USA).  The OES sensor was then inserted 
into the mouth to a depth pre-determined by the lead clinician that would situate the 
sensor approximately at the same level as the aorta.  As part of clinical procedure Patient 1 
had a chest x-ray scheduled that coincided with the trial.  Figure 12.1 is the chest x-ray with 
the OES sensor clearly visible.  Photographic consent was obtained from the parents for 
the use of all images (including x-rays) in publications related to this work. 
Photoplethysmograph signals were confirmed before the sensor was secured in place by 
the end of the tube being taped to the bed.   
 
Figure 12.1: Chest X-ray of the OES sensor in-situ of Patient 1.  The head of the sensor is sitting 
approximately 15 cm into the oesophagus, just behind the aorta of the heart. 
At this time the routine blood sample was taken for blood-gas analysis, and marked as a 
time stamp in the data file with the time-stamp function of the virtual instrument (VI).  
Recording of PPGs was continued for a maximum length of 30 minutes before the baseline 
of delivered oxygen concentration (FiO2) was increased by 50 %, .e.g. 30 % to 45 %.  The 
time of FiO2 changes were marked as time stamps.  Continued monitoring was maintained 
for a maximum time of one hour before the FiO2 was decreased back to the initial baseline 
value and PPGs were further monitored for 30 minutes before the trial ended.  The 
commercial sensor for Patient 1 was a transmission type SpO2 sensor on the index finger 
of the left hand.  The commercial sensor for Patient 2 was a disposable transmission type 
paediatric SpO2 sensor placed on the left ear (see figure 12.2). 
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Figure 12.2:Paediatric burns Patient, Patient 2, with commercial disposable ear sensor. 
12.2 Oesophageal and Periphery Photoplethysmographs 
Recording of PPGs from Patient 1 totalled a length of 61 minutes 13 seconds, recordings 
from Patient 2 totalled 59 minutes 46 seconds.  The monitoring periods are defined by the 
condition of FiO2 delivery; pre FiO2 increase, during FiO2 increase and post FiO2 increase.  
By direct observation of the PPG recordings Patient 1 had 4 sets of pre FiO2 stable PPG 
periods (total = 21 minutes 40 seconds), 4 sets of during FiO2 stable PPG periods (total = 
10 minutes 15 seconds) and 1 continuous set of post FiO2 stable PPGs (12 minutes 58 
seconds).  Patient 2 had 1 continuous set of pre FiO2 stable PPGs (24 minutes 26 seconds), 
one continuous set of during FiO2 increase stable PPGs (12 minutes 48 seconds) and 1 
continuous set of post FiO2 stable PPGs (19 minutes 16 seconds).  Figures 12.3 and 12.4 
are the complete recorded length of both sets of PPGs from the two patients from the 
OES and peripheral sensors.  Marked are the FiO2 monitoring periods; these PPGs have 
been normalised and filtered (oscillator noise removed) by the methods in section 9.1 and 
9.2 (Chapter 9).  Figure 12.5 and 12.6 are zoomed-in views (10 second samples) of the 
PPGs in figures 12.3 and 12.4. 
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Figure 12.3: Normalised PPG recording from Patient 1, top = OES sensor, bottom = periphery sensor on 
hand.  Red PPGs shown in red, Infrared PPGs shown in blue. 
 
Figure 12.4:  Normalised PPG recording from Patient 2, top = OES sensor, bottom = periphery sensor on 
temple.  Red PPGs shown in red, Infrared PPGs shown in blue. 
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Figure 12.5: Normalised and filtered PPG sample (10 seconds) from Patient 1, HR ≈ 78 – 80 BPM 
 
Figure 12.6: Normalised and filtered PPG sample (10 seconds) from Patient 2, HR ≈ 165 – 168 BPM. 
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12.3 Oesophageal and Periphery Normalised Amplitude Analysis 
Amplitudes were calculated by the method described in section 9.3 (Chapter 9), and 
erroneous readings identified and removed from further calculations by the method given 
in section 9.5 (Chapter 9).  Normalised amplitude results for both patients are tabulated in 
tables 12.1a and 12.1b.  No test for normality was performed on the amplitudes due to the 
small data set of two patients.  The tabulated data has been plotted graphically on the line 
graphs in figures 12.7 and 12.8, and computed for correlation in table 12.2. 
Table 12.1a: Mean red (660 nm) normalised AC amplitudes for each period per patient. 
Patient 
# 
RED Normalised Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
REF OES REF OES REF OES 
1 26.6 310.6 27.6 218.7 22.1 153.3 
2 69.3 119.9 71.0 138.9 89.1 208.4 
Mean 48.0 215.3 49.3 178.8 55.6 180.8 
SD 30.2 134.8 30.7 56.4 47.3 38.9 
Table12.1b: Mean infrared (940 nm) normalised amplitudes for each period per patient. 
Patient 
# 
IR Normalised Amplitudes (mV) 
Pre FiO2 increase 
During FiO2 
increase Post FiO2 increase 
REF OES REF OES REF OES 
1 40.3 336.1 42.6 314.5 32.3 317.8 
2 121.8 217.6 141.5 248.6 181.4 356.4 
Mean 81.0 276.9 92.1 281.6 106.9 337.1 
SD 57.6 83.8 70.0 46.6 105.4 27.3 
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Figure 12.7: Red PPG amplitude changes accross the monitoring periods for each patient.  Patient 1 is 
represented by the solid lines, Patient 2 by the dashed lines. 
 
Figure 12.8: Infrared PPG amplitude changes accross the monitoring periods for each patient. Patient 1 is 
represented by the solid lines, Patient 2 by the dashed lines. 
Table 12.2: Correlation of PPGs accross the periods between sensors, strong correlation = R > 0.5. 
Correaltion (R) Red PPGs IR PPGs 
Patient 1 0.702 0.166 
Patient 2 0.991 0.993 
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12.4 Estimation of SpO2 during FiO2 Increase and Decrease 
To make a comparison with actual SpO2 readings, as recorded by the clinical monitors, 
time stamps were marked into the raw data files using the time stamping function of the 
virtual instrument (VI) for both trials, coinciding with specific clinical events and/or 
observations (e.g. feeding, drug administration and readings from clinical monitors).  These 
values were then compared against the computed SpO2 values.  SpO2 was calculated by the 
methods set out in section 9.4 (Chapter 9).  Table 12.3 is the computed mean SpO2 values 
in each period against the commercial device.  Figure 12.9 and 12.10 show the computed 
SpO2 for each patient with the custom sensors against the clinical SpO2 values in each 
monitoring period.  Correlation was computed between the sensors and is tabulated in 
table 12.4. 
Table 12.3: Mean SpO2 values in each period for both patients. 
# 
SpO2 (%) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
REF OES Com REF OES Com REF OES Com 
1 92.4 86.7 96.8 93.5 91.5 99.4 92.9 97.8 97.5 
2 95.9 96.2 98.1 97.5 96.0 99.8 97.8 95.4 99.1 
Mean 94.2 91.4 97.5 95.5 93.8 99.6 95.3 96.6 98.3 
SD 2.5 6.7 0.5 2.8 3.1 0.3 3.5 1.7 1.1 
 
Figure 12.9: Mean SpO2 values in each monitoring period for Patient 1 from all three sensors. 
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Figure 12.10: Mean SpO2 values in each monitoring period for Patient 2 from all three sensors. 
Table 12.4a:  Correlation of SpO2s between sensor locations for Patient 1 
Correlation (R) OES REF Commercial 
OES - 0.383 0.184 
REF 0.383 - 0.978 
Commercial 0.184 0.978 - 
Table 12.4b:  Correlation of SpO2s between sensor locations for Patient 2. 
Correlation (R) OES REF Commercial 
OES - -0.792 -0.337 
REF -0.792 - 0.842 
Commercial -0.337 0.842 - 
 
  
Chapter Twelve | OES PPGS AND SPO2 ANALYSIS, PROOF-OF-CONCEPT DEMONSTRATIONS IN-VIVO 
 
Page | 171 
12.5 Oesophageal SpO2 Comparison with Commercial SpO2 and 
Blood Gas SaO2 
Each trial was commenced with the timing of a routine blood-gas sample drawn from an 
arterial line.  Over the time of the two studies a total of 5 samples were taken as part of 
routine care and are tabulated in table 12.5.  A linear regression scatter plot was drawn and 
is shown in figure 12.11.  A Bland and Altman test (Bland and Altman 1986) was then 
performed between each pairing of saturation values; SaO2 vs. COM SpO2; SaO2 vs. OES 
SpO2 and SaO2 vs. REF SpO2.  These are shown in figures 12.12, 12.13 and 12.14 
respectively. 
Table12.5: Blood gas samples (SaO2)taken as part of routine clinical procedure during the time of study 
with corresponding SpO2 from all three sensors. 
Patient SaO2 (%) COM SpO2 (%) OES SpO2 (%) REF SpO2 (%) 
1 93 96 96.0 91.0 
1 94 98 81.5 91.4 
1 99 100 95.8 94.6 
2 95 98 96.7 94.6 
2 97 100 95.3 97.7 
Mean 95.6 98.4 93.1 93.9 
SD 2.4 1.7 6.5 2.7 
 
Figure12.11: Linear regression plot of blood Gas SaO2 vs all three SpO2 sensors 
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Figure 12.12:Blood Gas vs. Comercial SpO2 readings. 
 
Figure 12.13: Blood Gas vs. Oesophageal readings 
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Figure 12.13: Blood Gas vs. reference sensor readings 
12.6 Oesophageal PPG and SpO2 Analysis Summary 
Placement of the OES sensor and its’ situation in the oesophagus has been confirmed by x-
ray imaging.  SpO2 monitoring from those patients whom no other periphery location 
(hands or feet) is available has been successfully demonstrated on a patient with 1st degree 
burns to those areas, demonstrating its’ attraction in the monitoring of neonates and 
children who have little or no peripheral blood supply, or who’s peripheral location is 
inaccessible.  These results are discussed in detail in the final chapter, Discussions, Conclusions 
and Future Work. 
 
Page | 174 
Discussions, Conclusions and Future Work 
he goal of this research was to assess photoplethysmography (PPG) for the purpose 
of blood oxygen saturation (SpO2) monitoring at alternative monitoring locations, in 
neonates and children, when periphery PPGs begin to become compromised by poor 
health, utilising custom-made miniature photometric sensors and instrumentation. 
Reflective mode photometric sensors have been successfully designed, constructed and 
tested for thermal and electrical safety, that can be placed on peripheral location, such as 
the hand or foot, on the neonatal anterior fontanelle (AF) or into the infant oesophagus 
(OES) (Chapter 6).  Acquisition of PPGs from these sensors utilising the instrumentation 
described in chapter 7 revealed good quality PPGs with large amplitudes.  Custom 
instrumentation and software developed simultaneously (Chapter 7 and 8) has successfully 
operated the sensors and recorded the raw PPG signals, with time-stamping information, 
to a laptop computer. 
Consultation with a clinical collaborator at Great Ormond Street Hospital for Children 
(GOSH), London, UK, helped to establish a protocol (Appendix E) for clinical trials that 
would utilise the developed sensors to look for changes in PPG amplitudes that coincide 
with blood oxygen saturation changes artificially induced by altering the delivered oxygen 
concentration (FiO2).  Two populations have been investigated, a neonatal population 
where the fontanelle sensor was tested, and an infant population where the oesophageal 
sensor was tested.  Following instrumentation safety testing by the biomedical engineering 
department at GOSH, the protocol was approved by a local ethics committee and trials 
began. 
13.1 Fontanelle PPG and SpO2 Monitoring 
The age and weight of the patients in these trials seems to have had little effect on the 
observed PPG amplitudes, with very weak correlation scores (R < 0.3) in nearly all 
correlation tests between the normalised amplitudes and each patient’s age or weight.  This 
suggests that the amplitudes obtained may be more dependent on the individuals’ anatomy 
and physiology and what treatment was being given at the time.   
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Figures 10.5 and 10.6 demonstrate that for these trials the largest normalised amplitude for 
the AC component of a PPG occurs at 525 nm, the green LED light source.  Infrared has 
the second largest and red has the lowest overall normalised amplitude.  The AC 
component of the PPG waveform is thought to be solely attributed to the oxygenated 
arterial blood, (which appears bright red in colour when fully oxygenated).  Red light is 
therefore reflected back and absorbed less, hence the small normalised amplitude, infrared 
light is more strongly absorbed by HbO2, and both HbO2 and Hb strongly absorb green 
light, hence the higher amplitudes. 
Altering the amount of delivered oxygen to the patient results in more or less blood being 
successfully oxygenated during pulmonary blood circulation (mean increase in SpO2 as 
reported by the clinical devices = 2.9 % during FiO2 increase; mean decrease = 1.3% post 
FiO2 increase). 
Initial amplitude analysis from the bar graphs and tables suggests a correlation between 
FiO2 increase and PPG amplitudes from the AF and foot simultaneously, and the 
amplitude trace from the AF in figure 10.4b visually demonstrates this for the infrared 
signal. The results in table 10.5 are highly suggestive of this strong correlation. 
Across all wavelengths for every monitoring period the PPGs from the fontanelle were 
smaller when normalised than the PPGs from the foot.  Difficulties during trials regarding 
the placement and securing of the fontanelle sensor may have lead to errors in capturing 
the PPG signal that were unobservable before PPG analysis.  A difficulty with making the 
AF sensor lie flat and remain in position was a particular problem and this may have caused 
the light from the sensor to reflect off the top layer of skin and hair rather than penetrate 
through and into the tissue beneath.  PPGs were observable for all neonates at the red and 
infrared wavelengths, even with a thick covering of hair, suggesting that the presence of 
hair does not affect light at these wavelengths enough to be of a concern when observing 
PPGs.  However as the acquisition of green PPGs from the fontanelle was relatively rare, 
hair may have affected the green light PPGs.  The anterior fontanelle is situated directly 
above a major venous reservoir in the skull (superior sagittal sinus), where a large amount 
of venous blood and other cerebral fluids are present.  As Hb absorbs strongly in the red 
region this may count for the lower amplitudes observed. 
Signals have been normalised for this analysis, the relative signal to noise ratio for each 
wavelength of light thus remains the same.  In figure 10.4a it is clearly observable that 
whilst the green light PPG normalised amplitudes are higher than the red or infrared 
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amplitudes, they are far more spread out (have a larger variation in amplitude).  This may 
be the cause of the poor green PPG amplitude results, however other contributing factors 
may have hindered green PPG acquisition from the AF; the photodiode sensitivity to green 
light is only around 40 % of the sensitivity to infrared light (see chapter 6), meaning that 
green light PPGs would initially be smaller before normalisation.  This coupled with the 
fact that green light is more heavily absorbed by Hb and HbO2 than red or infrared light 
would further reduce the initial relative amplitude before normalisation.  The tiny 
amplitudes observed in the raw data file may have suffered a large quantization error during 
digitisation, hence the large variance in amplitudes. 
Peripheral supply compromise cannot be induced in real patients ethically, so the method 
of FiO2 change was introduced to show that the AF sensor could detect a change in PPG 
amplitude and SpO2 during FiO2 increase/decrease that was in line with the SpO2 recorded 
on conventional sensors at conventional locations.  There were no cases within the trial 
period where peripheral compromise occurred.  However, an analysis of the difference 
between normalised amplitudes from the foot and the AF for the different classes of 
patients studied (ASA 1, 2 and 3) does show an decrease of the difference in amplitude of 
PPGs between the AF sensor and the foot sensor the more critical the individual child’s 
ASA was.  This is depicted in figures 10.7 to 10.9 as the trend lines for each set of PPG 
amplitude differences (pre, during and post FiO2 increase) increase.  Across all trials, across 
all monitoring periods 86 sets of amplitude differences (AF PPG amplitude minus Foot 
PPG amplitude) were computed (38 red, 38 infrared, 10 green).  Correlation of the results 
for red and infrared PPGs is strong (R ≥ 0.6) in all cases.  Due to the low success rate of 
green PPG acquisition it cannot be determined significantly if the very strong correlation of 
amplitudes of green PPGs (R > 0.9) is represented by the larger population.    The results 
for red and infrared PPGs, however, are highly suggestive that as the patient becomes more 
critical the smaller the difference in PPG amplitudes between the AF and foot becomes, 
demonstrating the autonomous function of the body to preserve blood supply in core 
locations, and hence the AF sensor could be a critical tool in measuring PPGs for the 
purpose of SpO2 estimation.   
The above amplitude analysis results of the PPGs and their overall corresponding strong 
correlations both with FiO2 change and patient health (ASA score) is a positive indicator 
that the AF may be suitable in the monitoring of SpO2 at times of periphery supply 
compromise.  Computation of SpO2 from the custom sensors and comparison with the 
commercial devices is discussed below. 
Chapter Thirteen | DISCUSSIONS, CONCLUSIONS AND FUTURE WORK 
Page | 177 
From the step response in SpO2, seen in figure 11.1, it is clear that the AF sensor can 
respond to changes in oxygen in the same manner as the commercial sensor and reference 
sensor.  For the example given in figure 11.1 there is an obvious discrepancy in the 
estimation of SpO2; both the foot sensor and the AF sensor appear to be underestimating 
the value reported by the clinical device.  Overall, across all the trails conducted, the mean 
SpO2 values (as estimated by the AF and foot sensor) is below the SpO2 reported by the 
clinical device (see figure 11.2), at all periods of monitoring.  A larger standard deviation is 
also observed.  These differences may arise from several sources; 1) The method described 
in section 9.4 (Chapter 9) for calculating SpO2 from the custom sensors is not the same as 
the method utilised by the clinical monitors (which is unknown and may include additional 
routines that correct for movement and other errors)  for this reason it is perhaps more 
beneficial to view SpO2 values from the custom sensors only as an estimation of SpO2 
from the commercial devices, and looking for corresponding changes that correlate across 
the different sensors; 2) The custom sensors, instrumentation and software developed is 
un-calibrated for SpO2 measurement, instead relying on the methods in section 9.4 to make 
an estimation, retrospectively.  It was noted by Dassel et al (Dassel, et al. 1997), that 
different locations on the head reveal different compositions of tissues, and so the 
relationship between arterial oxygen saturation and the ratio between the red and infrared 
PPG signal would also differ, and thus new calibrations would have to be derived for the 
different positions on the head; 3) The instrumentation was primarily developed for PPG 
acquisition and was optimised for the accurate retrieval and recording of said PPGs.  
Despite these limitations and differences and overall change in SpO2 from the AF is seen 
to correlate well with both the foot sensor and commercial device (AF/Foot R < -0.7, 
AF/Commercial R < -0.6, Foot/Commercial R ≈ 1).  The negative correlations seen 
between sensors may be explained by; 1) Changes in the orientation of the sensor on the 
AF between studies may have resulted in the optical signals received to be absorbed and 
scattered by underlying tissue differently, i.e. small blood vessels in the scalp directly under 
the sensor may have affected the light from one LED light source but not the other, 
resulting in different red to infrared PPG ratios.  Although an effort was made in trials to 
place the sensor in the same orientation for each patient it was sometimes impractical, 
either due to other clinical sensors, orientation of the child’s head (if they were on a 
ventilator that required the head to be turned to the side) or if the physical size of the 
fontanelle meant that orientation of the sensor in the desired position resulted in a failure 
to acquire PPGs in the first place; 2) The anterior fontanelle sits directly over the sagittal 
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sinus, a large venous reservoir observed to periodically rise and fall, and have a measurable 
heart-beat synchronous pulses as detected with a Doppler ultrasound device (Dassel, et al. 
1997).  As described in chapter 4, pulse-oximetry assumes that it is only the arterial blood 
that is pulsatile, and it is this property that is the basis of estimation of SpO2, however if 
the strongest pulsatile signal measured is venous in nature and getting mixed with the 
pulsatile signal from the arteries then the algorithms used would have no means to 
distinguish arterial blood from venous blood; 3) Finally it has also been reported that 
ventilator operation (Mark, 1989, Sami et al., 1991, Jørgensen et al., 1995) that causes 
changes in venous blood volume may also have an effect, 11 out of the 15 patients studied 
were on some form of mechanical ventilation, however since ventilator and respiratory 
noise were effectively removed in post-processing using the filters described in section 9.1 
(Chapter 9) it is unlikely that this was a contributing cause 
Comparison of SaO2 with commercial SpO2 reveals that there is a large mean difference 
and variance (-4.85 % with ± 15.8 % variance).  Figure 11.4 demonstrates that the 
conventional SpO2 estimation is most accurate where SaO2 > 95%.  In comparison the AF 
and reference foot sensor both have better mean differences in SpO2 estimation (-1.71 % 
and -1.2 % respectively), but slightly larger variance (± 23.9 % and ± 18.3 %), again the 
most accurate estimations (figure 11.5 and 11.6) are when SaO2 > 95 %.  This result is clear 
and suggests that the AF foot sensor is measuring closer to the true SaO2 than the pulse 
oximeter in the hospital, with the large variance also being of a similar magnitude; however 
for SaO2 < 95% the accuracy declines also.  It seems unusual that a calibrated device 
(commercial SpO2) has less accuracy than an un-calibrated one, and one could argue that 
the smaller variance observed from the commercial device compensates by reducing overall 
erroneous readings (falsely high and low SpO2s). 
The above analysis is interesting at highlighting the inaccuracy of commercial SpO2 
monitors when compared to the gold standard, and although it may be desirable to not 
draw blood for any testing purposes, the demonstrated error in SpO2 measurement 
compared to SaO2 reveals that for the most critical testing of blood oxygen saturation, 
blood gas analysis cannot be replaced.  However, a continuous measurement of SpO2 at 
times of peripheral supply compromise would be highly beneficial as it would negate the 
need for frequent blood gas tests.  The general low mean difference in SpO2 (Figures 11.8 
– 11.10) between custom and commercial sensors demonstrate good agreement with 
commercial SpO2 and SaO2, and with continued development the AF as a location for 
SpO2 monitoring is a viable alternative. 
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13.2 Oesophageal PPG and SpO2 Monitoring 
Paediatric oesophageal monitoring has been previously reported (Kyriacou, Jones et al. 
2008).  In this study five neonates were monitored for SpO2 that were compared against a 
commercial sensor placed on the toe.  This thesis aimed at developing the OES sensor  
study in paediatrics further by making comparisons of PPGs from a reference location, 
comparing SpO2s with blood gas test results and make an effort at attempting to acquire 
PPGs from the oesophagus in children who’s periphery circulation was failing or 
inaccessible. 
The oesophageal SpO2 study was carried out only on two patients.  This was due to 
considerable difficulty in recruiting patients who met the required approved criteria in the 
time allowed for the study.  Results and observations from the trials conducted are, 
however, of note.  Firstly, confirmed location of the OES in the oesophagus by x-ray 
imaging has been carried out; pre-scheduled chest x-ray imaging for the monitoring of a 
collapsed lung clearly shows the OES sensor in-situ (Figure 12.1).  Secondly, a burns-patient 
with inaccessible digits due to medical dressings (Figure 12.2) for the treatment of burns 
was successfully monitored using the OES sensor for approximately one hour. 
Amplitude analysis reveals that PPG signals in the oesophagus are of larger relative 
amplitude than PPGs from a reference location, either on the periphery (hand, Patient 1) or 
on the head (temple, Patient 2).  This suggests that the oesophagus may be well-suited to 
SpO2 monitoring. 
Correlation between the amplitudes of PPGs at both wavelengths during FiO2 change 
between the reference sensor and the OES sensor is very strongly positive (R > 0.7) for 
Patient 2, and strongly positive for Patient 1 at the red wavelength.  In Patient 2 there is 
strong evidence that changes in SpO2, artificially altered by changing FiO2, does correspond 
to a change in amplitudes detected by both sensors.  This suggests that the oesophagus is 
just as sensitive to changes in delivered oxygen as any other location.  Amplitudes from 
Patient 1 at the red wavelength exhibit this same behaviour, however at the infrared 
wavelength the correlation is weak (R < 0.2), and in this case the oesophagus may be 
unsuitable at detecting the level of change required for accurate SpO2 monitoring, however 
this is speculative as there was noticeable movement noise in the PPG signals at some 
stages in the trial due to other clinical procedures, and this may have had an effect. 
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Analysis of SpO2 is in general agreement with the SpO2 reported by the clinical devices, 
although generally lower in estimation.  These preliminary results suggest that the OES 
sensor is sensitive to changes in oxygen and may well be suited, with further development, 
as an alternative location for SpO2 monitoring. Correlation at times of FiO2 change is very 
strong between the commercial sensor and the reference sensor (R > 0.8), but only weak 
when compared to the OES sensor (R < 0.4 | R > -0.4).  Correlation between the custom 
sensors varies from weak to strong. 
Finally a comparison of the gold standard SaO2 and the SpO2 readings reveals that there is 
relatively little mean difference in accuracy (mean difference < ± 3%) in all of the sensors.  
It is interesting to note that the largest mean difference between any sensor and the SaO2 
value was from the commercial device, as reported also in the fontanelle study, and the best 
accuracy was from the reference sensor.  The commercial sensor reported higher values 
than actual SaO2 for all samples, whilst the oesophageal sensor, for all but one blood 
sample reported closer SpO2 values to the true SaO2 value than the commercial device.  
The one erroneous SpO2 reading from the OES sensor was noted to happen at the same 
moment as a movement in the OES tube, caused by other routine clinical care being 
administered.   
13.3 Future Work 
The effects observed in these investigations, and the limitations encountered, need to be 
further addressed in future investigations in order to develop the technology to the point 
where it is a viable alternative.  The future work is suggested: 
1. To see the effect of age and weight on paediatric PPGs a controlled study on a 
group of healthy individuals is suggested, perhaps within the setting of postnatal 
check-ups, commonly performed regularly a number of months after birth. 
2. Sensor geometry and the effect of different LED/photodiode arrangements is 
suggested, as well as studying what effect different colourings/thicknesses of hair 
have on the signals being received 
3. Further technical improvements to the sensor could be made, primarily a new 
sensor with multiple photodiodes (each tailored specifically to the wavelengths of 
light being used) could be implemented, this would in theory improve signal 
amplitude and signal to noise ratio, and the chances of obtaining green light PPGs 
from the AF may improve. 
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4. A larger population would need to be studied to confirm the behaviour of green 
PPGs in patients whose periphery blood supply may be at risk of failure. 
5. More effort needs to be made to look for patients who are more prone to periphery 
failure, and hence PPGs observed at such times. 
6. A larger study done to confirm the observation of the diminishing peripheral PPG 
in sicker patients is also needed as a PPG-based monitoring system could be 
developed to assess a patients’ relative health as an index of PPG amplitude 
difference between two monitoring locations (e.g. head and foot). 
7. Further studies into the effect of the vasculature of the head at the site of the 
sensor is needed in order to better understand the processes involved, especially the 
pulsation of the sagittal sinus synchronous with heart rate as observed with 
Doppler ultrasound imaging. 
8. The successful acquisition of oesophageal PPGs from a patient with no accessible 
peripheral pulse confirms the clinical usefulness of paediatric oesophageal SpO2 
monitoring.  A study conducted looking at SpO2 monitoring from the tongue (Coté 
et al., 1992) in similar circumstances noted that although their method was 
successful it was limited to those patients who were intubated; already the 
developed oesophageal sensor is small enough to be placed nasally, however due to 
the relatively large nasal-gastric tubing used to protect the prototype sensor during 
trials this was not a viable method of placement, but with little effort to make the 
device completely bio-inert the tubing could be omitted entirely and it would be 
possible to place the OES sensor nasally, rather than orally, into the oesophagus, 
thus eliminating the prerequisite of intubated patients only.  Further study is also 
needed, with data gathered from larger populations, with greater diversity in health. 
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Appendix A 




int main (void) 
{ 
 DDRB = 0x07;      //Sets Channels 0,1,2 & 3 as output 
  
 const float freq = 101.2;    //freq Hz of Main LED Clock, DEMUX clock 
3 times higher 
  
 const float time = 6*freq;    // Math to calculate delay time 
 const float delay = 1/time;   // for required frequency 
 const float delayus = delay*1000000; 
// const float delayus2 = delayus/2; 
  
 while (1)     //Clock Cycles 
 { 
  PORTB = 0b00000001; 
  _delay_us(delayus); 
  PORTB = 0b00000000; 
  _delay_us(delayus); 
  PORTB = 0b00000010; 
  _delay_us(delayus); 
  PORTB = 0b00000000; 
  _delay_us(delayus); 
  PORTB = 0b00000100; 
  _delay_us(delayus); 
  PORTB = 0b00000000; 
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Appendix B 
Frequency Response data of Filter Circuit 
B.1 Low-pass Frequency Response 
Frequency (Hz) Vin (V) Vout (V) Gain (Vout/Vin) 20*log(Gain) (dB) 
0.05 10.60 10.11 0.95 -0.41 
0.10 10.60 10.17 0.96 -0.36 
0.20 10.60 10.17 0.96 -0.36 
0.30 10.60 10.17 0.96 -0.36 
0.40 10.60 10.17 0.96 -0.36 
0.50 10.60 10.11 0.95 -0.41 
0.60 10.60 10.17 0.96 -0.36 
0.70 10.60 10.14 0.96 -0.39 
0.80 10.60 10.17 0.96 -0.36 
0.90 10.60 10.09 0.95 -0.43 
1.00 10.60 10.14 0.96 -0.39 
2.00 10.60 10.06 0.95 -0.45 
3.00 10.60 9.91 0.93 -0.59 
4.00 10.70 9.72 0.91 -0.83 
5.00 10.60 9.46 0.89 -0.98 
6.00 10.60 9.23 0.87 -1.20 
7.00 10.60 8.94 0.84 -1.48 
8.00 10.60 8.61 0.81 -1.81 
9.00 10.60 8.21 0.77 -2.22 
10.00 10.28 7.79 0.76 -2.41 
11.00 10.27 7.45 0.73 -2.79 
12.00 10.27 7.09 0.69 -3.22 
13.00 10.27 6.73 0.65 -3.68 
14.00 10.29 6.41 0.62 -4.12 
15.00 10.21 6.08 0.60 -4.50 
16.00 10.28 5.75 0.56 -5.05 
17.00 10.26 5.48 0.53 -5.45 
18.00 10.29 5.18 0.50 -5.97 
19.00 10.29 4.90 0.48 -6.44 
20.00 10.32 4.66 0.45 -6.91 
25.00 10.26 3.57 0.35 -9.17 
30.00 10.27 2.79 0.27 -11.33 
40.00 10.24 1.78 0.17 -15.19 
50.00 10.27 1.22 0.12 -18.50 
60.00 10.26 0.88 0.09 -21.29 
70.00 10.27 0.67 0.06 -23.76 
80.00 10.27 0.52 0.05 -25.94 
90.00 10.28 0.42 0.04 -27.81 
100.00 10.25 0.34 0.03 -29.54 
200.00 10.15 0.09 0.01 -41.02 
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B.2 Band-pass Frequency Response 
Frequency (Hz) Vin (V) Vout (V) Gain (Vout/Vin) 20*log(Gain) (dB) 
0.05 10.60 0.25 0.02 -32.55 
0.06 10.60 0.35 0.03 -29.75 
0.07 10.50 0.44 0.04 -27.48 
0.08 10.60 0.56 0.05 -25.48 
0.09 10.60 0.68 0.06 -23.84 
0.10 10.60 0.82 0.08 -22.21 
0.15 10.60 1.66 0.16 -16.12 
0.20 10.70 2.59 0.24 -12.32 
0.25 10.70 3.51 0.33 -9.68 
0.30 10.60 4.40 0.42 -7.64 
0.35 10.60 5.16 0.49 -6.25 
0.40 10.60 5.82 0.55 -5.21 
0.45 10.70 6.40 0.60 -4.46 
0.50 10.50 6.89 0.66 -3.65 
0.55 10.50 7.32 0.70 -3.13 
0.60 10.60 7.62 0.72 -2.87 
0.65 10.60 7.96 0.75 -2.49 
0.70 10.60 8.21 0.77 -2.22 
0.75 10.60 8.38 0.79 -2.04 
0.80 10.60 8.59 0.81 -1.82 
0.85 10.60 8.69 0.82 -1.73 
0.90 10.60 8.86 0.84 -1.56 
0.95 10.70 8.98 0.84 -1.53 
1.00 10.60 9.07 0.86 -1.35 
1.50 10.60 9.62 0.91 -0.84 
2.00 10.60 9.80 0.92 -0.68 
2.50 10.60 9.80 0.92 -0.68 
3.00 10.60 9.75 0.92 -0.73 
3.50 10.60 9.72 0.92 -0.75 
4.00 10.60 9.62 0.91 -0.84 
5.00 10.60 9.44 0.89 -1.01 
6.00 10.60 9.15 0.86 -1.28 
7.00 10.60 8.89 0.84 -1.53 
8.00 10.60 8.58 0.81 -1.84 
9.00 10.60 8.24 0.78 -2.19 
10.00 10.60 7.88 0.74 -2.58 
10.50 10.60 7.70 0.73 -2.78 
11.00 10.60 7.52 0.71 -2.98 
11.50 10.60 7.35 0.69 -3.18 
12.00 10.60 7.17 0.68 -3.39 
12.50 10.60 6.92 0.65 -3.70 
13.00 10.60 6.84 0.65 -3.81 
13.50 10.60 6.64 0.63 -4.06 
14.00 10.70 6.50 0.61 -4.33 
15.00 10.60 6.16 0.58 -4.71 
16.00 10.60 5.84 0.55 -5.18 
17.00 10.60 5.56 0.52 -5.60 
18.00 10.28 5.19 0.51 -5.93 
19.00 10.30 4.91 0.48 -6.44 
20.00 10.24 4.65 0.45 -6.86 
25.00 10.28 3.58 0.35 -9.15 
30.00 10.29 2.80 0.27 -11.31 
40.00 10.26 1.78 0.17 -15.20 
50.00 10.27 1.22 0.12 -18.53 
60.00 10.25 0.88 0.09 -21.31 
70.00 10.26 0.67 0.07 -23.75 
80.00 10.28 0.52 0.05 -25.91 
90.00 10.28 0.42 0.04 -27.74 
100.00 10.24 0.34 0.03 -29.53 
200.00 10.18 0.09 0.01 -40.72 
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Appendix C 
Final Printed Circuit Board Design 
C.1 Final Circuit Schematics with Component Values 
(PTO).
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C.2 Printed Circuit Board Layout / Photo-template 
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Appendix D 
PPG data file output sample 
(PTO)
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=datetime     %Header Information 
14/02/2013 09:42:58    %Date + Time 
=patID      % 
sytemtest0123     %Patient ID 
=fs      % 
200.00      %Sampling Rate 
=ProbLocs     % 
P1 P2     %Location of Probes 
Toe/Foot Anterior Fontanel   
=events      %Event Markers successfully merged with raw data 
Event 1 122.4700    % 
Event 2 128.4700    % 
Event 3 132.4710    % 
Event 4 136.4730    % 
Event 5 138.4690    % 
Event 6 142.4690    % 
Event 7 146.4720    % 
Event 8 150.4710    % 
Event 9 154.4720    % 
Event 10 160.4720    
      %Raw Data Starts here, each channel is a column separated by tabs, channel names included at top of 
=Start of Raw Data: data =   %column 
 
p1GNac p1GNmx p1IRac p1IRmx p1RDac p1RDmx p2GNac p2GNmx p2IRac p2IRmx p2RDac p2RDmx 
 
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4710 -1.7785 -2.1565 -1.8075 -7.2266 -5.0919 -0.6978  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4835 -1.7910 -2.1696 -1.8200 -7.2437 -5.1044 -1.3066  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4743 -1.7756 -2.1522 -1.8035 -7.2243 -5.0808 -1.3467  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4842 -1.7884 -2.1670 -1.8200 -7.2414 -5.0913 -1.2990  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4687 -1.7733 -2.1456 -1.8039 -7.2203 -5.0627 -1.2592  
-5.1553 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4723 -1.7684 -2.1361 -1.8016 -7.2108 -5.0492 -1.2375  
-4.9335 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4937 -1.7927 -2.1644 -1.8276 -7.2259 -5.0712 -1.2197  
-4.6747 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4723 -1.7657 -2.1361 -1.8052 -7.1927 -5.0360 -1.2388  
-4.3932 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4977 -1.7910 -2.1630 -1.8381 -7.2170 -5.0666 -1.2056  
-4.0970 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4760 -1.7621 -2.1364 -1.8174 -7.1818 -5.0347 -1.2003  
-3.9611 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4931 -1.7825 -2.1565 -1.8443 -7.1966 -5.0548 -1.2260  
-3.8882 5.4604 5.4604 5.4604 5.4604 5.4604 -1.5023 -1.7858 -2.1653 -1.8578 -7.2068 -5.0666 -1.1776  
-3.9512 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4917 -1.7756 -2.1594 -1.8473 -7.1927 -5.0597 -1.2306  
-3.9206 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4996 -1.7838 -2.1696 -1.8614 -7.1983 -5.0762 -1.2151  
-3.8153 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4931 -1.7772 -2.1597 -1.8562 -7.1855 -5.0748 -1.2082  
-3.7962 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4885 -1.7703 -2.1584 -1.8473 -7.1782 -5.0729 -1.2046  
-3.8546 5.4604 5.4604 5.4604 5.4604 5.4604 -1.5026 -1.7828 -2.1742 -1.8687 -7.1930 -5.0985 -1.2010 
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4710 -1.7785 -2.1565 -1.8075 -7.2266 -5.0919 -0.6978  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4835 -1.7910 -2.1696 -1.8200 -7.2437 -5.1044 -1.3066  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4743 -1.7756 -2.1522 -1.8035 -7.2243 -5.0808 -1.3467  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4842 -1.7884 -2.1670 -1.8200 -7.2414 -5.0913 -1.2990  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4687 -1.7733 -2.1456 -1.8039 -7.2203 -5.0627 -1.2592  
-5.1553 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4723 -1.7684 -2.1361 -1.8016 -7.2108 -5.0492 -1.2375  
-4.9335 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4937 -1.7927 -2.1644 -1.8276 -7.2259 -5.0712 -1.2197  
-4.6747 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4723 -1.7657 -2.1361 -1.8052 -7.1927 -5.0360 -1.2388  
-4.3932 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4977 -1.7910 -2.1630 -1.8381 -7.2170 -5.0666 -1.2056  
-4.0970 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4760 -1.7621 -2.1364 -1.8174 -7.1818 -5.0347 -1.2003  
-3.9611 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4931 -1.7825 -2.1565 -1.8443 -7.1966 -5.0548 -1.2260  
-3.8882 5.4604 5.4604 5.4604 5.4604 5.4604 -1.5023 -1.7858 -2.1653 -1.8578 -7.2068 -5.0666 -1.1776  
-3.9512 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4917 -1.7756 -2.1594 -1.8473 -7.1927 -5.0597 -1.2306  
-3.9206 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4996 -1.7838 -2.1696 -1.8614 -7.1983 -5.0762 -1.2151  
-3.8153 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4931 -1.7772 -2.1597 -1.8562 -7.1855 -5.0748 -1.2082  
-3.7962 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4885 -1.7703 -2.1584 -1.8473 -7.1782 -5.0729 -1.2046  
-3.8546 5.4604 5.4604 5.4604 5.4604 5.4604 -1.5026 -1.7828 -2.1742 -1.8687 -7.1930 -5.0985 -1.2010 
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4710 -1.7785 -2.1565 -1.8075 -7.2266 -5.0919 -0.6978  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4835 -1.7910 -2.1696 -1.8200 -7.2437 -5.1044 -1.3066  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4743 -1.7756 -2.1522 -1.8035 -7.2243 -5.0808 -1.3467  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4842 -1.7884 -2.1670 -1.8200 -7.2414 -5.0913 -1.2990  
-5.3228 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4687 -1.7733 -2.1456 -1.8039 -7.2203 -5.0627 -1.2592  
-5.1553 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4723 -1.7684 -2.1361 -1.8016 -7.2108 -5.0492 -1.2375  
-4.9335 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4937 -1.7927 -2.1644 -1.8276 -7.2259 -5.0712 -1.2197  
-4.6747 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4723 -1.7657 -2.1361 -1.8052 -7.1927 -5.0360 -1.2388  
-4.3932 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4977 -1.7910 -2.1630 -1.8381 -7.2170 -5.0666 -1.2056  
-4.0970 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4760 -1.7621 -2.1364 -1.8174 -7.1818 -5.0347 -1.2003  
-3.9611 5.4604 5.4604 5.4604 5.4604 5.4604 -1.4931 -1.7825 -2.1565 -1.8443 -7.1966 -5.0548 -1.2260  
-3.8882 5.4604 5.4604 5.4604 5.4604 5.4604 -1.5023 -1.7858 -2.1653 -1.8578 -7.2068 -5.0666 -1.1776
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Appendix E 
Approved Clinical Trials Protocol and Ethical Approval Confirmation 
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1. Introduction 
1.1  Background 
About twenty-five years ago most Neonatal Intensive Care Units (NICU) only had the 
ability to routinely monitor a baby’s ECG and respiration rate [1].  Times have changed 
dramatically and a typical NICU bedside monitor will incorporate ECG, heart-rate, 
respiration, temperature, non-invasive blood-pressure, oxygen saturation (SpO2) and 
invasive blood-pressure [2]. 
Pulse oximetry is a non-invasive photometric technique (pulse oximeter sensors are 
usually placed on the finger, earlobe or toe) that provides information about the arterial 
blood oxygen saturation (SpO2) and heart rate, and has widespread clinical 
applications.  Pulse oximeters estimate arterial oxygen saturation by shining light at two 
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different wavelengths, red and infrared, through vascular tissue. In this method the 
pulsatile PPG (ac PPG) signal associated with cardiac contraction is assumed to be 
attributable solely to the arterial blood component. The amplitudes of the red and 
infrared ac PPG signals are sensitive to changes in arterial oxygen saturation because 
of differences in the light absorption of oxygenated and deoxygenated haemoglobin at 
these two wavelengths. From the ratios of these amplitudes, and the corresponding dc 
photoplethysmographic components, arterial blood oxygen saturation (SpO2) is 
estimated.  Hence, the technique of pulse oximetry relies on the presence of adequate 
peripheral arterial pulsations, which are detected as PPG signals. 
In neonatal and paediatric monitoring, when peripheral perfusion is poor, as in states of 
hypovolaemia, hypothermia, vasoconstriction, low cardiac output and low mean arterial 
pressure, pulse oximeter readings become unreliable or cease altogether [3, 4]. The 
oxygenation readings become unreliable in these circumstances because conventional 
pulse oximeter sensors that are usually placed on the most peripheral parts of the body 
such as the finger or toe, where pulsatile flow is most vulnerable, as it is compromised 
by diversion of blood flow to more vital organs.  Hence, pulse oximetry becomes 
unreliable in a significant group of patients at just the time when the measurement of 
blood oxygen saturation would be clinically of most value.  
A previous pilot study [5] investigated PPG signals in the neonatal oesophagus based 
on the hypothesis that such a central site might provide better quality PPG signals and 
therefore enable the continuous monitoring of SpO2 when the peripheral sites fail  [3- 4, 
6 - 13].  This pilot study was only applied to a very small population plus the monitoring 
of oesophageal PPGs was only brief and therefore did not allow a more rigorous 
investigation of PPG signals and oxygen saturation values from the infant oesophagus. 
The proposed study aims to investigate PPG signals from the infant oesophagus more 
rigorously in a larger sample size, and for this reason a new miniaturised custom made 
oesophageal reflective PPG sensor, which fits in a 12F feeding tube (3.6mm diameter), 
will be used.  This new physiological measurement study will also give us the 
opportunity to compare the oesophageal oxygen saturation values with CE-marked 
commercial peripheral pulse oximetry devices, especially at times when the peripheral 
perfusion is compromised.  
This study will also investigate PPG signals from another monitoring site; the Anterior 
Fontanelle (AF) on the scalp of the neonate utilising a custom made non-invasive PPG 
sensor.  Fontanelle PPG signals and SpO2 values will be compared with toe or finger 
PPGs and SpO2s, and where possible with oesophageal PPGs and SpO2s.  So far 
there are no known similar studies where the fontanelle was used as a measurement 
site in intensive care. The only reported study, of similar nature, made preliminary 
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measurements of PPGs from the fontanelle [14], however the results of this study were 
inconclusive.  As well as direct brain oxygen saturation readings, our study aims to 
investigate what underlying anatomy may influence the readings we obtain, and 
whether there is a pulsatile venous signal that can be used to calculate venous oxygen 
saturation (SvO2) in the newborn.  Monitoring of the neonatal brain through the AF may 
also reveal information of other pathologies such as intracerebral bleeding and 
changes in intracranial pressure. 
For comparison purposes (with the oesophageal or fontanelle PPGs) a custom made 
toe PPG sensor will also be used in these investigations.  
[1] McIntosh, N., 1983. The Monitoring of Critically Ill Neonates. Journal of Medical 
Engineering & Technology, 7(3), 121-129.   
[2] Murković, I., Steinberg, M.D. & Murković, B., 2004. Sensors in neonatal monitoring: 
current practice and future trends. Technol. Health Care, 11(6), 399-412. 
[3] Poets, C.F. & Southall, D.P., 1994. Non-invasive monitoring of oxygenation in 
infants and children: practical considerations and areas of concern. Pediatrics, 93(5), 
737-746.   
[4] Poets, C.F., Urschitz, M.S. & Bohnhorst, B., 2002. Pulse oximetry in the neonatal 
intensive care unit (NICU): detection of hyperoxemia and false alarm rates. Anesthesia 
and Analgesia, 94(1 Suppl), S41-43. 
[5] Kyriacou, P.A. et al., 2008. A Pilot Study of Neonatal and Paediatric Esophageal 
Pulse Oximetry. Anesthesia and Analgesia, 107(3), 905-908. 
[6] Salyer, J.W., 2003. Neonatal and paediatric pulse oximetry. Respiratory Care, 
48(4), 386-396; discussion 397-398. 
[7] Fanconi, S., 1988. Reliability of pulse oximetry in hypoxic infants. The Journal of 
Pediatrics, 112(3), 424-427.   
[8] Hay, W.W., Brockway, J.M. & Eyzaguirre, M., 1989. Neonatal pulse oximetry: 
accuracy and reliability. Pediatrics, 83(5), 717-722.   
[9] Praud, J. et al., 1989. Accuracy of two wavelength pulse oximetry in neonates and 
infants. Pediatric Pulmonology, 6(3), 180-182. 
[10] Miyasaka, K., 2002. Pulse oximetry in the management of children in the PICU. 
Anesthesia and Analgesia, 94(1 Suppl), S44-46.   
[11] Hay, W.W. et al., 2002. Reliability of conventional and new pulse oximetry in 
neonatal patients. Journal of Perinatology: Official Journal of the California Perinatal 
Association, 22(5), 360-366.   
[12] Malviya, S. et al., 2000. False alarms and sensitivity of conventional pulse oximetry 
versus the Masimo SET technology in the pediatric postanesthesia care unit. 
Anesthesia and Analgesia, 90(6), 1336-1340.   
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[13] Wilson, S., 1990. Conscious sedation and pulse oximetry: false alarms? Pediatric 
Dentistry, 12(4), 228-232.  
[14] Dassel, A.C. et al., 1997. Effect of location of the sensor on reflectance pulse 
oximetry. British Journal of Obstetrics and Gynaecology, 104(8), 910-916.   
 
1.2  Biomedical Engineering Research Group, City University London 
The Biomedical Engineering research group at City University originated in the mid-
90’s with the aim of promoting research in the emerging field of Biomedical 
Engineering, a profession that applies the principles of the science of 
physics/engineering directly to the devices and operation of the complex medical 
devices used in the diagnosis and treatment of the sick and injured.  
 
The main objectives of the group are: 
to undertake theoretical and applied research  in the broad area of biomedical 
engineering 
to develop and exploit engineered solutions of the research 
to provide a focus for multi-disciplinary based research in the School of Engineering 
to provide advanced research training in the areas of its activities 
to develop strong collaborative research links with Industry, Services and Academia 
to work closely with the national health sector (NHS) 
 
The core of the group’s research activities lies in the application of electronic, optical 
and physical techniques to solve practical problems in surgery, anaesthesia and 
intensive care. The main research directions are focused upon the understanding, 
development and applications of instrumentation and measurements to facilitate the 
prognosis, diagnosis and treatment of disease or the rehabilitation of patients. 
Mathematical modelling and computed fluid dynamic (CFD) studies of various 
physiological and anatomical functions are also used as a basis for new 
instrumentation development. Challenges from various clinical specialities are being 
addressed, leading to interdisciplinary applications of advanced and novel 
technologies. Current areas of research are: 
 
Non-invasive techniques for blood gas measurements 
Electro-optical and fibre-optic medical sensors 
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Computer implemented virtual medical instruments 
Physiological measurements 




The group has close collaborations with scientists and clinicians with world renowned 
clinical institutions and industries such as: 
 
St Bartholomew’s Hospital 
Great Ormond Street Hospital for Children 
The Royal London Hospital 
St Andrew’s Centre for Plastic Surgery & Burns 
The Royal Brompton Hospital 





One of the main research areas that make the group nationally and internationally 
known is the area of Photoplethysmography, where many studies have been 
conducted in different populations and in different anatomical areas utilising custom 
made peripheral or indwelling PPG sensors. These investigations have a main focus 
the understanding of the PPG signal both in the time and frequency domain. These 
investigations seek to also understand the underlying haemodynamics of the various 
areas/organs that are monitored with an aim to contribute to the further knowledge of 
perfusion.  These studies are conducted using PPG systems/sensors customised to 
the different anatomical areas that are investigated (i.e. oesophagus, splanchnic 
organs, finger, toe, brain, etc). During these PPG investigations commercial 
technologies (pulse oximeter, blood gas analysers, co-oximeters) are also used as 
comparative tools. 
Some of the studies that were undertaken in this area are summarised below: 
04/Q0508/119 - Paediatric Oesophageal Pilot Study  
06/Q0603/110 - Evaluation of a new optical method for measuring brain tissue 
oxygenation in intensive care patients being monitored via an intra-cranial bolt. 
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07/Q0603/41 - Evaluation of a fibre-optic technique for the measurement of arterial 
oxygen saturation in the oesophagus of anaesthetised patients undergoing routine 
surgery 
08/H0703/22 - Custom made PPG sensor for assessing PPGs and SpO2s from 
splanchnic organ during open laparotomy splanchnic Study 
08/H0703/48 - Evaluation of a fibre-optic technique for the measurement of arterial 
oxygen saturation in the oesophagus of anaesthetised patients (Amendment of 
07/Q0603/41 to include jejunal flaps) 
10/H0703/39 – Non-invasive optical method for monitoring free flap perfusion in plastic 
surgery 
11/LO/0048 - Investigation of a new non-invasive optical technique for measurement of 
local venous oxygen saturation 
 
2 Study Aims and Objectives 
The aim of this study is to investigate oesophageal and anterior fontanelle 
Photoplethysmographic (PPG) signals in two study groups (critically ill neonates and 
infants) accordingly.  For this purpose two custom made optical PPG sensors (one for 
the oesophagus (OES) and one for the anterior fontanelle (AF)) and an in-house 
designed processing system (see Appendix A) have been developed.  The hypothesis 
underlying this project is that a more central site, such as the OES or the AF might 
remain adequately perfused in cases of compromised peripheral perfusion, giving the 
possibility of monitoring blood oxygen saturation (SpO2) at the oesophagus or the AF 
when conventional peripheral (finger or toe) oximetry fails. The work program will be 
carried out through experimental and clinical measurements in vivo encompassing the 
following objectives: 
 
To investigate PPG signals from nonconventional (finger and toe) anatomical locations 
and identify if such signals are reliable for the estimation of blood oxygen saturation by 
comparing them with commercial pulse oximeters and results from “gold standard” 
techniques, such as blood gas analysis. 
To determine if the fontanelle PPG signals obtained from the neonate can be used as a 
more reliable reading (compared with the periphery, i.e. toe) for arterial blood oxygen 
saturation in cases of low perfusion. 
To determine if the oesophageal PPG signals obtained from the infant can be used as 
a more reliable reading (compared with the periphery, i.e. toe) for arterial blood oxygen 
saturation in cases of low perfusion. 
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Investigate if either site yields signals that may contain a venous component that could 
be used to calculate venous oxygen saturation. 
To determine whether fontanelle PPG signals can be used to detect other pathologies 
associated with neonates in intensive care, i.e. intracerebral bleeds, change in 
intracranial pressure, etc. 
 
3 Study Design 
3.1. Outline 
Studies will be performed using two custom, in-house made, non-invasive optical 
reflectance PPG sensors for each study group.  The infant study will utilise a custom, 
in-house made, reflectance PPG/pulse oximeter sensor for the monitoring of PPGs and 
oxygen saturation in the oesophagus.  The neonatal study will exploit a custom, in-
house made, reflectance sensor with geometry adapted to the AF for the non-invasive 
monitoring of brain PPGs.  For each group a second custom, in-house made, periphery 
toe PPG/SpO2 sensor, identical in geometry of a commercial sensor and electrically 
and optically identical to the oesophageal and fontanelle sensor will also be used.  This 
is to facilitate comparison of PPG signals from the periphery and the oesophagus or 
the fontanelle.   
3.2 Patient Selection and Location 
Following Ethical Committee approval and approved consent from the parent or 
guardian, 30 (maximum) neonates (Fontanelle study) and 30 (maximum) infants 
(Oesophageal study) on the intensive care unit at Great Ormond Street Hospital for 
Children, and who meet the inclusion criteria (section 4.1), will be recruited for this 
study.  
3.3 Study Procedure 
3.3.1  Oesophageal study 
 The oesophageal PPG probe will be inserted into a sealed 12 French gauge stomach 
tube (used routinely in clinical practice). The tube will then be inserted by the lead 
clinician through the mouth into the oesophagus under direct vision. The stomach tube 
will be advanced into the oesophagus until the end of the probe itself is at a depth of 3-
5 cm into the oesophagus Depth will be assessed outside the body prior to insertion 
and measured to sit in a mid-thoracic position.  
The toe sensor will also be placed by the lead clinician around the foot of the neonate. 
PPG traces and SpO2 values from the oesophagus and the toe (using the custom 
made toe PPG sensor), along with ECG traces, will be recorded simultaneously.  
During the trial values of blood oxygen saturation from a commercial toe pulse oximeter 
will also be recorded.  The Oesophageal and toe SpO2 values will also be compared 
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with any routine blood gas analysis measurements that will take place during this 
investigation.  
Oesophageal and toe PPG measurements will be recorded up to a period of 30 
minutes as a baseline.  After the initial period, oxygen concentration delivered will be 
increased by a factor of 50% above the baseline.  Continuous monitoring will continue 
for a period of up to 1 hour.  Delivered Oxygen concentration will be decreased back 
down to the baseline level and monitoring will continue for up to 30 minutes before 
termination of the trial.  The total maximum study time for each recruited subject will be 
2 hours unless otherwise stopped by the lead clinician (see section 4.4).  All signals will 
be further analysed offline using the statistical methods described in section 5. 
3.3.2  Fontanelle Study 
The fontanelle sensor will be placed by the lead clinician on the anterior fontanelle (soft 
spot) of the neonate’s scalp. The fontanelle sensor will adhere to the skin surface 
utilising a commercially available sterile reflectance oximeter adhesive patches/tape 
(Appendix A). 
The toe sensor will also be placed by the lead clinician around the foot of the neonate. 
PPG traces and SpO2 values from the fontanelle and the toe (using the custom made 
toe PPG sensor), along with ECG traces, will be recorded simultaneously. During the 
trial values of blood oxygen saturation from a commercial toe pulse oximeter will also 
be recorded. The fontanelle and toe SpO2 values will also be compared with any 
routine blood gas analysis measurements that will take place during this investigation.  
Fontanelle and toe PPG measurements will be recorded for a period of up to 30 
minutes as a baseline. After the initial period oxygen concentration delivered will be 
increased by a factor of 50% above the baseline.  Continuous monitoring will continue 
for a period of up to 1 hour. Delivered Oxygen concentration will be decreased back 
down to the baseline level and monitoring will continue for up to 30 minutes before 
termination of the trial.  The total maximum study time for each recruited subject will be 
2 hours unless otherwise stopped by the lead clinician (see section 4.4).  All signals will 
be further analysed offline using the statistical methods described in section 5. 
3.4  Study endpoints (applies to both studies) 
After 2 hours of monitoring or earlier if the lead clinician responsible for the subject 
requests that we stop the study, or if the parent or guardian who is present requests 
that we stop the study (see section 4.4) 
4 Subject Selection and Withdrawal  
4.1 Inclusion Criteria 
Parental/Guardian consent given 
Normal oesophageal anatomy 
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Normal fontanelle anatomy (Neonates) 
Over 3Kg 
Greater than 36 weeks gestational age (Neonates) 
Ventilated 
Sedated 
4.2 Exclusion Criteria 
No Parental/Guardian consent given 
Abnormal oesophageal anatomy/oesophageal procedures previously carried out 
Abnormal fontanelle anatomy/closed fontanelle (Neonates) 
Less than 3 Kg 
Less than 36 weeks gestational age (Neonates) 
Not ventilated 
Not sedated 
4.3 Subject Recruitment and Screening 
 Subjects will be assessed using the inclusion and exclusion criteria from 
available patient lists within the ICU.  The screening will be carried out by a researcher 
acting under arrangements with the responsible care organisation.  The researcher will 
have medical qualifications (e.g. medical research fellow). 
 Once a subject has been identified the parent/guardian will be approached at a 
time before the intended study.  If they agree they will be handed an information sheet, 
given adequate time to reflect and consider and then they will be asked to sign a form 
of consent for the patient if they agree. 
4.4 Withdrawal of Subjects 
If the lead clinician responsible for the subject requests that we stop the study 
If the parent or guardian who is present requests that we stop the study 
5 Statistical Plan 
5.1 Sample Size Determination 
 This pilot study is not intended to provide information for medical decisions 
affecting the direct care of the patients under examination, it is however intended that 
this study be used to inform further studies.  Following discussion with the clinical 
experts it is suggested that the number of patients proposed for this investigation will 
yield enough data to allow comparative analysis between the proposed monitoring 
sites, and provide meaningful information about the sites under investigation. 
5.2 Statistical Methods 
Tests for normality.  
Demographic statistics will be presented, mean, median, confidence intervals.  
Non-parametric test for significant difference. 
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5.3 Recording of Adverse Events 
Documented in full as per GCP guidelines 
5.4 Study Stopping Rules 
If the lead clinician responsible for the subject requests that we stop the study or if the 
parent or guardian who is present requests that we stop the study.  This will be 
documented with reasons explaining why. 
 
6 Data Handling and Record Keeping 
6.1 Confidentiality 
 The personal data and measurements recorded will be kept locked in the office 
of the Principal Investigator.  All study data will be anonymised and kept in electronic 
format in a password protected file on a personal computer.  The computer will be kept 
in a locked office. 
6.2 Study Documents 
Parental information sheet. 
Consent form. 
Case Report Forms. 
6.3 Records Retention 
 Following the publication of the study results, the database will be stored on a 
CD−ROM and filed in a locked filing cabinet.  The Research Group will act as 
custodians for this data. 
7 Study Monitoring, Auditing, and Inspecting 
7.1 Study Monitoring Plan 
The study will be conducted according to ICH/GCP standards. The chief investigator 
and members of the study research group will be responsible for monitoring the 
conduct of the study. 
8 Ethical Considerations 
8.1 Local Regulations  
The local Investigator will ensure that this study is conducted in accordance with the 
Principles of the “Declaration of Helsinki” (as amended in Tokyo (1975), Venice (1983), 
Hong Kong (1989), South Africa (1996) and Edinburgh (2000)). 
http://www.wma.net/e/policy/b3.htm or with the laws of the country in which the 
research is conducted, whichever accords greater protection to the individual. The 
study will fully adhere to the principles outlined in the Guidelines for Good Clinical 
Practice” ICH Tripartite Guideline (January 1997) 
8.2 Informed Consent  
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The investigators will obtain written informed consent from the parent/guardian of each 
patient prior to participation in the study, following adequate explanation of the aims, 
methods, anticipated benefits and potential hazards of the study. 
8.3 Independent Ethics Committee/Institutional Review Board  
This protocol and the accompanying material given to a potential patient (Patient 
Information Sheet, Consent form) as well as any advertising material will be submitted 
by the Investigator to an Independent Ethics Committee in the UK. Full approval by the 
Committee will be obtained prior to starting the study and will be fully documented by 
letter to the Chief Investigator naming the study site, local PI (who may also be the 
Chief Investigator) and date the Committee deemed the study as permissible at that 
site. 
9 Study Finances 
9.1 Funding Source 
The study will be financed by the Engineering and Physical Sciences Research Council 
(EPSRC). 
9.2 Indemnity for the performance of the study 
The Chief Investigator and PhD Researcher have indemnity from City University 
London for clinical trials. 
 The Lead Clinician has indemnity from the NHS trust for clinical trials 
9.3 Subject Payments 
None 
10 Publication Plan 
The results of the study will be presented in international and national conferences and 
published in peer-reviewed journals 
11   Attachments 
This section should contain all pertinent documents associated with the management 
of the study. The following is a list of attachments, those with an asterisk* must be 
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Appendix F 
Pre-Normalised AC and DC Amplitudes 
Patient 
# 
RED AC Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot AF Foot AF Foot AF 
1 93.1 118.2 91.1 131.7 86.8 152.2 
2 194.3 64.0 150.7 54.4 159.5 43.2 
4 136.5 86.4     
5 510.9 70.8 458.5 70.0 371.2 98.7 
6 896.1 50.3 432.4 70.5 485.0 123.9 
7 205.3 56.2 165.8 47.3 148.2 53.5 
8 63.5 127.1 49.4 134.5 71.4 116.5 
9 140.5 110.1 75.7 107.4 197.1 93.0 
10 421.4 148.6 372.9 124.2 256.7 133.4 
11 417.6 157.4 401.8 205.7 429.6 179.5 
12 66.2 60.9 69.4 53.6   
13 57.5 97.0 46.3 64.5 53.3 64.4 
14 553.9 130.5 775.9 86.7 1016.9 116.6 
15 864.2 56.3     
16 421.4 45.2     
Mean 336.2 91.9 206.0 76.7 218.4 78.3 
SD 279.1 37.7 229.4 57.4 273.1 60.3 
Measurements 
(n) 15 15 12 12 11 11 
Patient 
# 
IR AC Amplitudes (mV) 
Pre FiO2 increase 
During FiO2 
increase Post FiO2 increase 
Foot AF Foot AF Foot AF 
1 324.2 233.8 309.2 341.2 299.1 412.5 
2 348.0 350.8 332.8 260.6 307.1 261.2 
4 171.2 283.0     
5 1917.0 734.0 1790.7 643.6 1440.9 665.3 
6 1544.5 89.6 1493.7 104.5 1922.5 235.6 
7 308.1 130.5 224.1 105.8 202.3 88.7 
8 75.3 296.9 84.4 354.9 100.0 352.3 
9 160.5 370.5 158.0 189.8 197.4 238.3 
10 982.9 618.8 943.6 395.8 539.8 438.7 
11 592.3 562.5 690.8 641.7 648.2 495.0 
12 144.0 178.7 164.4 127.6   
13 152.5 281.1 146.4 216.6 141.9 215.2 
14 1559.5 218.2 1991.5 236.2 2277.2 358.1 
15 1285.8 162.0     
16 707.3 150.4     
Mean 684.9 310.7 555.3 241.2 538.4 250.7 
SD 618.3 190.0 680.5 206.5 737.5 206.0 
Measurements 
(n) 15 15 12 12 11 11 
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Patient 
# 
GREEN AC Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot Font Foot Font Foot Font 
1 29.8  28.5  27.9  
2 80.0  74.9  72.7  
4 59.7      
5 460.8 16.2 441.4 15.2 397.1 18.5 
6 897.5  729.6  734.7  
7 178.4 26.9 212.4 21.2 182.7 21.7 
8 64.3  70.6  79.3  
9 78.1  59.7  100.1  
10 624.4 19.4 521.0  318.4  
11 386.6  385.1  340.4  
12 159.8  186.1    
13 60.8 38.6 60.7 26.1 59.1 30.4 
14 669.7  848.0  901.0  
15 746.2      
16 84.4      
Mean 305.4 6.7 241.2 4.2 214.2 4.7 
SD 299.2 12.5 279.2 8.9 280.0 10.0 
Measurements 
(n) 15 4 12 3 11 3 
Patient 
# 
RED DC Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot AF Foot AF Foot AF 
1 758.6 1771.1 786.8 1771.9 783.2 1750.5 
2 3965.6 1896.6 4092.1 1891.2 3989.7 1903.2 
4 5303.1 2820.7     
5 3583.9 1956.3 3740.7 1950.1 3787.8 1901.7 
6 4351.4 1988.0 4795.5 1906.0 4953.3 1917.2 
7 6115.0 1448.5 6504.7 1400.1 6260.5 2068.6 
8 2924.6 3700.0 2991.5 3687.9 3009.7 3663.8 
9 2585.8 3686.0 2616.5 3553.8 2689.4 3560.4 
10 3066.8 4317.3 3115.9 4276.9 3061.7 4271.6 
11 4013.1 3983.1 4095.2 3948.1 4022.8 3978.9 
12 3848.3 2886.8 4019.5 2685.0   
13 3846.1 3932.1 3881.5 3938.9 3887.4 3912.9 
14 3745.7 3277.0 3947.4 3084.4 3923.2 3048.6 
15 3955.4 3209.5     
16 6387.0 4542.2     
Mean 3896.7 3027.7 2972.5 2273.0 2691.2 2131.8 
SD 1379.8 1011.1 1949.5 1487.2 2040.9 1578.2 
Measurements 
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Patient 
# 
IR DC Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot AF Foot AF Foot AF 
1 6501.4 2432.2 6511.1 2425.2 6538.6 2471.3 
2 3967.3 3509.7 4069.4 3495.0 4165.6 3499.9 
4 7101.8 6568.4     
5 7057.8 4812.6 7096.0 4737.7 7072.8 4525.4 
6 6144.9 4233.3 8299.3 4117.8 8664.4 4077.2 
7 7022.1 3715.0 7623.0 3647.0 7910.9 3913.5 
8 3206.7 7093.4 3320.8 7087.3 3363.6 7119.7 
9 2706.2 6268.8 2659.5 5997.7 2745.5 6017.7 
10 3129.4 6772.3 2928.0 6802.0 2872.2 6791.6 
11 4331.4 6067.5 4306.0 5933.1 4294.2 5986.1 
12 5962.7 3261.7 5921.5 3163.7   
13 4312.9 5548.4 4374.9 5643.9 4446.4 5512.2 
14 7862.9 4941.4 7749.0 4742.0 7468.3 4653.2 
15 6708.3 4335.8     
16 5566.6 8767.5     
Mean 5438.8 5221.9 4323.9 3852.8 3969.5 3637.9 
SD 1684.9 1712.2 2870.1 2392.8 3076.6 2579.6 
Measurements 
(n) 15 15 12 12 11 11 
Patient 
# 
GREEN DC Amplitudes (mV) 
Pre FiO2 increase During FiO2 increase Post FiO2 increase 
Foot Font Foot Font Foot Font 
1 80.5  82.5  83.8  
2 1479.5  1490.6  1491.1  
4 1192.8      
5 820.8 155.6 799.4 155.1 799.4 149.3 
6 1345.1  1280.9 0.0 1266.4  
7 1389.9 428.1 1469.4 413.9 1445.7 563.7 
8 1505.8  1472.3  1470.6  
9 1094.0  1111.6  1118.2  
10 1260.4 155.1 1325.1  1333.2  
11 1030.1  1021.6  1011.8  
12 1018.4  1016.7    
13 1532.9 395.2 1541.8 415.5 1536.6 405.7 
14 1118.2  1052.6  1018.6  
15 1200.0  0.0    
16 1680.0  0.0    
Mean 1183.2 75.6 911.0 65.6 838.4 74.6 
SD 382.3 146.9 594.1 147.2 634.3 173.5 
Measurements 
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Appendix G 
Fontanelle Study Patient Statistics. 
Patient # Age (Days) Weight (Kg) Gender ASA 
1 5 2.8 m 2 
2 115 3.3 m 3 
3 7 3 f 1 
4 4 3.2 f 3 
5 7 3.2 m 1 
6 30 1.14 f 2 
7 3 2.8 m 2 
8 36 3 m 3 
9 88 2.3 m 2 
10 56 3.7 f 1 
11 161 4.95 f 1 
12 3 3.99 m 2 
13 6 3.1 m 2 
14 24 3.9 m 1 
15 4 3.45 f 2 
16 35 1.39 f 2 
Mean 36.5 3.07   
SD 46.8 0.93   
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